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ABSTRACT 
PRETREATMENT CLIENT CHARACTERISTICS AND TREATMENT RETENTION 
IN AN INTENSIVE OUTPATIENT SUBSTANCE ABUSE TREATMENT PROGRAM 
 
 
Shauna Fuller, MSW 
 
Marquette University, 2010 
 
 
The effectiveness and efficacy of substance abuse treatment is well established. 
At the same time, clients often prematurely drop out of substance abuse treatment, 
negatively impacting their chances of achieving favorable outcomes. Investigating 
variables associated with treatment retention has become increasingly important 
considering one of the most robust findings in substance abuse treatment outcome 
research is the positive relationship between the amount of time spent in treatment and 
post-treatment outcomes (e.g., decreased drug/alcohol use, decreased criminal activity, 
improved social functioning). This study examined the relationship between pre-
treatment client characteristics and treatment drop-out among 273 adults who were 
admitted to intensive outpatient substance abuse treatment. An intake assessment battery 
was administered to all participants in an effort to gain a broad understanding of client 
attributes at the point of treatment entry. A series of regression analyses were used to 
investigate if client characteristics could help predict treatment completion status, time to 
drop-out, and number of treatment sessions attended. Results indicate that age and 
meeting criteria for an anxiety disorder were statistically significant predictors in all three 
regression analyses. Meeting criteria for a cocaine disorder was found to be a statistically 
significant predictor of treatment completion status and time to drop-out. Finally, number 
of years using alcohol regularly was found to be a statistically significant predictor of the 
number of treatment sessions attended. The clinical implications of these findings are 
discussed and recommendations to help improve client retention in the substance abuse 
treatment program utilized for this study are provided.  
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Chapter I: Introduction 
Substance Use Disorders 
Clinical Definition of Substance Use Disorders 
Substance use disorders encompass a wide spectrum of symptoms and 
characteristics and include the taking of either drugs (both prescribed and illicit) and/or 
alcohol. These disorders are often characterized by a strong desire to continue using 
drugs and/or alcohol despite experiencing repeated negative consequences (American 
Psychiatric Association, 2000). Substance use disorders are generally distinguished as 
being substance dependence or substance abuse. For the purpose of this study, the term 
substance use disorder will be used to describe either category of substance abuse or 
substance dependence.  
According to the Diagnostic and Statistical Manual of Mental Disorders (2000), 
the hallmark of substance dependence is when an individual experiences “a cluster of 
cognitive, behavioral, and physiological symptoms indicating that the individual 
continues use of the substance despite significant substance-related problems” (p. 192). 
Although it is not specifically included as a criterion of a dependence diagnosis, these 
individuals are likely to experience cravings of the substance(s) used. A diagnosis of 
dependence is contingent upon the individual demonstrating a maladaptive pattern of 
substance use, leading to clinically significant impairment or distress, manifested by three 
(or more) of the following, occurring at any time in the same 12-month period: tolerance; 
withdrawal; taking of the substance in larger amounts or over a longer period than 
intended; a consistent desire or unsuccessful efforts to cut down; spending a lot of time 
attempting to obtain and use the substance as well as time to recover from the effects of 
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use; social, occupational, or recreational activities are reduced or stopped altogether 
because of the use; use of the substance is continued despite experiencing recurrent 
physical or psychological problems related to the use (pp. 192-193). A diagnosis of 
substance dependence trumps a diagnosis of substance abuse. 
Substance abuse, on the other hand, includes the cardinal feature of “a 
maladaptive pattern of substance use manifested by recurrent and significant adverse 
consequences related to the repeated use of substances” (p. 198). This diagnosis requires 
that the individual demonstrates this maladaptive pattern, which results in impairment or 
distress as demonstrated by at least one of the following within a 12-month period: 
repeated use of a substance resulting in inability to fulfill responsibilities at home, work, 
or school; repeated use in situations where it is physically dangerous; repeated legal 
problems associated with the use; continued to use despite having experienced consistent 
social or interpersonal difficulties resulting from or exacerbated by the use. 
Prevalence of Substance Use Disorders 
 Substance use disorders are both common and problematic. The National 
Longitudinal Alcohol Epidemiologic Survey (1991-1992) reported on national estimates 
of drug and alcohol abuse and dependence (National Institute on Alcohol Abuse and 
Alcoholism, 1992). Their survey found that approximately 7.4% of adults in the U.S. 
were either dependent on alcohol (4.4%) or abused it (3%). This 7.4% comprised more 
than half of the heavy drinkers identified. One and a half percent of adults in the U.S. 
were identified as being either dependent (.5%) or abusing (1%) drugs (National Institute 
on Alcohol Abuse and Alcoholism, 1992). These rates have remained fairly consistent 
since the early 90s. For example, results from the 2005 national survey on drug use 
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indicated that 9.1% of the population (22.2 million people) met criteria for either 
substance abuse or dependence, 7.7% were classified as abusing or dependent on alcohol, 
and 1.7% were classified as dependent upon or abusing illicit drugs (Substance Abuse 
and Mental Health Services Administration, 2006). As these numbers illustrate, substance 
use disorders continue to be a significant problem that millions of individuals face each 
year. In 2005, the number of people in need of treatment for a substance use problem was 
approximately 23.2 million. Unfortunately, roughly 20.9 million of those who needed 
treatment did not receive it (Substance Abuse and Mental Health Services 
Administration, 2005). This is noteworthy considering there are a myriad of problems, on 
a variety of levels, which result from substance abuse disorders. 
Substance Abuse Impact on Society and Individuals 
Substance use disorders are a great public concern. The economic costs of alcohol 
and drug use are wide reaching and include but are not limited to: increased health care 
costs, premature death, lost earnings, increased costs to employers, vehicle crashes, and 
crime (National Institute on Drug Abuse, 1992). According to the Marin Institute (2006), 
25-40% of hospital patients are treated for health problems that are a direct result of their 
alcohol use. Furthermore, health care costs associated with alcohol related problems have 
been estimated at 22.5 billion. It should come as no surprise then that individuals who are 
considered to be heavy drinkers consistently incur greater health care costs than moderate 
drinkers and/or abstainers (Marin Institute, 2006).  
As reported, substance users experience a variety of negative consequences. 
Physical problems often associated with alcohol and drug use include liver disease, 
ulcers, cognitive impairments, cancers, reproductive problems, sexually transmitted 
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diseases, and cardiovascular problems. The National Survey on Drug Use and Health 
(2007) reported that individuals with a sexually transmitted disease were more likely to 
demonstrate recent use of alcohol and an illicit drug than those individuals without a 
sexually transmitted disease.  Alcohol is also commonly implicated in traffic-related 
accidents and deaths and is thought to be a factor in 40% of traffic related deaths 
(National Institutes of Health, 2006). Psychological ramifications are also evident. 
Clients reporting for substance use treatment often present with co-occurring psychiatric 
problems. Substance use treatment populations have documented rates of comorbid 
psychiatric symptoms around 63-69% (Castel, Rush, Urbanoski & Toneattto, 2006; 
Charney, Palacios-Boix, Negrete, Dobkin & Gill, 2005). Data from 2004-2005 
demonstrated that approximately 2.7 million adults (about 1.2 % of the population) were 
dually diagnosed with both an alcohol and depressive disorder (Substance Abuse and 
Mental Health Services Administration, 2007). Psychological symptoms often include 
depression and anxiety, suicidal thoughts, insomnia, and intense cravings for substances 
(Kessler et al., 1996). Moreover, when calculating general patterns of co-occurring 
psychiatric and addictive disorders, “all the mental disorders are consistently more 
strongly related to dependence than to abuse” (Kessler et al., 1996, p. 19).  
In addition to co-occurring psychiatric problems, clients who enter treatment for 
substance abuse often also experience problems in other areas of their life. Increased 
problem severity in medical, employment, family and legal arenas has been shown to 
negatively impact a client’s ability to reduce their substance use for a prolonged period 
(Hser, Evans, Huang & Anglin, 2004). These consequences, coupled with the often high 
rates of substance use recidivism (Fletcher, Tims & Brown, 1997), point to the 
5 
 
importance of and need for substance use treatment. Unfortunately, there are a number of 
issues that often complicate the seeking of treatment. Various barriers to treatment have 
been identified and include but are not limited to: individuals being unable to afford 
substance use treatment (including not having insurance to cover the costs), and limited 
child care options while attending treatment (Green, 2006). There is also the stigma 
associated with one admitting that he or she struggles with substance use, which has the 
potential to interrupt the process of seeking treatment. 
Benefits of Substance Abuse Treatment 
Even though barriers exist that prevent individuals from seeking substance abuse 
treatment, when individuals do attend treatment there are significant positive effects. 
More specifically, as Simpson (1993) reported,  
Drug use, crime, and other social functioning measures generally improve during 
and following treatment in the three major modalities used: methadone 
maintenance, therapeutic communities, and outpatient drug-free programs. Clients 
in these treatment settings have better outcomes than drug users who undergo 
detoxification only and thosewho enter treatment but fail to continue (p. 122).  
 
Individuals with an alcohol dependence diagnosis have also been found to achieve 
significant reductions in the percentage of days they drink and the amount consumed 
when drinking after participating in substance abuse treatment (Anton, Miller, O'Malley, 
Zweben, & Hosking, 2006). Over three decades of investigations both within and outside 
of the United States have demonstrated that substance abuse treatment significantly 
decreases substance use and helps improve overall social functioning (Gerstein & 
Harwood, 1990, as cited in Simpson and Joe, 2004; Gossop et al., 1997; Gossop, 
Marsden, Stewart & Kidd, 2003; Hubbard, Craddock, Flynn, Anderson, & Etheridge, 
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1997; Hubbard et al., 1989; Longabaugh, Donovan, Karno, McCrady, Morgenstern & 
Tonigan, 2005; Pearson & Lipton, 1999).  
Substance Abuse Treatment Dropout 
Although the efficacy and effectiveness of substance abuse treatment is well 
established, in order for treatment to produce favorable outcomes a client must be 
retained in it. This can be a challenge due to high rates of dropouts typically associated 
with substance abuse treatment. For example, Weisner, Mertens, Tam, and Moore (2001) 
note that approximately 29-42% of clients who are admitted for treatment do not 
subsequently return to receive it. Other research has demonstrated similar results in that 
about a third of clients have been found not to return for treatment following the initial 
intake assessment (Jackson, Booth, McGuire & Salmon, 2006; King & Canada, 2004; 
Weisner et al., 2001). Once clients are engaged in treatment, attrition rates have been 
reported to be around 65% (and up to 75%) and those clients who leave treatment tend to 
do so early on in the process (i.e., before completing even half of the treatment regimen) 
(Justus, Burling, & Weingardt, 2006; Sayre et al., 2002; Siqueland et al., 2002; Veach, 
Remley, Kippers, & Sorg, 2000). Outpatient treatment has been known to demonstrate 
some of the worst dropout rates, often exceeding 70% (Stark, 1992; Wickizer, Maynard, 
Atherly, & Frederick, 1994). Client retention has been identified as the most important 
variable positively associated with treatment outcomes (Ball, Carroll, Canning-Ball, & 
Rounsaville, 2006) and as such, has been considered a critical intermediate outcome 
measure in research (Chou, Hser, & Anglin, 1998).  
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Rationale for Studying Treatment Retention 
Investigating variables associated with treatment retention has become 
increasingly important considering one of the most robust findings in substance abuse 
treatment outcome research is the positive relationship between the amount of time spent 
in treatment and post-treatment outcomes (e.g., decreased drug/alcohol use, decreased 
criminal activity, improved social functioning) (Chou et al., 1998; Etheridge, Hubbard, 
Anderson, Craddock, & Flynn, 1997; Hser, Evans, Huang, and Anglin, 2004; Roffman, 
Klepsch, Wertz, Simpson, & Stephens, 1993; Simpson & Joe, 2004; Simpson, Joe, and 
Rowan-Szal, 1997; Simpson & Sells, 1982). More specifically, according to Simpson and 
Joe (2004), better treatment outcomes have been found to be predicted by minimum 
retention thresholds associated with different treatment modalities (i.e., 90 days for 
residential and outpatient treatment, and 12 months for methadone treatment). 
Unfortunately, “because of their high initial attrition rates, very few substance-abusing 
clients receive the potential benefit from treatment, and once having dropped out, most 
suffer relapse and its attendant ills” (Stark, 1992, p. 97).  
It is not just client treatment outcomes that are impacted by client retention in 
substance abuse treatment programs. Poor client retention has obvious negative 
implications for agencies providing services as well (Simpson et al., 1997).  Poor 
retention is problematic because early dropouts cost a significant amount of money, and 
require increased time from staff, due to the heavy front-end requirements including 
assessments and subsequent treatment planning by nurses, doctors, and therapists. 
Therefore, “agencies with high overall client dropout rates operate at a comparatively low 
organizational efficiency and effectiveness levels” (Simpson et al.,1997, p. 280).   
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Importance of Program-Level Research 
It has been noted that efficacy and effectiveness research have typically remained 
fairly distinct modes of inquires; they have been considered as existing at opposite ends 
of internal-external validity continuum and each approach has limitations associated with 
it (Rounsaville, Carroll, & Onken, 2001). Although treatment effect is more clearly 
determined in efficacy studies, the ability to generalize the treatment approach into real-
world settings is often a significant challenge. Additionally, it can be a challenge for 
individual programs to determine if and how efficacy research results pertain to their 
individual programs. Rounsaville et al. (2001) have argued that some of the criticism 
associated with RCTs is unfounded since RCTs are not intended to be an end point of 
research. Rather, the authors define RCTs as “an essential hurdle a treatment must clear 
to justify subsequent research on its transportability, robustness, and mechanisms of 
actions” (p. 135). Seen this way, investigating factors associated with effectiveness 
studies are not dismissed but encouraged once a treatment is first deemed efficacious.  
Indeed, one model that illustrates the path by which investigations should follow 
from large-scale to local-level investigations has been illustrated by Onken, Blaine and 
Battjes (1997), who proposed a Stage Model of Behavioral Therapies research in an 
effort to “maximize the breadth and depth of information obtained about a particular 
therapy” ( p. 479). This stage model creates a system whereby a therapeutic approach is 
first scientifically established prior to being widely disseminated to the clinical 
community for implementation. In this way, a stage model has been likened to the 
approach typically employed by pharmaceuticals for medication development (Onken et 
al., 1997). This approach consists of three stages to guide behavioral therapy research 
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(Stage I, Stage II, and Stage III), “that leads from initial clinical innovation through 
efficacy research to effectiveness research” (Rounsaville et al., 2001). Stage I involves 
the development of the therapy itself. This development includes reviewing research 
findings on treatment approaches, creating new approaches, manualizing treatments, 
adjusting treatment approaches based on patient and clinician feedback, and conducting 
preliminary testing of the treatments (Onken et al., 1997). If the pilot testing indicates 
that a treatment approach is capable of producing clinically meaningful change then 
research can progress to the subsequent phase, Stage II. 
Stage II research involves efficacy studies (RCTs) to investigate therapeutic 
approaches and the therapeutic elements identified in Stage I that appear to be the 
mechanisms of action for change. Those therapies deemed efficacious are replicated at 
different sites. Additionally, “as a rule, in Stage II research, comparison interventions 
should be operationally defined, standardized, and manualized” (p. 482). It is 
recommended that control/comparison groups are carefully considered and selected by 
researches so as to most appropriately answer the research question. It is not until Stage 
III that the degree to which a specific therapy is transferable and useful in the clinical 
realm at the community level is evaluated (Onken et al., 1997). Only those therapies that 
have been found to be efficacious in at least two RCTs are evaluated further (Rounsaville 
et al., 2001). For example, a Stage III study might investigate the feasibility with which a 
therapy that has been well established through efficacy studies is able to be packaged and 
delivered in a community setting. The investigation might also include the development 
of training materials to deliver the therapy and even refine the approach if necessary. By 
following this stage model it is argued that therapeutic approaches can follow a predictive 
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path from conceptualization to validation. Rounsaville et al. (2001) also stress that a 
strength of this model is the recognition that the study of therapeutic approaches does not 
begin and end with RCTs. In fact, the authors argue that Stage III research efforts are 
“crucial for the process of bridging the much-noted gap between research findings and 
clinical practice” (p. 134).  
Although this specific study did not investigate the effectiveness of a specific 
treatment approach, it was conducted in the spirit of stage III research by evaluating a 
treatment phenomenon at the local level. For example, the existing corpus of literature 
suggests that retention is a critical factor related to treatment outcomes. As such, results 
from previous studies considered to be Stage I and II research were utilized to inform this 
investigation. For example, since age has been implicated as impacting client retention, 
client age will be considered a potential covariate for this analysis. Consistent with the 
philosophy of Stage III research, the results of this study are intended to be used to 
inform the specific treatment program of potential factors related to their retention rates, 
and less so about generalizability beyond this specific treatment program. By assessing 
treatment phenomena locally, the results are immediately and directly applicable to the 
treatment program involved.  
Statement of the Problem 
Despite there being a large body of literature focusing on varied correlates and 
predictors of treatment retention, these studies have produced conflicting findings, hence, 
it remains difficult to draw broad conclusions about any consistent predictors of treatment 
retention. This lack of consensus stems from a number of factors. First, investigations 
previously conducted at the local level that have identified client factors related to 
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retention may have limited generalizability. More specifically, different programs 
incorporate different treatment approaches, offer differing services, and employ providers 
at varied skill levels. The variability in treatment approaches, client representations, and 
services offered at different treatment programs is one of the only consistent between-
program characteristics (Simpson et al., 1997). Even treatment programs that embody 
similar theoretical orientations and approaches still operate uniquely as a result of distinct 
management approaches, financial resources, environmental settings, the legal systems 
they are connected to, and the needs of their clients (Simpson et al., 1997). Perhaps not 
surprising then, when similar treatments are delivered and differences in client 
characteristics are controlled for, retention rates have still been found to differ between 
programs (Broome, Simpson, & Joe, 1999; Joe, Simpson, & Broome, 1998). Therefore, 
although a number of potential correlates and predictors of retention have been 
suggested, “there is little agreement on the generalizability of the findings” (Sayre et al., 
2002, p. 56). Limited generalizability can make it difficult for treatment programs to 
deduce if and how research findings pertain to their respective programs.  
Although a wide variety of factors have been implicated as potentially impacting 
retention, these have not been investigated comprehensively and more accurately 
identifying the factors remains an ongoing research challenge (Simpson, 2004). “In 
addition to replicating previous findings concerning treatment retention, more work is 
needed to address these effects in terms of treatment compliance and related process 
indicators for different therapeutic settings and types of clients” (Simpson et al., 1997, p. 
294). Recommendations from researchers of large-scale multi-site drug treatment 
evaluations have also echoed the need for smaller scale investigations to be conducted in  
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treatment settings (Etheridge et al., 1997; Fletcher et al., 1997). Important variations in 
treatment philosophies and clientele across modalities need to be considered and 
investigated. Such investigations have been especially recommended to take place in 
outpatient treatment programs due to the vast variability typically seen in both the range 
of substance users that are treated, as well as the orientations that guide the treatment 
approaches utilized at such settings (Simpson et al., 1997).  
Purpose of the Study 
The primary purpose of this study was to examine if pretreatment client 
characteristics are predictive of retention in an intensive outpatient substance abuse 
treatment program. Clinically, this study has relevance as retention is clearly linked to 
client attributes that are amenable to change through the therapeutic process (e.g., 
motivation and psychiatric distress) (Klag, O'Callaghan, & Creed, 2004). Research 
results can be used to inform treatment staff of the specific client characteristics that are 
related to retention, thereby allowing for a process where at-risk clients can be screened 
up front and treatment approaches can target the client factors in need of change 
(McKellar, Harris, & Moos, 2006). Moreover, it would also be useful to be aware of how 
those client characteristics that are considered “static” (e.g., gender, age) relate to 
completion rates. Even though static characteristics cannot be changed by the therapeutic 
process, the treatment process itself could be altered in an effort to provide more tailored 
treatment to at-risk groups (i.e., delivering culturally sensitive services to remove barriers 
to treatment). 
Additionally, the importance of evidenced-based treatment in the area of 
substance abuse treatment has gained momentum in recent years (Tucker & Rother, 
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2006). This movement, coupled with the challenge individual treatment programs face in 
determining if and how research results pertain to their specific program, provided an 
ideal opportunity for this study to bridge the gap between science and practice. In doing 
so, not only can the results contribute to and be compared with the larger body of 
retention literature, but they can also provide practical information for the treatment 
program to inform their practice and additional research efforts. Key stakeholders from 
the treatment center involved in this study, and managed care systems, are increasingly 
making demands for treatment programs to prove treatment and cost effectiveness. This 
increased pressure provided an ideal opportunity to further narrow the science and 
practice gap that exists in the field of substance abuse (Tucker & Roth, 2006). In turn, 
this might help the treatment center improve their retention rates and outcomes, while at 
the same time help to demonstrate that smaller research studies on the local level can be 
useful in informing treatment approaches and future research efforts. An additional 
advantage to conducting research on-site is that client populations, in terms of their 
patterns and severity of use, are constantly in flux which calls for consistent evaluation of 
treatment outcomes to help identify important factors of treatment dropouts from specific 
programs (Mammo & Weinbaum, 1993). 
From an empirical perspective, the findings of this study contribute to the current 
scientific literature base on treatment retention. More specifically, the results should help 
to clarify some of the inconsistencies found in the literature related to the correlates and 
predictors of retention. Additionally, the study results provide evidence regarding how 
comparable the obtained findings at this treatment center are with the current body of 
literature.  
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Research Questions 
Based upon the stated problem and need for this study, the following research questions 
were addressed: 
1) What client characteristics, at the point of treatment intake, are found to predict 
treatment completion status among those attending an intensive outpatient 
chemical dependency treatment program at a nonprofit, freestanding mental 
health hospital? 
2) Can time to dropout of treatment be predicted by client characteristics at the point 
of treatment intake? 
3) What pre-treatment client characteristics are found to predict the number of 
treatment sessions attended by clients?  
Definition of Terms 
Addiction – “Any psychological or physiological overdependence of an organism on a  
 drug” (Reber & Reber, 2001, p. 11). This term will be used interchangeably with  
 the DSM-IV diagnostic category of substance dependence. 
Substance Abuse Treatment – A “specific procedure designed to cure or to lessen the  
 severity of” a substance use disorder (Reber & Reber, 2001, p. 765). 
Substance Use Disorder – Problematic use of a drug of abuse (including but not limited  
 to: alcohol, cocaine, marijuana, heroin) that can lead to difficulties in social  
 functioning and medical illness (American Psychiatric Association, 2000). 
Treatment Completion – For this study, a treatment completer will be defined as one who  
 was found to have met all, or a sufficient amount, of the treatment goals to  
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warrant what was considered to be successful completion as determined by 
his/her counselor. Specifically how this determination was made is described in 
detail in Chapter III.    
Treatment Non-Completer – “A client who terminates treatment before it is completed”  
(VandenBos, 2007, p. 302). For this study, a client who was not found to meet 
treatment goals, or who left the program prematurely, either on his/her own 
volition or due to mandatory dismissal for non-compliance with treatment rules, 
will be considered treatment non-completers. This term will be used 
interchangeably with treatment drop- outs. 
Retention – For the purposes of this study, a client will be considered retained in  
 treatment if s/he remains in treatment through completion. 
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Chapter II: Literature Review 
Introduction 
An extended literature review in the area of substance abuse treatment retention 
was already conducted by this author and evaluated by the chair and committee members 
of this project. Therefore, per the instruction of the chair of this study, the extended 
literature review will not be repeated in its entirety here. Instead, a more concise and 
succinct review can be found in this chapter, focusing primarily on the literature that 
specifically relates to this study. As this study’s focus is on the predictive relationship of 
pretreatment client characteristics with treatment retention, only previous treatment 
retention research investigating such relationships will be included herein. However, the 
previously submitted extended literature review, excluding sections in this chapter to 
reduce redundancy, can be found in Appendix A for reference. 
Treatment Retention – Review of the Literature 
To date, a substantial amount of retention research has been concerned with the 
relationship between client demographic variables and treatment retention (Brocato & 
Wagner, 2008). This area of study was rooted in the assumption that when clients left 
substance abuse treatment prematurely it was a result of their own personal traits versus 
programmatic or treatment factors. (Chou, Hser, & Anglin, 1998; Fiorentine, Nakashima, 
& Anglin 1999). As such, a large portion of previously conducted research ignored the 
dynamic interplay between program and client factors and instead, focused only on client 
characteristics that were thought to impact retention like demographic variables. 
Additionally, when program and client factors were investigated, they were often studied 
in isolation of one another (Roffman, Klepsch, Wertz, & Simpson, 1993). Although the 
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field now recognizes that retention is a complex phenomenon (Simpson, 2001), much of 
this previous body of retention literature has still helped point to how various client 
factors may be related to or impact retention. Although client characteristics are certainly 
not the only factor related to retention, they have been found to play an important role. 
By identifying client characteristics that could put one at a greater risk of premature 
dropout, programs could develop more appropriate interventions in an attempt to retain 
such clients. As such, a review of the retention literature will be discussed as it relates to 
client characteristics since that was the focus of the present study. 
Client’s Level of Motivation 
Client motivation is thought to be an important factor related to the recovery of 
substance abusers. “Treatment motivation” is a complex theoretical construct that has 
been oversimplified and undifferentiated from “treatment readiness” in substance abuse 
research (Simpson, 2004). Nonetheless, motivation is generally distinguished as internal 
or external. Internal motivation has been conceptualized as including problem 
recognition, desire for treatment, and a commitment to take behavioral steps towards 
change (Joe, Broome, Rowan-Szal, & Simpson, 2002). External motivation generally 
involves coercion into treatment as prompted by the criminal justice system.  
Client motivation has consistently been found to be positively related to treatment 
retention (Brocato, 2004; Broome et al., 1999; Simpson & Joe, 2004; Simpson et al., 
1997). A client’s level of motivation at treatment onset has also been found to be 
positively associated with therapeutic participation and therapeutic alliance (Brocato, 
2004; Brocato & Wagner, 2008; Joe et al., 1999), which also appears to be related to 
increased retention and engagement (Brocato & Wagner, 2008; Simpson, Joe, Rowan-
18 
 
Szal, & Greener, 1997). Clients are often externally motivated or pressured to seek 
treatment for substance abuse problems. For example, a spouse may threaten to leave if 
treatment is not pursued, or an impending job loss due to substance use may prompt 
treatment seeking. External motivation may prompt initial attendance in treatment 
(DiClemente, Bellino & Neavins, 1999; Weisner et al., 2001), however it often will not 
result in an individual committing to treatment, or assist the client in actively engaging in 
the treatment process (Battjes, Onken, & Delany, 1999). Men engaged in outpatient 
treatment who were pressured to do so from family members were found to remain in 
treatment for shorter periods of time than those who were not engaged in treatment due to 
a family induced ultimatum (Mertens & Weisner, 2000).  
Indeed, even reports from clients who prematurely left outpatient treatment cited 
lack of motivation or hope for change as the most consistent reason for their inability to 
have remained in treatment (Ball et al., 2006). Interestingly, these findings do not appear 
to be consistent when a treatment episode is legally coerced based on a “driving while 
intoxicated” infraction or other illegal activity. In these cases, when clients are engaging 
in treatment to satisfy a court order or are involved in the criminal justice system in some 
other way, they are more likely to complete treatment (Hser et al., 2004; Maglione, Chao, 
& Anglin, 2000b; Mammo & Weinbaum, 1993). It could be hypothesized, however, that 
treatment effects may not hold if an individual is motivated to complete treatment to 
satisfy a court order rather than an internal desire to alter the substance use. Indeed, it has 
also been found that client relapse rates can increase significantly once monitoring 
probation programs end (Brecht, Anglin, Whang, 1993) and clients legally coerced to 
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attend treatment have been found to demonstrate worse outcomes (Perron & Bright, 
2008) 
 Taken together, research suggests that motivation appears to be a critical factor of 
treatment retention, hence the utilization of techniques that can enhance a clients’ 
motivation for substance treatment have emerged. Motivational Interviewing and 
Motivational Enhancement Therapy are two examples of such an approach. Supporting 
the research that stresses the importance of motivation on retention, investigations have 
found that when motivational enhancement techniques are utilized in a treatment setting, 
they have been found to increase early retention rates (Carroll et al., 2006), retention rates 
as far as six months after treatment engagement (Secades-Villa, Fernande-Hermida & 
Arnaez-Montaraz, 2004), and the probability of clients initiating and returning for 
treatment (Carroll, Libby, Sheehan, & Hyland, 2001).  
Client Personality Characteristics/Disorders  
The personality characteristic of persistence has also been found to be related to 
treatment retention. Clients who present with high degrees of persistence have been 
found to remain in inpatient alcohol treatment for a longer period of time than those 
clients who scored lower on persistence measures (Cannon, Keefe, & Clark, 1997). 
Additionally, clients who enter treatment with increased levels of hostility and are high 
risk takers have been found to be more likely to drop out of treatment prematurely 
(Broome, Flynn, & Simpson, 1999; Lang & Belenko, 2000). Although these studies 
suggest that personality factors could play a role in treatment retention more research is 
this area is called for. Client personality factors or even personality disorders have the 
potential to significantly impact how a person responds to adversity and challenging 
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situations (like changing substance abuse patterns), but presently, there is very little 
known in this area.  
Personality disorders (i.e., Axis II), which tend to be less amenable to change than 
clinical syndromes (i.e., Axis I), have also been found to be associated with treatment 
retention. For example, clients who were dually diagnosed with a substance abuse and 
personality disorder, were found to drop out of residential and outpatient treatment more 
often than clients without such a diagnosis (Justus et al., 2006; Mueller & Wyman, 1997). 
Siqueland et al. (2002) replicated these findings that a diagnosis of ASPD was a predictor 
of earlier treatment dropout. These results are not surprising in that individuals diagnosed 
with ASPD display characteristics including a failure to conform to social norms 
(including a disregard for lawful behavior), impulsivity, and a reckless disregard of safety 
for self. Each of these symptoms could theoretically put an individual at a greater risk for 
using and abusing alcohol or drugs and refusing to adhere to a treatment regimen. 
Client Cognitive Deficits  
Cognitive impairments are common among substance abusers and can result from 
moderate to heavy drug and alcohol use over time. Although deficits associated with 
cognitive processing have been reported, the clinical implications of clients exhibiting 
such deficits have received less attention (Aharonovich, et al., 2006). Cognitive 
impairments that are typically associated with substance toxicity also have been directly 
linked to retention. Aharonovich et al. (2006) investigated the retention rates of cocaine 
users and found that those clients who demonstrated poorer cognitive functioning were 
more likely to drop out of treatment than those clients who were retained. The authors 
measured overall cognitive functioning across domains including memory, attention, and 
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spatial ability and those who dropped out differed significantly on each domain compared 
to completers. The effect sizes associated with these differences were medium to large, 
ranging from 0.64 for memory to 0.87 for “global cognitive functioning”. The strongest 
relationship between cognitive functioning and retention appear to be related to client’s 
ability to attend, suggesting that those individuals who are not as able to focus and 
maintain attention are more likely to prematurely drop out of treatment. These findings 
were supported through unpublished dissertation research which suggested that clients 
who demonstrated neurocognitive impairments remained in treatment for a shorter period 
of time than clients who were cognitively intact (McKenzie, 2007). Considering that 
treatment episodes for individual sessions typically last for 45-50 minutes, and group 
sessions for an even longer period, these results suggest that clients with cognitive 
impairments may not be able to attend for extended periods during treatment episodes. 
The authors hypothesize that the inability to attend may negatively impact a client’s 
ability to process and encode information that is needed for successful treatment 
outcome, like learning to develop alternative coping strategies.  
Client Psychiatric Comorbidity 
Clients reporting for substance abuse treatment often present with co-occurring 
psychiatric problems. Substance abuse treatment populations have documented rates of 
comorbid psychiatric symptoms around 63-69% (Castel et al., 2006; Charney et al., 
2005). This phenomenon of substance abuse and comorbid psychiatric symptomology 
has also been documented with high prevalence rates in non-clinical populations, and 
increases the probability of seeking and receiving various types of treatment (e.g., 
specialty addictive, specialty mental health, general medical, self-help group) (Kessler et 
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al., 1996). The data suggest that not only is there a risk of clients entering substance use 
treatment with a co-occurring mental illness, but that when they do, they are more likely 
to exhibit a more severe substance use disorder. If the future reflects previous trends, then 
the number of clients entering treatment with co-occurring disorders is likely to increase 
considering that from 1995 to 2001 the proportion of clients entering substance abuse 
treatment with a dual diagnosis grew from 12 to 16 percent (Substance Abuse and Mental 
Health Services Administration, 2004). 
Clients who are diagnosed with more substance use disorders tend to experience 
more psychiatric symptoms as well (Castel et al., 2006). Treatment retention and 
outcomes have been shown to suffer when substance abuse treatment clients also 
experience psychiatric distress. Substance abuse treatment clients who experience 
symptoms of depression or anxiety have been found to demonstrate worse treatment 
outcomes (Charney et al., 2005). Not to mention, “many people with comorbid 
psychiatric illness are not receiving specialized substance abuse treatment” (Petrakis, 
Gonzalez, Rosenhack, & Krystal, 2002). It may not be surprising then, that clients 
experiencing depressive symptomology when entering substance treatment have been 
found to dropout of treatment early on (Curran, Kirchner, Worky, Rookey & Booth, 
2002). Furthermore, clients who have histories of psychiatric problems in their lifetime 
(not just at the time of treatment engagement) are less likely to be retained in outpatient 
methadone and residential alcohol or drug treatment (Broome et al., 1999; Justus et al., 
2006; Lang & Belenko, 2000). Contrary to these findings, Ross, Culter, and Sklar (1997) 
found very weak associations between client psychiatric distress and treatment retention, 
although this investigation did not include clients who presented for substance abuse 
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treatment coupled with “severe levels” of psychiatric distress, which could have impacted 
these results. Other investigations have not supported the finding that co-occurring 
depressive symptomology negatively impacts retention. Instead, research has 
demonstrated that clients with co-occurring depressive symptomology have been more 
likely to remain in treatment for longer periods and complete treatment more often than 
clients without depressive symptoms (Broome et al., 1999; Justus et al., 2006). One 
possible explanation for these results could be that for some clients experiencing co-
occurring depressive symptoms could actually motivate them to remain in treatment to 
alleviate symptoms, provided the depression is not severe enough to negatively impact 
their ability to do so. Seen this way, it might not be the mere presence of depressive 
symptoms itself that impacts retention, but instead the severity of such symptoms. 
Indeed, the severity of the psychiatric symptoms has been identified as a factor 
related to treatment retention. Clients who report high levels of psychiatric distress have 
been found to be less likely to complete treatment (Roffman et al., 1993). This may be 
especially true among women for females who were identified as entering treatment with 
high levels of depressive and anxiety, were more likely to drop out of treatment than 
women with less severe psychiatric disturbance (Haller, Miles & Dawson, 2002; Mertens 
& Weisner, 2000). Drug use patterns also appear to suffer when clients exhibit 
psychiatric distress. For example, one investigation found that clients who were identified 
as experiencing more severe psychiatric distress while in treatment were more likely to 
continue to use drugs after dropping out of treatment (Siqueland et al., 2002).  
A client’s ability to tolerate psychological distress also appears to be related to 
early treatment dropout. More specifically, clients who have a higher tolerance for 
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psychiatric distress have been found to persist in residential treatment for over 30 days; 
clients with lower levels of tolerance for psychiatric distress were found to drop out of 
treatment more often during the same first 30 days of treatment (Daughters et al., 2005). 
These findings support the hypotheses posited in the previous paragraph while also 
pointing to the importance of identifying co-occurring psychological problems early on in 
treatment. This way, ancillary psychological services or more specialized substance abuse 
treatment could be offered and efforts to reduce dropout could then be tailored to such 
individuals. Additionally, it appears prudent for clinicians to work with clients on 
developing healthier coping techniques which can be utilized to better tolerate 
psychological distress that often accompanies attempts to abstain from alcohol or drug 
use. The literature supports this notion; when clients are offered more comprehensive 
treatment services (which include psychiatric services) they are more likely to remain in 
treatment through completion (Marrero et al., 2005). Additionally, pharmacological 
treatment of psychiatric distress and substance abuse disorders appears to have some 
clinical utility. For example, a recent meta-analytic review of the literature by Nunes and 
Levin (2004) found that anti-depressant medication has a “modest beneficial effect for 
patients with combined depressive-and substance-use disorders” (0.38 effect size, 95% 
confidence interval, 0.18-0.58). The review found that when anti-depressants are 
successful in treating depressive symptoms substance use decreases, but pharmacological 
approaches are not suggested as a stand-alone treatment. When clients present with co-
occurring disorders pharmacological treatment should be combined with 
psychotherapeutic treatment as well (Nunes & Levin, 2004). And although the review 
was restricted to depressive disorders, it still provides evidence suggesting that 
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supplementing substance abuse treatment with psychiatric treatment when indicated can 
provide beneficial results. Further, if clients feel as though their treatment is specialized 
enough to treat both their psychiatric and substance abuse symptoms they may be more 
likely to remain in treatment. 
Drug of Abuse and Severity of Substance Abuse by Client  
Not surprisingly, clients who enter treatment with longer standing and more 
severe substance use problems (i.e., daily use) have been found to remain in treatment for 
shorter periods of time regardless of the treatment setting or substance of choice 
(Alterman, McKay, Mulvaney & McLellan, 1996; Lang & Belenko, 2000; Maglione et 
al., 2000b; Marrero et al., 2005; Mertens & Weisner, 2000; Westreich, Heitnre, Cooper, 
Galanter & Gued, 1997), and are more likely to return for subsequent treatment episodes 
(Booth, Yates, Petty, & Brown, 1991). These results conflict with other research, 
however, which failed to find that a higher degree of alcohol dependence or increased 
level of alcohol related problems was directly related to dropout of treatment (Kavanagh, 
Sitharthan, & Sayer, 1996). Nonetheless, in a review of the literature, Stark (1992) 
indicates that a great deal of evidence suggests that clients who use more drugs 
demonstrate higher drop-out rates. Easton, Mandel, Babuscio, Rounsaville, and Carroll 
(2007) found that men who entered treatment abusing drugs and alcohol, versus alcohol 
only, were more likely to drop out of treatment prematurely and less likely to remain 
abstinent from alcohol while in treatment. 
Furthermore, while in treatment, if clients are more successful in abstaining from 
using substances, their chances of remaining in treatment appear to improve. For 
example, Mammo and Weinbaum (1993) found that clients who decreased their alcohol 
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use while in treatment  (but did not abstain from use) were 1.26 times more likely to 
prematurely leave treatment and those clients who did not decrease their use at all were 
over seven times more likely not to complete treatment compared to those who abstained. 
Additionally, an unpublished dissertation study found that initial positive urine 
toxicology screens, regardless of the type of drug indicated, predicted early attrition from 
an intensive outpatient program (Sapadin, 2006). When clients enrolled in treatment for 
cocaine dependence demonstrated an initial positive urine toxology result, or reported 
using cocaine more frequently either in the 30 days prior to admission or upon entering 
treatment, they were less likely to complete treatment (Alterman et al., 1996; White, 
Winn, & Young, 1998). The fact that clients who use more substances while in treatment 
are more likely to drop out is likely due to the impairments associated with substance use 
that can interfere with a client’s ability to successfully engage and remain in treatment 
(Stark, 1992). For example, a client’s judgment is likely impaired when using substances 
which will likely impact their decision to return to treatment. They may no longer deem it 
necessary. Additionally, many programs will not allow clients to return for treatment if 
they begin using while engaged in the program. If clients are aware of such rules they 
may simply make a decision to leave treatment before being asked by treatment staff to 
leave. 
Drug of abuse has also been found to impact treatment retention, treatment 
outcomes, and relapse rates. The type of substance abused has been found to be the 
strongest predictor of dropout when compared with demographic factors, treatment 
history, psychiatric status, employment and legal problems and family history 
(Paraherakis, Charney, Palacios-boix, & Gill, 2000). When comparing alcohol, cocaine, 
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opiate and sedative addictive disorders with one another, those addicted to opiates have 
been found to demonstrate worse retention rates than the other groups. Those clients 
addicted to opiates were found to use the drug more often, demonstrate lower levels of 
abstinence and attend treatment sessions less often than clients in the other groups 
(Paraherakis et al., 2000). Interestingly, clients addicted to opiates were also found to be 
younger than clients in the alcohol or sedative addicted groups. Perhaps a constellation of 
factors (i.e., age, intensity of use, daily patterns of use) contributed to the significant 
difference in this group’s retention rates. 
Type of substance abused has been found to be related to retention and outcomes 
in other studies as well. The large-scale national Treatment Outcome Prospective Study 
(TOPS) found that clients who were cocaine dependent were especially likely to relapse 
after being discharged demonstrating an overall relapse rate of 57% one month post-
discharge (Fletcher et al., 1997). Cocaine abuse has been linked to early retention 
problems. For example, one sample included in a substance abuse investigation found 
that treatment clients who were dependent on cocaine demonstrated a 69% premature 
dropout rate (Siqueland et al., 2002). Clients entering treatment due to cocaine abuse 
have been found to drop out of treatment prematurely more often than those with an 
alcohol-only or cannabis addiction (Sapadin, 2006; Veach et al., 2000). Treatment 
outcomes associated with cocaine abusers also appear to suffer. When clients enter 
treatment with cocaine as their drug of choice this has been found to be predictive of 
more negative treatment outcomes (King & Canada, 2004). And, those clients who use 
crack, a subset of cocaine users, have been found to be retained in treatment for a shorter 
period than non-crack users (Rowan-Szal, Joe, & Simpson, 2000).  
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These findings suggest that both type and intensity of substance use (both prior to 
and while in treatment) can significantly impact retention. Clients’ use of substances 
obviously influences how well they are able to engage in and benefit from treatment. This 
is not only due to the impairments associated with substance use, but also the negative 
consequences of using while in treatment. At the very least clients stand to frustrate 
treatment providers when using while in treatment, which can impact the manner with 
which staff interact with them. Worse however, is the fact that many clients are dismissed 
from treatment prematurely by staff if they are found to be using substances during 
treatment, negating treatment effects since they are unable to receive it. Regarding type 
of substance abused, decreased retention rates associated with cocaine or crack use may 
be related to the type of treatment typically delivered. Many outpatient programs 
incorporate treatment that is based upon models developed for alcohol dependent 
individuals (Veach et al., 2000). Clients entering treatment with a cocaine or crack only 
dependence diagnosis may not fare as well in programs with such an approach that 
focuses so intensely on alcohol abuse and does not consider factors that may be distinct 
for those with a positive dependence for cocaine. Such clients may be more appropriately 
suited for different types of treatment interventions, supporting the notion that the fit 
between client and program is a critical factor (Wickizer, et al., 1994). Indeed, research 
has indicated that clients engaged in intensive inpatient alcohol treatment, whose primary 
substance of abuse was not alcohol, were more likely to drop out of treatment than those 
clients with alcohol as their primary drug of choice (Wickizer, et al., 1994). On the other 
hand, clients who use drugs more often prior to entering treatment may also find it 
difficult to follow any type of treatment program as it is counter to “the antisocial 
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lifestyle frequently adopted by substance abusers” (White et al., 1998, p. 56). Regardless, 
these types of issues should be considered by treatment providers when determining 
appropriate level of care as well as developing treatment plans and interventions for 
clients. 
Age   
The relationship between client age and retention has been identified as one of the 
most consistently significant findings in the literature. More specifically, older clients are 
found to be retained in treatment for longer periods and prematurely dropout of treatment 
less frequently than younger clients, regardless of the treatment modality (Chou et al., 
1998; Green, Polen, Dickinson, Lynch, & Bennett, 2002; Kavanagh et al., 1996; Mammo 
& Weinbaum, 1993; Mitchell-Hampton, 2006; Roffman et al., 1993; Rowan-Szal et al., 
2000; Satre, Mertens, Arean, & Weisner, 2004; Stark, 1992). This phenomenon has been 
especially true among male clients with older males remaining in treatment for longer 
periods as well as demonstrating more favorable treatment outcomes than their younger 
counterparts (Hser et al., 2004; McCaul, Svikis & Moore, 2001; Mertens & Weisner, 
2000). One investigation indicated that in regards to age, “for each one-year increase in 
age, there was a 2.8% increase in the likelihood of completing treatment” (Siqueland at 
al., 2002, p. 29). The consistency of age being a significant predictor of treatment 
retention may be due to younger persons using more substances, using a more wide 
variety of substances, being less likely to have children who rely on them, or possessing a 
behavioral impulsivity that is often associated with teens and younger adults (Satre et al., 
2004; Stark, 1992). These results do suggest that older adults can be retained in treatment 
and fare well while engaged. Although older individuals tend to represent a small 
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percentage of substance abuse treatment samples (Satre et al., 2004), their presence in the 
therapeutic milieu could potentially assist younger clients by modeling longer stays in 
treatment. 
Gender  
Gender has also been implicated as being related to treatment retention. Past 
research often focused solely on male substance abuse populations, although this 
tendency has changed (Jarvis, 1992). Historically, women have been excluded from 
research samples since they often represented such a small percentage of the overall 
sample, which prevented researchers from being able to conduct separate analyses 
adequately (Booth, Blow, Cook, Bunn, & Fortney, 1997). Nonetheless, it has been 
documented that women generally face more barriers to seeking and engaging in 
treatment than men (Green, 2006) and report experiencing different types of problems 
outside of their drug or alcohol use when entering treatment.  
The literature on treatment retention and how gender relates to it has been mixed. 
For example, in a large multi-site and multi-modality treatment sample (Joe et al., 1999), 
among methamphetamine users (Maglione, Chao, & Anglin, 2000a; 2000b), and 
uninsured African Americans (Mitchell-Hampton, 2006), women have been found to 
remain in outpatient treatment for a longer period than men, though this finding was not 
confirmed in methadone maintenance programs or inpatient treatment. Other studies 
including outpatient samples demonstrated opposite findings suggesting that men not 
only attended more counseling sessions but also remained in treatment for a longer period 
than women (Hser et al., 2004; Arfken, Klein, di Menza, & Schuster, 2001; King & 
Canada, 2004; Mammo & Weinbaum, 1993; McCaul et al., 2001).  
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Research conducted in the 70s to early 90s suggested that females were less likely 
to initiate, engage in, and remain in substance abuse treatment compared to males (Green, 
2006; Stark, 1992). This may be an artifact of the concept that treatment approaches have 
been geared towards men more than women. Male-focused treatment may have resulted 
from, historically, men being diagnosed with substance use disorders more often than 
women (Keyes, Grant, & Hasin, 2008); hence men have comprised a larger proportion of 
the treatment population. More recently however, research has found that gender 
differences associated with the prevalence of substance abusers are shrinking. For 
example, there is increasing evidence that the gender gap previously linked with alcohol 
use between men and women is closing. Although men have typically been found to 
drink more alcohol and are diagnosed with alcohol disorders more often than women, 
these gender differences are decreasing. Since the 1970s women have been using alcohol 
more often, in larger quantities, and suffering from alcohol related disorders in increasing 
numbers (Keyes et al., 2008). This may be a consequence of the changes in traditional 
roles typically associated with women since the 1970s as evidenced by more women 
working outside of the home and having children later in life or not at all. Furthermore, 
recent studies suggest that women are just as likely as males to engage in, remain in, and 
complete treatment (Green, 2006; Green et al., 2002; Hser, Evans, & Huang, 2005; 
Jarvis, 1992). These findings may be reflective of the more recent trend to provide 
thoughtful, gender-sensitive treatment addressing specific treatment needs associated 
with the different genders (Green et al., 2002). For example, treatment programs may 
offer child-care services or make other attempts to remove the barriers that could 
potentially impede women from remaining in substance abuse treatment.  
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The inconsistent results regarding gender differences has prompted the hypothesis 
that more specific factors associated with certain subgroups of men and women may be 
related to treatment retention. This deduction has resulted in the claim that “sex-specific 
risk factors are an understudied area” (Mertens & Weisner, 2000, p. 1526). For example, 
younger female veterans who were diagnosed with depressive disorder (Justus et al., 
2006), and women engaged in a program that accepted private and public funding (Chou 
et al., 1998) have been documented as remaining in treatment for a longer period than 
men. At the same time, women were more likely to drop out of treatment than men when 
they indicated higher problem severity in the employment arena (Green et al., 2002) or 
with regards to psychiatric distress (Mertens & Weisner, 2000; Siqueland et al., 2002). 
This latter finding is noteworthy considering that a larger proportion of women are 
admitted into treatment with a co-occurring psychological disorder (44%), compared to 
males (30%) (Substance Abuse Mental Health Services Administration, 2004). Men have 
also been found to be less likely than women to complete treatment when they report 
experiencing greater psychiatric distress (Green et al., 2002) and have drug dependence 
diagnoses (Mertens & Weisner, 2000). On the other hand, men have been found to be 
more likely to remain in outpatient treatment than women when they also identified a 
strong need for employment counseling (McCaul et al., 2001), were better educated 
(Mammo & Weinbaum, 1993) and were over the age of 40 (Mertens & Weisner, 2000).  
These results suggest that although there do not appear to be significant 
differences between males and females in terms of their initiating, engaging in, and 
completing substance abuse treatment, the correlates and predicators associated with 
treatment retention and outcomes between the genders are likely distinct. Therefore, men 
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and women may respond to different types of treatment interventions. For example, 
women may respond more favorably to approaches that help to eliminate barriers and 
provide more comprehensive support both within and outside of the treatment realm, 
whereas men may benefit from treatment identifying employment related problems and 
include interventions that focus specifically on improving such functioning. Research has 
supported this notion. When the same treatment was delivered to single gender groups, 
treatment retention and completion was not significantly higher than the retention and 
completion rates of the mixed-gender treatment groups (Bride, 2001).  
Ethnicity  
Ethnicity has been linked to length of stay in and premature dropout of substance 
use treatment across treatment modalities. For example, when developing a predictive 
model for retention among cocaine users, Siqueland et al. (2002) found that younger, 
African American clients who were unemployed remained in treatment for a shorter 
period of time. Furthermore, in an outpatient HMO treatment sample, African American 
women were found to be at an increased risk of prematurely dropping out of treatment 
compared to the Whites and Latinos in the sample (Mertens & Weisner, 2000). Other 
studies have found similar results demonstrating that African American clients were more 
likely than Whites to dropout of substance abuse treatment before it was completed (King 
& Canada, 2004; Mammo & Weinbaum, 1993). This is especially noteworthy because 
although African Americans are “overrepresented in treatment centers relative to their 
population size, an indication of the prevalence of the problem in this race group, few 
remain to complete the (treatment) program” (Mammo & Weinbaum, 1993, p. 94).  
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Milligan, Nich and Carroll (2004) investigated results from two previous studies 
examining treatment differences between African American and White clients. Their 
results demonstrated that poorer retention among African Americans was the most salient 
difference between the two groups. The less favorable retention rates of African 
Americans remained even after pretreatment characteristics and expectations regarding 
treatment were controlled for. A review of earlier research unveiled more conflicting 
results with studies finding higher, lower, and no difference in rates of dropout for 
African American clients compared to that of Whites and other ethnic minorities (Stark, 
1992). White et al. (1998) found that outpatient Hispanic clients were over two and half 
times more likely to demonstrate premature attrition than Whites or African Americans. 
Ethnic minorities have also been found to spend fewer days in methadone maintenance 
and inpatient treatment modalities to treat heroin addiction (Verdurmen, Smit, Toet, Van 
Driel, & Van Ameijden, 2004). 
Reasons for the demonstrated associations between ethnicity and retention have 
not been adequately explained. Although the links between ethnicity and treatment 
retention have underscored the need to address this issue, the factors that appear to deter 
minorities from remaining in treatment remain elusive. The question remains whether 
such differences are due to the programs’ inabilities to appropriately address the distinct 
needs of different ethnic groups, including offering more culturally competent services, 
or if other treatment factors are involved. It has been hypothesized that treatment 
practices are often designed to suit the needs of the majority population (Verdurmen et 
al., 2004). For example, some research has suggested that a client’s ethnicity may impact 
how well a client “fits” with the norms or cultures associated with different treatment 
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models and settings since African Americans have been found to fare better in intensive 
inpatient versus intensive outpatient, where the opposite has been found to be true for 
White clients (Wickizer, et al., 1994). The reasons for these differences in “fit” have not 
been identified. Moreover, minority populations do not have the same access to quality 
treatment and tend to experience more serious consequences of substance use than 
Whites. For example, African Americans and Hispanics are more likely to develop new 
problems of dependence over their life and more likely to die from alcohol cirrhosis than 
Whites (Schmidt, Greenfield, & Mulis, 2006). These disparities between ethnic 
minorities and Whites may be illustrated by the fact that alcohol consumption and 
problems have decreased since the 1980s for Whites, but these rates have remained fairly 
stable among African Americans and Hispanics (Schmidt et al., 2006).  
Summary of Retention Literature/Conclusions 
The cited body of retention literature presents conflicting findings and wide 
variability regarding the correlates and predictors of retention. Some of these 
inconsistencies could be due to a number of methodological limitations. For example, the 
challenge inherent in comparing findings between studies may have to do with the variety 
of methods and instruments employed to measure client characteristics (Rounsaville, 
1993, as cited in Broome et al., 1999). For example, psychiatric factors were measured in 
different ways and by different people, including the use of self-report measures like the 
Symptom Check List, (Roffman et al., 1993), and the Addiction Severity Index (Lang & 
Belenko, 2000), or clinician driven determinations through the Structured Clinical 
Interview for the DSM (SCID) (Daughters et al., 2005; Justus et al., 2006). Related, it can 
be difficult to measure predictor variables suspected of being related to retention when 
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there are a number of ways to conceptualize and define the variables. Motivation is a 
good example of this. As was indicated above, motivation is a complex theoretical 
construct that has been defined and measured in various ways (Klag et al., 2004; 
Simpson, 2001). Although it has been recommended that standardized assessments be 
used across studies to address this variability, it is likely that the large number of 
substance abuse investigations, spanning many years, has prevented this standardization 
from taking place (Rounsaville, 1993, as cited in Broome et al., 1999). 
Another common methodological problem associated with retention 
investigations includes the manner with which the variable “retention” is measured and 
defined. Some investigations looked at treatment completion status as indicative of 
retention (e.g., Green et al., 2002; Sinqueland et al., 2002), while others included specific 
lengths of stay as representative of retention (Broome et al., 2002; Hser et. al., 2003). The 
duration of time utilized to define retention through these specific lengths of stay has also 
been inconsistent. These definitions have been found to vary significantly from study to 
study, and the only consistency is the inconsistency with which variables like completion, 
drop-out, and retention are defined (Wickizer et al., 1994). This inconsistency interferes 
with one’s ability to interpret, apply and aggregate research results across studies while 
also making it challenging for treatment programs to extrapolate meaningful conclusions 
as they relate to their program. The lack of consistency in how retention is being defined 
begs the questions of whether retention studies are investigating the same phenomenon 
and if some of the lack of reliability associated with the results is related to the variability 
in definitions of retention (Wickizer et al., 1994).  
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In summary, it is perhaps not surprising that much of the retention literature is 
conflicting. If different programs attract different types of clients, and the programs 
themselves offer different types of treatments and services, retention trends and 
predictive characteristics are likely to vary (Joe et al., 1999). Indeed, client factors that 
have been found to be predictive of retention in one study are not consistently implicated 
in others, and single variables that are repeatedly predictive of retention have not been 
unequivocally identified (Kayman, Goldstein, Deren, & Rosenblum, 2006). 
Compounding these issues is the variability of the treatment approaches employed at 
various centers and the types of clients they attract. Even when similar treatments are 
delivered and differences in client characteristics are controlled for, retention rates have 
been found to differ between programs (Broome et al., 1999; Joe et al., 1998). Although a 
wide variety of factors have been implicated as potentially impacting retention, these 
have not been investigated comprehensively and more accurately identifying the factors 
remains an ongoing research challenge (Simpson, 2004).  
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Chapter III: Method 
Overview 
The purpose of this chapter is to illustrate the method that was utilized to 
investigate client predictors of retention in an intensive outpatient substance abuse 
program. A description of the participants, the data collection procedure, the assessments 
utilized, and the approach utilized for the data analysis is included. The data collection 
process was completed in November of 2006. This research project was carried out as a 
collaborative effort between a Midwest intensive outpatient substance abuse program and 
a professor and graduate students from Marquette University’s Counseling Psychology 
Department. The primary purpose of the collaboration was an effort to standardize the 
intake assessment procedure at the treatment center creating a method whereby the 
assessment information could be utilized both for treatment planning and research 
purposes. Based upon the treatment process research conducted by Simpson (2004) and 
colleagues at Texas Christian University (TCU), it is recommended that thorough 
information be collected on clients at intake and the data should focus on “patient 
attributes” including motivation for change and indicators of problem severity. Both level 
of motivation for change and problem severity have been found to predict retention in 
treatment and hence a client’s level of these indicators should be assessed at the point of 
treatment onset (Miller & Rollnick, 2002; Simpson, 2004).  
For the purpose of this investigation, the intake information was collected for dual 
purposes. First, the information was summarized and compiled into an intake report 
which was utilized to inform clinical staff of the clients’ pertinent treatment issues and 
treatment plan recommendations. Secondly, for those clients who agreed to participate, 
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the intake information was also to be utilized for research purposes in an effort to assist 
the program in gaining a better understanding of the types of clients that are engaging in 
treatment and the predictive elements associated with their treatment retention rates. 
Participants 
Participants were individuals who entered into the intensive outpatient substance 
abuse program from the period of January 2005 – November of 2006. The treatment 
program was offered through a private, non-profit, psychiatric hospital in the Milwaukee 
metropolitan area. Although it was attempted to conduct the intake assessment procedure 
with every client that entered the program during the indicated duration, this was not 
possible for a number of reasons. It will be detailed later in this chapter what prevented 
every client from being tested, but it should be noted therefore that the sample utilized for 
this study was a convenience sample and consisted of a total of 273 participants. Only 
clients enrolled in the intensive outpatient program were included in the sample. All 
participants were of adult age (at least 18 years) and deemed competent to give consent to 
participate. Each participate was read the informed consent form, and consent was 
obtained prior to the assessment procedure taking place. 
Treatment Program 
The intensive outpatient substance abuse program is an abstinence based, 12-step 
focused treatment approach. This approach is similar to the Minnesota Model of 
treatment, although it does remain distinct from how the Minnesota Model was originally 
designed. For example, the origins of the Minnesota Model include inpatient treatment 
for a 28-day period focusing on an abstinence prescribed and family involvement 
treatment approach. The Minnesota Model began in the 1950s, and more recently, it has 
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been adjusted so as to be utilized in outpatient settings as well (Anderson, McGovern, & 
DuPont, 1999). The treatment program utilized for this study employs some of the basic 
tenets of the Minnesota Model including being abstinence based and 12-step focused. 
Yet, it should also be noted that it does differ from the origins of the Minnesota Model as 
it is not a 28-day inpatient program that intimately involves family members. The 
treatment program utilized for this study also includes educational components about 
addiction as well as opportunities for emotional processing. Homework assignments are 
an integrated part of the treatment process. Upon entry into the program, and at various 
points through treatment, drug screens and breathalyzers are administered to monitor 
sobriety. Clients are expected to participate in the screens and refusal to do so results in 
an automatic assumption that the screen is positive and can thus result in immediate 
discharge from the program. The treatment approach employs a group format; the 
morning group sessions are three hours and run daily seven days a week; the evening 
group sessions are also three hours and run on Monday, Tuesday, and Thursday late 
afternoons. In addition to the groups, clients meet weekly with an assigned individual 
therapist. Both the group therapy component and completion of the homework 
assignments are required for treatment completion. Upon entry into the program each 
client meets with a physician for a physical examination. The physician has been working 
for this treatment program for over ten years and is also a licensed addictionologist. The 
entire treatment team consists of the physician, two primary counselors, and a nurse. Both 
counselors hold MSW degrees and are licensed clinical social workers. They also each 
hold an advanced license in order to provide specialized clinical services in the area of 
addition (CADC-III). Both counselors have been working clinically in the field of 
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addiction for over 20 years and at this specific treatment center for at least five years. 
Decisions about treatment regimens are made individually by the physician and 
counselors as well as collaboratively during a weekly staffing.  
Intake Assessment Procedure 
Assessor Recruitment, Training, and Supervision 
Two Ph.D. students (this author and a colleague) from the Department of 
Educational and Counseling Psychology were supervised by a faculty member, Todd C. 
Campbell, Ph.D., a licensed psychologist, in implementing the standard assessment 
procedure. Both Ph.D. students were considered the research project coordinators. To this 
end, the two Ph.D. students recruited, trained, and supervised Master’s student volunteers 
to assist with the assessment administration. A total of approximately 16 students 
comprised the assessment team at any given point in time during the two-year data 
collection period. All members of the assessment team had received prior training in 
basic counseling skills, ethics, and clinical psychopathology. Additionally, the Ph.D. 
students conducted two formal trainings for all volunteers that covered the background, 
administration, and scoring of the assessments utilized. Each training period lasted 
approximately four hours and included lecture components as well as didactic practice 
sessions. The first training focused primarily on the background and purpose of the study, 
the policies and procedures that were developed to inform the assessment procedure, and 
ethical issues pertinent to the research including the informed consent procedure, suicide 
risk protocol, supervision, and confidentiality. The second training included formal 
instruction on the background, administration, and scoring of the assessment instruments 
utilized. Once students completed the formal training sessions they were required to be 
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observed by at least one of the Ph.D. students during at least one mock administration 
session with a fellow student. During, and following the administration, feedback was 
given to the volunteers. In an effort to ensure proper and standardized administration, the 
mock observations were required before the assessment volunteers were permitted to be 
observed with clients enrolled in the treatment program. Additionally, before the program 
coordinators or volunteers were allowed patient contact at RMH, all were required to 
complete a human resources orientation through RMH. The orientation included CPR 
certification, self-defense training, and general information about the policies and 
procedures of the hospital. Finally, the entire assessment team completed an on-line 
tutorial through the Institutional Review Board on conducting human subjects research. 
 Once the volunteers completed all the necessary training they were permitted to 
administer an assessment battery with a treatment client under live supervision by one of 
the Ph.D. students. Following administration the volunteers were also required to score 
and interpret the results and compile the results into a feedback form for treatment 
planning purposes for the clinical staff. At least two administrations of the battery, while 
under live supervision, were mandatory. Once both were completed the volunteer’s 
comfort level with and proficiency of administration was discussed. When the volunteer, 
project coordinator, and University supervisor were in agreement that a volunteer was 
adequately prepared for solo administration they were assigned to a time slot that 
corresponded with the group times to conduct assessments. The project coordinators had 
regular contact with the clinical staff in an effort to provide quality assurance checks 
related to the volunteers performance. Additionally, individual and group supervision was 
provided by the project coordinators and University supervisor on an as-needed basis. 
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Intake Battery Administration 
 The intake assessment battery was utilized in an effort to gain a broad 
understanding of client attributes at the point of treatment entry. This was done in 
accordance with the TCU model for treatment evaluations which indicates that important 
client attributes should be considered to comprehensively evaluate for proper level of 
care placement and other treatment planning efforts (Simpson, 2004). Patient attributes 
that were included in the assessment procedure included but were not limited to: DSM 
diagnosis, level of motivation, consequences of substance use, and problem severity. 
Because these attributes are amenable to change through the therapeutic process and the 
assessment results were to be used for treatment planning purposes, it was the goal of the 
project to test new clients within the 48 hour period following treatment entry. 
Furthermore, it was anticipated that clients would be capable of answering assessment 
questions around the time of intake since they would have completed any necessary 
detoxification prior to their admission into the outpatient program. 
 The assessment team was notified when new clients entered treatment by the 
clinical staff. The assessment team maintained an ongoing log of clients which indicated 
if and when they had been assessed. The log was kept in a lock drawer in the assessment 
office. When a new client was added to the list an assessor would report to the group 
room during the morning or afternoon session and the therapist on staff would locate the 
new client. It was explained to all clients that the intake assessment procedure was a 
mandatory component of their treatment regimen and that the results would be utilized 
for clinical planning purposes as well as shared with the individual clients during a 
feedback session if requested. If the next client on the testing log was not available for 
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testing the subsequent client on the list was located. In the event that there was more than 
one client that needed to be tested the client with the oldest treatment entry date was 
given priority. If time permitted more than one client would be tested during a group 
period. 
It was a collaborative decision between the researchers and clinical staff to 
administer the assessments during group time. There was a dual purpose for this 
approach. First, the assessment procedure was being viewed as part of the client’s clinical 
treatment (just like any intake session) and hence treatment time could then be used for 
this purpose. Secondly, it allowed for an ease of scheduling both for the clients and the 
assessors, and did not require the client to devote additional personal time to complete the 
assessment protocol. Despite making a vigilant effort to test all clients within the 48 hour 
period of treatment entry, this was not always feasible for a variety of reasons. Early on 
in the data collection process, the clinical staff would periodically forget to notify the 
treatment staff of new clients. Also, when a large influx of clients entered treatment at the 
same time it was not always possible to complete testing on all the clients within the two 
days since there was only one four hour block available and one office available to 
conduct the assessments each day. When the master’s level volunteers graduated there 
was often a period of time during the summer months before the next group of volunteers 
could be trained, when the assessment team was smaller and unable to adequately cover 
every group time slot. Finally, client attendance also impacted the timeliness with which 
they could get assessed. Clients would often miss group or prematurely drop out of 
treatment. Similar obstacles have been noted in the literature as commonly taking place 
when research is conducted in naturalistic settings (Joe et al., 1999; Simpson et al., 1997). 
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Although the intake assessment was a required component of the clients’ 
treatment regimen, participation in the study was optional. All clients were asked if they 
would be willing to participate in an intake assessment research project and the study was 
described to them. Only a small number of clients declined to participate in the study 
(n=3). Reasons given for refusal to participate included one client’s frustration with the 
intake testing process in general, and two other clients who expressed discomfort with 
sharing personal information that was then to be utilized for research purposes. For those 
clients who agreed to participate, the informed consent was read verbatim to them, they 
were given an opportunity to ask any questions pertaining to the study, and a copy of the 
informed consent was provided to each participant for future reference (Appendix B). 
After the informed consent procedure was completed the assessor would begin 
administering the intake battery.  
The length of time required to complete the battery would range from 
approximately 90 to 150 minutes. The battery was always administered in the same order 
and the assessor would read all the questions aloud to the clients and record their 
answers. The Addiction Severity Index (ASI; McLellan et al., 1992) was administered 
through the computer-assisted version. The program would then automatically generate a 
report incorporating the client’s responses. The report was passed on to clinical staff for 
treatment planning purposes. The data collected through the ASI was exported directly 
into an SPSS file through an export program. The Mini-International Neuropsychiatric 
Interview (M.I.N.I; Sheehan et al., 1998) was initially administered through a paper-
pencil format. When a computer assisted program was released it was purchased 
(February, 2006) and utilized to collect the remaining data. Because an export program 
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was not available to export the data into SPSS, the paper-pencil responses and 
computerized data was all manually entered into an SPSS database by the program 
coordinators. The remaining assessments, Form90 Drinking Assessment Interview 
(Form90; Miller, 1996), Inventory of Drug Use Consequences (InDUC; Miler, Tonigan, 
& Longabaugh, 1995), and Stages of Change Readiness and Treatment Eagerness Scale 
(SOCRATES; Miller & Tonigan, 1996), were originally administered in paper-pencil 
format and later converted to an on-line format (February, 2006) for ease of 
administration and data export. All the completed paper-pencil assessments were 
retrospectively entered into the on-line format for ease of data export. The project 
coordinators were responsible for compiling and managing the data base. The Alcohol 
Abstinence Self-Efficacy Scale (AASE; DiClemente, Montgomery, & Hughes, 1994) was 
also part of the assessment process, but was incorporated long after the data collection 
process started. Because of this, and the fact that the instrument was only utilized with 
clients who abused alcohol, it was not included in the data analysis process. 
After the administration of the battery was completed, the assessor would 
manually score all the instruments and utilize the results to complete a personalized 
feedback form (Appendix C). The computer generated ASI report was also printed out. 
Both documents were given to the client’s primary clinician and became part of their 
medical chart. The feedback form was designed with a few purposes in mind. First, it 
provided a means to efficiently summarize the assessment results for utilization in 
treatment planning by the clinical staff. Second, it was also designed to facilitate a 
discussion with the client during a feedback session as a clinical intervention. Although 
the treatment staff did not consistently conduct feedback sessions with the clients, all 
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clients were informed that a feedback form would be provided to their counselor and they 
were able to request a feedback session if interested. The original completed instruments, 
a copy of the ASI generated report, and feedback form, were maintained on all clients 
who agreed to participate. Each packet was de-identified and assigned a code number. All 
de-identified files were maintained in a locked filing cabinet at RMH. The signed 
informed consent packets were held in a locked cabinet at Marquette University. The data 
will be kept for approximately seven years and then destroyed. 
Measures 
 The psychometric quality of assessment instruments is a critical factor when 
attempting to collect reliable and valid data. Psychological practice and research tends to 
measure a broad constellation of factors included but not limited to: problem severity, 
clinical diagnosis, symptomology, and impairment (Blacker & Endicott, 2008). In order 
for the assessment of these factors to be useful for both clinical and research purposes 
measures should be selected that help to improve the reliability and validity of the 
information gleaned then what might be gathered from an unstructured interview. 
According to Blacker and Endicott, “thus, an evaluation of each measure’s reliability and 
validity is key to judging the potential value of each measure for a particular purpose” (p. 
7).  
There has been a lack of consensus, however, in establishing standards or 
guidelines of acceptable reliability and validity (Charter & Feldt, 2001). Established 
guidelines have been found to vary depending on whether the instrument is to be used for 
research or clinical purposes and a variety of standards have been identified by various 
authors throughout the years (Charter, 2003). For example, Nunnally and Bernstein 
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(1994) indicated that for research purposes (i.e. exploring group differences) “time and 
energy can be saved using instruments that have only modest reliability, e.g., .70. It can 
be argued that increasing reliabilities much beyond .80 in basic research is often wasteful 
of time and money.” (pp. 264-265). When making decisions about people based upon test 
scores however, Nunnally and Bernstein purported that more rigorous standards be 
implemented. When decisions based upon test scores say for education placement 
purposes are to be made, Nunnally and Bernstein indicated that a reliability coefficient of 
.90 is “the bare minimum” and a coefficient of .95 is more ideal. Cicchetti (1994) also 
reported reliability standards when measures are utilized for clinical purposes. He 
provided the following guidelines: r < .70, unacceptable; .70 ≤ r < .80, fair; .80 ≤ r < .90, 
good; and r ≥ .90, excellent. It should be noted, however, that Cicchetti’s standards have 
been argued as being too lenient (Charter, 2003). Other standards have been identified 
when making clinical decisions. For example, a reliability of at least .85 was identified by 
Aiken (2003) and Rosenthal and Rosnow (2008). Furthermore, according to Sternberg 
(1994), when utilizing instruments for screening or diagnostic purposes, reliability 
estimates should not fall below .85 and ideally, be around .90.  
As illustrated, there is variability in what constitutes an adequate reliability 
coefficient and fittingly, it has been stated that “any [reliability] threshold values are 
bound to be arbitrary” (Mäkelä, 2004). Nonetheless, for the purposes of this study, we 
attempted to utilize measures that demonstrated reliability coefficients of at least .80. It 
should be noted though, that because the clinical utility of the measures was also 
important, we may have sacrificed some psychometric strength in exchange for increased 
clinical utility at times, especially since we were not utilizing the result to make 
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important decisions about the clients (i.e., level of treatment placement). Hence, when 
selecting measures for this study, we attempted to find a balance between being 
scientifically rigorous by utilizing psychometrically sound instruments, while also 
attempting to create an assessment battery that was not too lengthy, despite collecting 
comprehensive client information. 
Because the assessment results were utilized to construct a feedback form for 
treatment planning purposes, the type of clinical information yielded by the assessments 
was also considered when selecting the instruments. As indicated by Donovan (2003) the 
client’s level of awareness as it relates to their substance use patterns (including 
frequency and quantity), the consequences of their use, and their own perceptions of 
these factors, is an important consideration. Donovan stated that it is the use of 
assessment instruments that can help increase this awareness as “an important step in the 
process to initiate behavior change and treatment-seeking behavior” (Donovan, 2003, p. 
138). In order to collect comprehensive intake data on the clients, measures were selected 
that would investigate a broad range of factors that have been indicated in the substance 
abuse literature as potentially impacting client retention. These factors include, but are 
not limited to, problem severity, client motivation, legal difficulties, and comorbid 
psychiatric distress (Simpson, 2004).  
Addiction Severity Index, 5th Edition (ASI) 
 The ASI is a semi-structured interview that has been used widely both for clinical 
and research purposes for almost 30 years and “is probably the most commonly used 
instrument in the substance abuse treatment field” (McLellan et al., 1992; Rush, First, & 
Blacker, 2008, p. 454). It was developed by A. Thomas McLellan and colleagues at the 
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Center for Studies of Addiction in Philadelphia primarily for research purposes (Mäkelä, 
2004). The ASI was designed to collect broad client information that is thought to be 
impacted by substance abuse treatment (i.e. psychiatric severity, employment problems, 
and criminality) and was done so in a format that would allow for follow-up 
administrations. One of the strengths of the ASI is that it can be used to identify problems 
outside of, but perhaps related to, substance use and hence be used as a multidimensional 
measure of substance abuse treatment outcomes (Donovan, 2003). The primary reason 
the authors designed the ASI to collect such broad information, through various points of 
treatment, was in an effort to conduct outcome assessments across programs (McLellan at 
al., 1992). The ASI is currently in its 5th edition as changes were implemented in an effort 
to reflect how drug use patterns and knowledge of substance use disorders have changed 
over time. For example, when the ASI was first introduced the use of “crack” and 
polysubstance abuse was not as common as phenomenon as now. The instrument was 
updated to reflect such cultural shifts and the growing body of scientific knowledge 
regarding addictive behaviors (McLellan et al., 1992). 
 Administration of the ASI is completed in an interview format and takes 
approximately 45-60 minutes when conducted by a trained assessor. This author attended 
a two-day training covering proper administration and scoring of the ASI by the 
Treatment Research Institute (TRI). Training materials were provided and subsequently 
utilized during the volunteer assessor training at Marquette University. Proper 
administration of the ASI requires specific wording of the questions and the 
comprehensive training by TRI included formal instruction and mock sessions in an 
effort to help increase the consistency with which the data is collected and to reduce 
51 
 
errors (McLellen, Cacciola, Alterman, Rikoon, & Carise, 2006). A computer assisted 
program can also be utilized to increase consistency of administration since there are 
specific prompts that specify the exact wording of each question. The computer assisted 
program was utilized for every administration in this study. 
Administration of the ASI is conducted in a semi-structured format and consists 
of items to identify potential problems in seven distinct areas that are often negatively 
impacted by substance abuse: medical status, employment status, drug and alcohol use, 
legal status, family/social status, and psychological status. Both a client’s subjective 
appraisal of problem severity, and objective questions to assess for problem severity are 
included (Rush, First, & Blacker, 2008). Each of the seven sections focuses questions on 
the frequency, intensity, and duration of the problems experienced by the client both 
within the past 30 days and over the course of their lifetime. At the conclusion of each 
section the client indicates, based upon a four point scale, how troubled or bothered they 
have been by the related problems over the past 30 days and how important it is to 
receive treatment for those problems. The interviewer also indicates the client’s severity 
rating (between 0-9) for that section based upon clinical judgment and the information 
shared by the client. Per the manual, it is suggested that the interviewer first identify a 
two to three point range of severity and then refine this estimate based upon the answers 
provided by the client (Alterman, Brown, Zaballero, & McKay, 1994). There are two 
separate summary indices for each of the seven sections, composite scores, and 
interviewer severity ratings. Sample items from the ASI include the following: “How 
many times have you been treated for any psychological or emotional problems?” and 
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“How much have you been trouble or bothered by these psychological or emotional 
problems in the past 30 days?” (Rush et al., 2008, p. 455). 
 A number of strengths and limitations of the ASI have been identified. One of the 
most frequently noted strengths is that the ASI is able to gather a large amount of broad 
data with a wide range of substance abusers (Rush et al., 2008). This data can be used to 
gather information at the point intake, throughout treatment, at discharge, and at various 
follow-up points, to evaluate client progress and change. As such, the information 
gleaned from the ASI can be utilized for treatment planning, treatment monitoring, 
program evaluation, and treatment outcome studies (McLellan et al., 1992). In addition to 
the ASI being used throughout the world, there is a great deal of normative data available 
on a number of client populations and as such it has the potential to facilitate 
communication between clinicians and researchers (Rush et al., 2008). It should also be 
noted that the ASI is available through the public domain and can be utilized at no 
additional cost to treatment programs. There have also been noted limitations associated 
with the use of the ASI, however. Longer administration time, a required interview 
format, and high face validity are a few limitations of the ASI. Furthermore, until 
recently, the use of ASI with adolescent populations had not been validated and further 
study in this area is warranted. Finally, the determination of the severity ratings have 
been described as subjective and point to the importance of proper training of ASI 
interviewers (Rush et al., 2008). 
 Psychometric Properties of the Addiction Severity Index 
 A fair amount of research has been conducted on the psychometrics associated 
with the ASI. For example, in a review article by Mäkelä (2004), 37 investigations were 
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identified as reporting psychometric data on the ASI. Historically, the reliability and 
validity associated with the ASI has been summarized in the literature as “very positive” 
(Mäkelä, 2004, p. 398). As will be discussed, however, when looking more closely at the 
data, there have been variations detected in the ASI’s ability to generate reliable and valid 
data, especially among specialized populations.  
 Reliability estimates were investigated by McLellan et al., (1985) through three 
treatment centers providing both outpatient and inpatient care. Concurrent and test-retest 
reliability estimates were evaluated. Concurrent reliability coefficients for each scale 
were calculated separately and overall were found to be “high” (McLellan et al., 1985). 
The authors concluded, “thus the data indicate that for any given scale, the coefficient of 
reliability will fall between .74 and .99 depending upon the method used to calculate it, 
and that eight judges will agree within 2 points on the 10-point estimate 89% of the time” 
(McLellan et al., 1985, p. 415). The same study also investigated test-retest reliability 
with a time frame of three days. The severity rating assigned by the interviewers were 
quite similar as demonstrated by coefficients of .92 or higher, even when two 
interviewers were utilized (McLellan et al., 1985). A longer test-retest time period (13 
days) of the “lifetime” questions of the ASI was examined in a more recent investigation. 
Results demonstrated that longer interval test-retest reliability of the ASI generated 
reliability coefficients deemed “good to excellent” for most of the lifetime items included 
in the medical, employment, drug, alcohol and legal problem areas. Questions included 
on the family/social and psychiatric sections of the ASI, however, had many items that 
did not achieve acceptable reliability coefficients. These interpretations were based upon 
the following cutoff scores of the ICC and kappa: less than .40, poor; between .40 and 
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.59, fair; between .60 and .74, good; greater then .74, excellent (Cacciola, Koppenhaver, 
McKay, & Alterman, 1999). The authors suspect that part of these conflicting results may 
be related to the notion that problematic interpersonal relationships and psychiatric 
distress involve more subjective interpretations that can vary over time, versus more 
objective medical and substance use histories. Still, the authors conclude that the ASI is 
capable of producing reliable data over longer interval test-retest conditions overall 
(Cacciola, Koppenhaver, McKay, & Alterman, 1999). 
 In Mäkelä’s review article the results of test-retest studies of the ASI composite 
scores have been varied. For example, among homeless populations there was 
considerable variation across sites with ICCs ranging from .03 (family/social 
relationships) to.97 (alcohol use) (Drake, McHugo, & Biesanz, 1995). Additionally, 
Mäkelä cited a 10-day test-retest study that included alcohol dependent patients which 
demonstrated reliability coefficients between .71 and.95 for composite scores (Daeppen, 
et al., 1996). After reviewing a total of eight studies that investigated the test-retest 
reliability of the ASI, Mäkelä concluded that the reliabilities ranged from excellent to 
unsatisfactory. It should be noted however, that the majority of studies which 
demonstrated unsatisfactory reliabilities coefficients were conducted with “special 
populations” including homeless populations (Drake, McHugo, & Biesanz, 1995) and 
individuals with severe mental illness (Corse, Zanis, & Hirschinger, 1995). On the other 
hand, a study that included alcohol-dependent participants (who are more closely related 
to the sample for this current study), results demonstrated test-retest reliabilities of 
composite scores between .71 and .95 (Daeppen at al., 1996). 
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 Internal consistency has also been investigated in a number of studies since the 
1980s. Zanis, McLellan, and Corse (1997) reported that all ASI domains demonstrated at 
least acceptable internal consistencies, except for the legal section (α=.57). Internal 
consistency for ASI composite scores has also been evaluated. Results demonstrated a 
mean alpha of .80, with a range of .89 (medical) to .70 (employment) (Lawrence, Vida, 
Edward, & Daniel, 1997). In a sample of psychiatric patients, Appleby, Dyson, Altman, 
and Luchins (1997) reported an overall high internal consistency with a mean alpha of 
.80 for the composite scores. Individual alpha scores were found to range from .89 
(medical) to .70 (employment). In Mäkelä’s (2004) review article, of the 12 studies cited 
for reporting internal consistency, high internal consistencies were regularly reported for 
the medical, alcohol, and psychiatric composite scores. In four of the 12 studies, lower 
consistencies were reported for the other domains including employment, drug use, legal 
status, and family/social relationships.  
 Inter-rater reliabilities have also been examined. Some studies have demonstrated 
high reliabilities for severity ratings (above .80) among clients entering substance abuse 
treatment (McLellan et al., 1980, 1985; Stoffelmayr, Bertram, Mavis, Brian, & Kasim, 
1994). Appleby et al. (1997) reported inter-rater reliabilities utilizing the ICC. The ASI 
severity ratings assigned by eight raters demonstrated an average ICC of .74. Reliability 
for the medical (.75), employment (.74), and alcohol (.79) sections was defined as 
substantial. The reliability for the drug (.83) and legal (.87) sections were defined as very 
high. The ICC for the family/social section was .70 and only moderate for the psychiatric 
section (.48). Agreement between the raters was very high for the composite scores on all 
seven sections with the lowest coefficient at .95. Zanis et al. (1997) reported inter-rater 
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reliabilities with coefficients ranging from .71 (employment) to .95 (legal) with an overall 
mean of .79. Mäkelä’s (2004) review article reported inter-rater reliabilities ranging from 
high to unstable. He asserts that the employment, drug, family/social, and psychiatric 
severity sections were found to demonstrate the lowest coefficients. Inter-rater 
reliabilities of the composite scores though, were found to be consistently higher, likely 
due to the notion that there is more subjective judgment associated with the assigned 
severity ratings. 
Because the authors of the ASI made a considerable effort to create seven distinct 
domains, discriminant validity associated with the ASI has been investigated. Satisfactory 
discriminate validity would be represented by stronger relationships existing between 
conceptually corresponding measures than non-corresponding measures. As reported by 
Mäkelä (2004), the studies conducted on the ASI are limited to investigations focused on 
intercorrelations of the ASI problem areas themselves and not other conceptually similar 
or distinct measures. Appleby et al. (1997) reported that both the drug and legal section, 
and family and psychiatric section were moderately correlated. Nonetheless, the authors 
concluded that despite some overlap, the domains are “largely independent of each other” 
(p. 159). Appleby et al. (1997) also investigated the ASI’s criterion validity, which 
“refers to the extent to which the measurement correlates with an external criterion of the 
phenomenon under study” (Mäkelä, 2004). The alcohol severity and composite scores of 
the ASI were correlated with the CAGE and the Short Michigan Alcoholism Screening 
Test (SMAST). The CAGE is an instrument that assesses for alcohol problems over one’s 
lifetime and the SMAST is an instrument that measures lifetime alcohol use. The drug 
severity and composite scores of the ASI were correlated with the CAGE-AID, which 
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assesses lifetime drug use problems, the Chemical Use, Abuse, and Dependence Scale 
(CUAD), which provides a substance use diagnosis and severity ratings for drug and 
alcohol use, and the Drug Abuse Screening Test (DAST), which measures drug abuse. 
Moderately significant relationships between the alcohol severity rating and alcohol 
composite score with the CAGE (.45, .50) and SMAST (.52, .59) were reported. More 
robust relationships were identified in the assessment of drug problems. The drug 
composite score was strongly related to the CAGEAID (.64), DAST (.73), and CUAD 
(.70) (Appleby et al., 1997). 
A more recent investigation looked at how well the ASI composite scores could 
predict DSM-IV substance dependence diagnoses (Rikoon, Cocciola, Carise, Alterman, 
& McLellan, 2006). Two samples were utilized, each with a different diagnostic tool. 
One group included the ASI with DSM-IV questions included and the other included the 
Structured Clinical Interview for DSM Disorders (SCID) for the DSM-IV. Statistically 
significant correlations were found to exist between the alcohol and drug composite 
scores with the DSM-IV diagnoses of alcohol dependence (r>.66, p<.01) and drug 
dependence (r>.72, p<.01). Additionally, “the ASI identified dependent clients with 
approximately 85% sensitivity and 80% specificity” (p. 17), leaving the authors to 
conclude that the ASI could be utilized as a useful diagnostic screening instrument. The 
sensitivity and specificity of the psychiatric subscale has also been investigated. The 
authors reported that ASI psychiatric section was able to identify clients with concurrent 
depression with 89% sensitivity and 67% specificity (Kosten, Rounsaville, & Kleber, 
1983). 
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Concurrent validity of the ASI has also been investigated in an effort to determine 
how well the ASI measures what it intends to measure by comparing it with validated 
instruments designed to measure similar constructs (McLellan et al., 1985). In the first 
independent study to evaluate concurrent validity was conducted with a sample of 204 
opiate dependent individuals seeking substance use treatment. Results indicated that the 
family/social relationships, employment, legal and psychiatric severity ratings 
demonstrated good concurrent validity with self-report measures of social adjustment 
issues, employment problems, legal issues, and psychiatric problems (r = .39 - .59, p < 
.001). On the other hand, the drug section demonstrated little concurrent validity with 
drug abuse problems (r = .11) and the medical subscale was not included in the 
evaluation as no instrument assessing physical health as a comparison was available 
(Kosten,et al., 1983). McLellan et al. (1985) evaluated the concurrent validity of the ASI 
severity ratings by dividing the sample into low, middle, and high severity across the 
seven domains. Comparisons were then made between the groups and items that were 
identified as clearly indicating problem status. Results indicated that “clear evidence of 
concurrent validity for the ASI scale ratings” (p. 417). Current validity was also 
investigated with participants from specialized populations. Carey, Coccoo, and Correia 
(1997) investigated the ASI’s concurrent and discriminate validity when administered to 
a group of clients with severe mental illness. Results indicated that support for 
convergent validity was indicated for many scales but evidence to support the 
discriminate validity was less consistent especially for the family/social and employment 
subscales. 
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As illustrated by the variety of studies cited, the ASI has demonstrated both 
favorable and questionable psychometric properties. Most of the less favorable findings 
were found to be indicated when the ASI was used with special populations, including 
those with severe mental illness and homeless populations (Carey et al., 1997; Zanis et 
al., 1997). Taken together, the results also suggest that the ASI can produce both reliable 
and valid data, especially when administered by a trained assessor. The population 
utilized for this study was drawn from clients entering an outpatient substance abuse 
treatment program and hence the utilization of the instrument with this type of group 
appears to be appropriate. Additionally, the counselors at the treatment center were found 
to appreciate the clinical utility associated with the ASI. Psycho-social reports were 
automatically generated after the interview was completed and provided the counselors 
with a helpful picture of their client at treatment outset. This reason, coupled with the 
evidence that the ASI is appropriate to use with such a population, is why the instrument 
was utilized for this study. 
Form 90 Drinking Assessment Interview (Form 90) 
 Perhaps one of the most important dependent variables to measure in substance 
abuse treatment research is alcohol consumption (Miller & Del Boca, 1994). Historically, 
there has been much debate about the ideal manner with which to measure this critical 
variable. Previously “it was once common to simply assess if treated alcoholics were 
successful (abstinent) or relapsed (drinking) at treatment discharge” (Rice, 2007, p. 615). 
During the 1990s, the approach used to measure alcohol consumption shifted from this 
binary method to four popular approaches: (1) quantity-frequency questionnaires, (2) 
average consumption grids, (3) timeline follow-back calendars, and (4) self-monitoring 
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diaries (Miler & Del Boca, 1994, p. 112). Quantity-frequency methods are deemed as 
being useful to collect reliable information about the total amount of alcohol consumed 
and total number of days drinking. This can be a relatively quick method recommended 
when used for evaluating drinking behaviors that are not pattered (Sobell & Sobell, 
2003). Average consumption grids can be useful when the client has an established 
pattern of regular or episodic use. One of the benefits of this type of approach is that 
blood alcohol concentration (BAC) and total number of hours intoxicated can be 
calculated relatively easily (Miller & Del Boca, 1994). The timeline follow-back 
approach is a widely used method that utilizes a calendar to allow the client to 
retrospectively chart their alcohol use (Rush et al., 2008). The approach is designed for 
the interviewer to attempt to account for the amount of consumption every day on the 
assessment calendar. This will help to illustrate how times through the day and events are 
linked to drinking patterns, and helps the interviewer to classify drinking patterns as 
“abstinent”, “light”, “medium”, or “heavy” (Miller & Del Boca, 1994). Finally, self-
monitoring diaries are distinct from timeline follow-back methods by providing a client 
with a prospective calendar and asking them to keep a diary of their drinking as it takes 
place. Some noted limitations with this approach is that compliance to regularly fill out 
the diary can be compromised especially over long periods of time, and also the process 
of self-monitoring could impact patterns of drinking behavior (Miller & Del Boca, 1994). 
 Because no single method was identified as being superior, a number of 
researchers developed a new instrument in an attempt to incorporate the strengths of the 
methods identified above. The result was a hybrid instrument that combined the timeline 
follow-back and average consumption grid, which would record alcohol consumption 
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over a 3-month period (Miller & Del Boca, 1994). Hence the “Form90” was born. The 
Form90 is a structured, interviewer conducted assessment that incorporates the use of a 
calendar illustrating each of the 90 days of drinking behavior that are get recorded. 
Holidays, and other memory prompts (e.g. NFL games), are included to assist with recall. 
Alcohol consumption is measured for each of the 90 days in the assessment window. All 
abstinent days are recorded first and then the interviewer begins to determine if the client 
demonstrated steady patterns of drinking. A steady pattern chart is then constructed to 
represent steady and consistent patterns of drinking. Exceptions to steady patterns are 
also calculated by documenting episodic patterns (to represent recurring drinking 
episodes) and finally, idiosyncratic drinking days that do not fall into steady or episodic 
categories are calculated. For any drinking episode the client’s BAC can also be 
calculated by inquiring about the period of time in which the alcohol was consumed 
(Miller &Del Boca, 1994). To calculate peak BAC levels for clients in this study we 
utilized a computer program, The Blood Alcohol Concentration Computation System 
(BACCuS), which converts alcohol quantities into standard drink units and indicates 
BAC levels based upon gender, weight, and time spent drinking. Administration of the 
Form90 is complex and requires adequate training (Miller & Del Boca, 1994). For the 
purposes of this study the program coordinators received formal training on 
administration and mirrored this training for the volunteers. The training involved both 
lecture based format as well as an audio taped mock interview so the volunteers could 
practice recording the information and feedback was provided. 
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 Psychometric Properties of the Form90 
 Tonigan, Miller, and Brown (1996) conducted two reliability studies of the 
Form90, one cross-site study to investigate inconsistencies between site interviewers, and 
one within-site study to investigate inconsistencies between paired interviewers. 
Reliability estimates were calculated on the outcome measure of drinking, illicit drug use, 
and general adjustment. Outcomes were found to be “relatively consistent” in both tests 
with r ≥ .90 in 57 of the 81 comparisons. More specifically, results indicated fair to 
excellent reliability of drinking outcome indices (ICC = .55-.97) and comparisons of the 
weekly ICCs demonstrated that the Form90 can produce reliable alcohol consumption 
data over time (Tonigan et al., 1996). Rice (2007) also investigated the retest reliability of 
the Form90 with 83 participants demonstrating heavy drinking patterns. Comparison of 
the initial and retest interviews indicated a kappa coefficient of .766 (95% confidence 
interval: .750-.782).  
 A study investigating the convergent validity of the Form90 with similar alcohol 
consumption measures was also conducted. Grant, Tonigan, and Miller (1994) looked to 
compare the Form90 with two other alcohol consumption measures, a quantity-frequency 
scale and a grid measure. Adequate convergent validity of the Form90 was reported by 
the authors. More specifically, the comparisons between the Form90 and the grid method 
demonstrated the highest correlation on drinking days (r = .80) and modest correlations 
on standard drinks consumed (r = .59) and peak BAC (r = .66). Comparisons between the 
Form90 and the quantity-frequency measure on days of drinking demonstrated 
similarities between the measures in number of days drinking (r = .80) and total number 
of standard drinks consumed (r = .70).  
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 Because the Form90 has demonstrated adequate convergent validity and 
satisfactory reliability it has been recommended for use for a variety of applications and 
in a variety of settings when assessing for alcohol problems (Sobell & Sobell, 2003). It 
was selected for this project for these reasons coupled with the benefits associated with 
providing feedback to clients about their drinking behaviors. The very detailed 
accounting of previous drinking patterns has the capability to assist clients in gaining a 
more accurate understanding of actual drinking behaviors and degree of intoxication. In 
this way, the results of the Form90 can be utilized as a feedback tool to enhance client 
motivation for change (Sobell & Sobell, 2003).  
The Mini-International Neuropsychiatric Interview (M.I.N.I.) 
 Making a clinical diagnosis is a component of the intake process to ensure proper 
treatment planning and approaches. In substance abuse treatment clinical diagnoses 
typically include both substance use disorders and other psychiatric problems (Maisto & 
Tiffany, 2003). Conducting structured interviews to make an accurate diagnosis is 
critically important for research purposes in order to make comparisons across sites and 
helps to ensure “diagnostic precision” in non-research clinical settings (Sheehan et al., 
1998, p. 22). An extensive psychiatric interview is not always feasible during substance 
abuse treatment intakes however, since it is only one component of the intake procedure 
and can take in the upward of 90-120 minutes (Maisto & Tiffany, 2003). In an effort to 
address the problem of time constraints associated with clinical interviews, the Mini-
International Neuropsychiatric Interview (M.I.N.I.) was developed to “bridge the gap 
between the detailed, academic, research-oriented interview and the ultrashort screening 
tests designed for primary care” (p. 23). The development of the M.I.N.I. was intended to 
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be short, inexpensive, easy to administer, very sensitive, specific, compatible with the 
International Classification of Diseases (ICD-10) and Diagnostic and Statistical Manual 
of Mental Disorders (DSM-IV), capture symptoms that are not severe enough for a 
diagnosis, and have both clinical and research utility (Sheehan et al., 1998). 
 Psychometric Properties of the M.I.N.I.  
 Reliability and validity studies have been conducted on the M.I.N.I. Two parallel 
validation studies looked to assess the agreement between a diagnosis on the M.I.N.I. 
with the standards of diagnosis of the DSM-IV (SCID-P) and for the ICD-10 (Composite 
International Diagnostic Interview [CIDI]). Each of the 17 Axis I diagnoses determined 
by the M.I.N.I. was assessed for accordance with the standard instrument utilized for the 
DSM-IV and ICD-10 using Cohen’s kappa, sensitivity, specificity, efficiency, and 
positive and negative predictive values (Sheehan et al., 1998). When comparing the 
M.I.N.I with the SCID-P, the M.I.N.I. diagnoses were described as good or very good 
kappa values. There was only one kappa value reported below .50 (concurrent drug 
dependence: .43). Sensitivity values were at .70 or higher for all categories with the 
exception of dysthymia (.67), obsessive-compulsive disorder (.62), and current drug 
dependence (.45). The operating characteristics of specificity and negative predictive 
values were .85 or higher across all diagnostic categories. Finally, the positive predictive 
values ranged from good to acceptable. When comparing the M.I.N.I. with CIDI 
diagnosis kappa values were found to range from good to very good for all but two 
categories (simple phobia: .43 and generalized anxiety disorder: .36). The operating 
characteristics of sensitivity, specificity and negative predicative values were also found 
to be good at .70 or higher for all categories but four (Sheehan et al., 1998). 
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 The mean length of the interview associated with the M.I.N.I. was approximately 
half of that associated with the SCID-P (18.7 ± 11.6 minutes vs. 43 ± 30.6 minutes) and 
approximately one fourth of the CIDI (21 ± 7.7 minutes vs. 92 ± 29.8 minutes). The 
M.I.N.I. “provided a reduction in the median administration time over the SCID-P of 
more than 50% for patients with primary diagnoses of anxiety, major depression, and 
mania and of more than 70% for those with a primary diagnosis of psychotic disorder” 
(Sheehan et al., 1998, p. 30). Reliability estimates were also investigated. The authors 
reported inter-rater reliability as excellent with all kappa values over .75 and 70% of all 
kappa values at .90 or higher. Test-retest reliability was described as good with 61% of 
the values above .75 and only one below .45 (current mania) (Sheehan et al., 1998). 
Based on these studies the authors conclude that the M.I.N.I. “succeeds” in producing 
both valid and reliable data for making clinical diagnoses in a shorter period of time. The 
results of these studies also prompted some changes to the M.I.N.I. in an effort to 
strengthen some questions as well as the sensitivity, specificity, and positive predictive 
values of the instrument. Additionally, the various modules of the M.I.N.I. were updated 
to be consistent with DSM-IV and its associated time frames. Finally, a computerized 
version was also developed to assist with ease of administration. 
 These findings, coupled with the importance of gaining accurate clinical 
diagnoses, promoted the use of the M.I.N.I. for this research study. In additional to 
providing clinical diagnoses of Axis I disorders, the M.I.N.I. also features a suicidaility 
module that identifies a client’s potential risk for suicide as “low”, “medium”, or “high”. 
All information gleaned from this module was shared directly with the counselors and 
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treatment staff. A suicide protocol was developed to provide a standard procedure for all 
assessors to follow in the event that clients endorsed items in this section of the M.I.N.I. 
Inventory of Drug Use Consequences (InDUC) 
 Although making an accurate diagnosis of a substance use disorder is critical 
“knowledge of a diagnosis of substance use disorder does not in itself provide an 
adequate basis for developing a full treatment plan” (Maisto et al., 2003, p. 69). Other 
assessments evaluating domains like severity and consequences of use were also included 
to assist the counselors with the treatment planning process. It is well known that 
individuals who abuse alcohol and/or drugs often experience a variety of negative 
consequences related to their use (e.g. legal problems, relationship strain, physical 
injury). It has been suggested that evaluating consequences of use can provide relevant 
information to clinician when making a diagnosis and also assist clients in the process of 
change (Maisto et al., 2003). More specifically, by helping a client make connections 
between their substance use and the negative consequences of that use, this can bolster 
client motivation for change and help address issues of ambivalence the client may be 
experiencing about the change process (Maisto et al., 2003).  
The Inventory of Drug Use Consequences is a measure that assesses for negative 
consequences an individual may have experienced as it relates to their alcohol and drug 
use. Its “parent” inventory is the Drinker Inventory of Consequences (DrInC; Miller, 
Tonigan, & Longabaugh, 1995), which was designed to measure alcohol use related 
consequences only. The DrInC was a first step in addressing the paucity of instruments 
available to assess for alcohol use related consequences. The DrInC was later revised to 
create the InDUC in an effort to allow for a broader use of the instrument since it is 
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known that clients often use both alcohol and drugs. In this way, the InDUC allowed for 
the assessment of both alcohol and drug use consequences, becoming one of the first 
standardized assessments to do so (Blanchard, Morgenstern, Morgan, Labouvie, & Bux, 
2003).  The InDUC is a self-report measure and evaluates the consequences as they fall 
broadly into the five following domains: (1) Impulse Control (2) Social Responsibility (3) 
Physical (4) Interpersonal, and (5) Intrapersonal (Tonigan & Miller, 2002). There are two 
forms available, one that assesses for consequences experienced in the past 90 days, and 
the other, assessing for consequences over a person’s lifetime (Blanchard et al., 2003). 
For this project the version assessing consequences over one’s lifetime was employed in 
an effort to more comprehensively evaluate a client’s background in terms of their 
substance use. 
For the purpose of this project the clients were read the directions and each 
question aloud. For the version assessing for consequences over one’s lifetime clients 
could respond dichotomously with “yes” or “no” answers if they “ever” experienced 
specific consequences related to their drug and/or alcohol use. Item examples include: 
“My physical appearance has been harmed by my drinking or drug use” (Physical 
domain), “I have not done what is expected of me because of my drinking or drug use: 
(Social Responsibility domain); “I have felt bad about myself because of my drinking or 
drug use” (Intrapersonal domain). The five different domains were separately tabulated 
and the overall score was calculated with higher scores indicating a greater number of 
consequences experienced. Scores for each of the separate domains were also calculated 
in an effort to illustrate any specific areas where clients have experienced more 
consequences than others. The assessment can be utilized at the time of intake to 
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determine baseline characteristics, as well as throughout the course of treatment to help 
detect change over time. The InDUC also includes a control scale to help detect 
preservative or careless answering (Tonigan & Miller, 2002). The InDUC is designed to 
be utilized by clinicians and/or researchers and administration time is approximately 10 
minutes (Tonigan & Miller, 2002).  
Psychometric Properties of the InDUC 
In one of two studies conducted by Tonigan and Miller (2002), the test-retest 
reliability of the InDUC was evaluated with a sample of outpatient clients. They reported 
that four of the five subscales of the INDUC demonstrated “good-to-excellent stability” 
(p. 167). More specifically, the intraclass correlations (ICC) for each scale are as follows: 
Physical: ICC=.68 (r= .77); Intrapersonal: ICC=.33 (r=.34); Social Responsibilities: 
ICC=.88 (r=.89); Interpersonal: ICC=.73 (r=.75); Impulse Control: ICC=.92 (r=.93). As 
demonstrated by these scores, the intrapersonal domain was the exception of the good to 
excellent stability demonstrating poor reliability. A more recent study conducted by 
Gillaspy and Campbell (2006) also investigated the test-retest reliability of the InDUC 
with a sample of outpatient clients. Their findings demonstrated good to excellent 
stability for all five subscales, indicated as follows: Physical: ICC=.71 (r= .89); 
Intrapersonal: ICC=.86 (r=.94); Social Responsibilities: ICC=.83 (r=.96); Interpersonal: 
ICC=.82 (r=.89); Impulse Control: ICC=.64 (r=.89). The full measure also demonstrated 
high test-retest estimates with an intraclass correlation of .94 (r=.97). Questions of 
validity have also been examined but with some conflicting results. The second study 
conducted by Tonigan and Miller (2002) attempted to determine the validity of the 
InDUC with a sample of clients from both outpatient and inpatient treatment programs. 
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Confirmatory factor analysis results demonstrated a better fit with a four-factor model, 
versus the original five-factor model, by excluding the Intrapersonal subscale. The 
authors indicated that “the same four scales were sufficient to depict the larger construct 
of adverse consequences” (p. 167). On the other hand, Blanchard et al. (2003) reported 
that the items comprising the InDUC loaded primarily on one main factor related to 
adverse consequences. High internal consistency between items on the full measure (α = 
.96) and a significant amount of shared variance between subscales provided evidence to 
support a single factor model. 
 All three of the cited studies examining the psychometric properties of the InDUC 
suggest that the instrument’s scores can be both reliable and valid, and particularly the 
overall score. Gillaspy and Campbell (2006) state that the InDUC can therefore be an 
effective tool to be utilized both for clinical purposes to help motivate clients for change, 
and for research purposes as an intake assessment tool and to measure client change over 
time. 
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) 
 Client motivation to change their substance use has consistently been found to be 
positively related to treatment retention (Brocato, 2004; Broome et al., 1999; Simpson & 
Joe, 2004; Simpson, Joe, & Rowan-Szal, 1997). One component of treatment motivation 
includes a client’s recognition and awareness of their substance use problems. Problem 
recognition has been identified as a necessary step in seeking treatment and making 
positive behavior changes (Donovan, 2003). Originally, the SOCRATES was designed to 
assess for the stages of change introduced by Prochaska and DiClemente (1992). The five 
stages of change include pre-contemplation, contemplation, preparation, action, and 
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maintenance, and essentially describe the various phases an individual goes through 
during a behavior change, including that of altering substance use. Determining where a 
client is at in their change process allows for specific interventions to target movement 
towards more favorable behavior (Donovan, 2003).  
The original form of the SCORATES was developed to include items that would 
assess for each of the stages in the change model excluding maintenance, since the 
instrument was designed to be used with clients in need of treatment (Miller & Tonigan, 
1996). The SOCRATES went through a number of iterations in an effort to improve 
items and psychometrics. A fifth version was finally settled upon and is available in both 
longer (39 items) and shorter forms (19 items). Because the scores on the longer version 
were found to converge quite well with scores on the shorter form, and the shorter form 
has greater simplicity, the authors recommend usage of the shorter version (Miller & 
Tonigan, 1996). For these reason also, it was decided that the shorter version would be 
utilized for this study. Although originally designed to include factors from each of the 
stages of change, factor analytic studies of the current version yielded three scales: 
readiness for change, taking steps for change, and contemplation (Donovan, 2003; Miller 
& Tonigan, 1996). Administration time of the SOCRATES is typically quite brief, 
typically around five to 10 minutes, and requires little training for proper administration. 
The SOCRATES is available at no charge including scoring templates and guidelines for 
interpretation on the CASAA website (http://casaa.unm.edu/). Separate versions for drug 
and alcohol use are available. 
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Psychometric Properties of the SOCRATES 
 Miller and Tonigan (1996) investigated the psychometric properties of the 
SOCRATES with two samples. The first included 1,672 alcohol dependent clients who 
were seeking substance abuse treatment and the second included 82 heavy drinkers. 
Reliability coefficients (Cronbach’s α) for the two studies follow respectively: 
Ambivalence (.60, .88), Recognition (.85, .95), and Taking Steps (.85, .95). Two day test-
retest coefficients were calculated with the sample of 82 heavy drinkers and are as 
follows: Ambivalence = .83, Recognition = .99, and Taking Steps = .93. 
 As previously noted, Miller and Tonigan (1997) identified the three factors of 
readiness for change, taking steps for change, and contemplation, which led to the three 
main categories of the SOCRATES. Research on this factor structure with adult 
populations has not confirmed this three factor model. Maisto et al. (1999) found that the 
contemplation (or ambivalence) factor has not been found to be as stable as originally 
thought. This finding is not particularly surprising since Miller and Tonigan’s (1997) 
factor analysis demonstrated that the ambivalence scale accounted for the least amount of 
variance (7%) of the three scales (Taking Steps accounted for 27% of the item variance 
and Recognition accounted for 11% of the variance). In reference to concurrent validity, 
Miller and Tonigan (1997) found that the scores on the Recognition scale were correlated 
the strongest with substance use problem severity (based upon consumption variables and 
Alcohol Use Inventory), reflecting up to 15% common variance. 
 The SOCRATES is an instrument that can demonstrate excellent clinical and 
research utility. Motivation for change has been implicated in substance abuse retention 
literature and this construct can be used as a clinical indicator to develop interventions 
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aimed at specific levels of motivation to facilitate the change process. The SOCRATES is 
an instrument that can be used to help indicate level of motivation and can be utilized at 
various times throughout the course of treatment to monitor changes in client motivation. 
The ease of administration and sound psychometric properties, coupled with the clinical 
utility, provided ample evidence to include the SOCRATES as a measure in this 
assessment battery. 
Pretreatment Covariates 
 The following table illustrates the various covariates that were included in the 
study, their respective levels of measurement and the specific instruments from which 
they were assessed. The covariates listed are those variables that were thought to be 
possibly predictive of the dependent variables (Hinkle, Wiersma, & Jurs, 2003). The 
instruments that were used to assess for the specific predictors are also indicated. As 
previously noted, the possible predictors were chosen based upon the TCU model for in-
house treatment evaluations (Simpson, 2001), as well as what would provide clinically 
meaningful information for the counselors in their treatment planning. The information 
gathered on the following categories was collected at the point of treatment intake only. 
Table 1 
Pretreatment Covariates 
   Variable    Level of        Instrument 
       Measurement 
Client Factors     Age     Continuous  ASI 
   Race     Nominal  ASI 
   Gender    Nominal  ASI 
   Marital Status    Nominal  ASI 
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   Education Level   Continuous  ASI 
   Income    Continuous  ASI 
   Religion    Nominal  ASI 
Substance Use  Years of Lifetime Substance Use Continuous  ASI 
   Substance use past 30 days  Continuous  ASI 
   Alcohol Only Disorder  Nominal           M.I.N.I. 
   Drug Only Disorder   Nominal           M.I.N.I. 
   Alcohol and Drug Disorder  Nominal           M.I.N.I. 
   Previous Substance Use Treatment Nominal  ASI 
   # Drinking Days, Past 90  Continuous                Form90 
   # Heavy Drinking Days, Past 90 Continuous               Form90 
   # Drug Using Days, Past 90  Continuous           Form90 
   Average Weekly SEC   Continuous           Form90 
   SEC for Heaviest Drinking Episode Continuous           Form90 
   Peak BAC, Drinking Episode  Continuous           Form90 
   Adverse Consequences of Use Continuous  InDUC 
Psychiatric Factors Current Psychiatric Symptoms Nominal  ASI 
Previous Psychiatric Treatment Nominal  ASI 
   Been Prescribed Psychotropics Nominal  ASI 
   History of Abuse    Nominal  ASI 
   Axis I Diagnosis(es) 
    Depressive Disorder  Nominal                    M.I.N.I 
    Suicidal Ideation  Nominal           M.I.N.I 
    Bipolar Disorder  Nominal           M.I.N.I 
    Anxiety Disorder  Nominal           M.I.N.I 
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    Eating Disorder  Nominal           M.I.N.I 
   Dual Diagnosis Status   Nominal         M.I.N.I 
Motivation      Recognition    Continuous SOCRATES 
   Ambivalence    Continuous SOCRATES 
   Taking Steps    Continuous SOCRATES 
   Composite Score   Continuous SOCRATES 
ASI Composites Medical    Continuous  ASI 
   Employment    Continuous  ASI 
   Alcohol    Continuous  ASI 
   Drug     Continuous  ASI 
   Legal     Continuous  ASI 
   Family/Social    Continuous  ASI 
   Psychiatric    Continuous  ASI 
 
Dependent Variables 
The first dependent variable is treatment completion status (used to address 
research question #1). Treatment completion status was defined in the following way. 
First, we consulted the program census log in which the counselors were to record 
whether a client successfully completed the treatment program. Unfortunately, for about 
half of the participants this information was not included in the log. Consequently, when 
the information was not readily available, the two psychometrists accessed the clients’ 
electronic file and reviewed case notes to determine completion status. A treatment 
completer is one who was found to have met all, or a sufficient amount, of the treatment 
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goals to warrant what was considered to be successful completion as determined by the 
counselors. This information was explicitly stated in their medical chart (examples are to 
follow). Additionally, a treatment completer is one who, according to their medical chart, 
celebrated their graduation/medallion ceremony, or was discharged from the program 
with staff approval. Some of the following statements are examples of the types of 
information that were used to identify those clients considered to be treatment 
completers: patient completed treatment assignments and was given a medallion for 
completion of treatment; patient was discharged today with staff approval and is seen as 
reaching maximum benefit in treatment; and patient discussed her discharge plans with 
group, received feedback from peers, and received her medallion. Conversely, those 
clients who were not found to meet treatment goals, or who left the program prematurely, 
either on their own volition or due to mandatory dismissal for non-compliance with 
treatment rules, are considered to be non-completers. Some of the following statements 
are examples that were used to identify those clients considered to be treatment non-
completers: patient needs to complete the last two assignments in the group and also 
needs to obtain a temporary sponsor; patient was discharged due to noncompliance; and 
patient seems disinterested in the group, coming in late, on the phone during breaks and 
away from peers, no meeting attendance, and no assignment completion. For a small 
number of the cases (n=12) the psychomterists were unable to determine treatment 
completion status by consulting with the client medical record. For these cases, the 
counselors were asked to review the chart and assist the psychometrists in determining 
completion status based upon the aforementioned criteria. 
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The second dependent variable is time to dropout. This dependent variable was 
explored in an effort to predict the time (# of calendar days) to treatment dropout 
(research question # 2). Finally, the third dependent variable was defined as the total 
number of treatment sessions attended by each client (to address research question #3). 
This dependent variable was explored to determine if it is possible to predict the number 
of sessions attended by clients based upon their pretreatment characteristics. A brief 
description of the statistical analyses used to address the research questions related to 
these dependent variables is provided next.  
Data Analysis 
Initial descriptive statistics were conducted on independent and dependent 
variables in an effort to describe the clients that entered the treatment program during the 
data collection period. As previously indicated, not every client that entered the chemical 
dependency program during the time period of the data collection process was tested. The 
psychometrists had access to a list of patients that were admitted to the program during 
the same time frame of the data collection process but not tested (n=171). Basic 
information on these clients was gathered through their electronic chart, including 
gender, age, ethnicity, and treatment status (i.e., treatment completion or treatment 
dropout and number of treatment sessions attended). Therefore, the convenience sample 
of this study was compared to the group of individuals not tested on basic demographic 
characteristics and treatment status information, to determine if the groups significantly 
differ from each other. Chi square was used to test the differences between the 
categorical variables (e.g., gender) and t-tests were used to test the differences between 
continuous variables (e.g., length of time in treatment) (Hinkle et al., 2003). Groups were 
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considered to be statistically significantly different if p < .05 (Huck, 2000). These 
analyses helped to yield information about the generalizability of the findings of this 
study while also helping to inform decision-making about conducting the more advanced 
statistical analyses. 
To determine if any client characteristics were predictive of treatment completion 
status (Research question #1), binary logistic regression analysis was run. Logistic 
regression is designed specifically to be used with dichotomous dependent variables and 
provides the probability associated with the prediction (Wright, 1995). “In logistic 
regression analyses for a dichotomous dependent variable, one attempts to predict the 
probability that an observation belongs to each of the two groups” (Wright, 1995, p. 219). 
The assumptions of logistic regression outlined by Wright (1995) were met, including: 
the dependent variable is dichotomous; the outcomes of the dependent variable are 
independent (i.e. clients can only belong to one group – treatment completers or non-
completers); the categories are mutually exclusive; and the sample size was adequate 
(minimum of 50 cases per predictor variable). Due to the fact that there is considerable 
variability in how client characteristics at intake are related to treatment retention, the 
null hypothesis for this analysis was that the predictor coefficient for any of the client 
variables is 0 in the population. Predictors were considered statistically significant if p < 
.05 (Wright, 1995). 
In an effort to predict time (# of calendar days) to treatment dropout (research 
questions #2) survival analysis was conducted. Survival analysis is a method utilized to 
predict time to an event taking place. It has been noted that when research questions aim 
to evaluate phenomena associated with time, it presents unique research challenges. For 
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example, at some point in time the data collection processes cease and not all the 
participants will have necessarily experienced the event being targeted. To address these 
unique challenges, a number of statistical techniques were identified, one of which is 
survival analysis (Singer & Willett, 1991). In short, survival analysis is used “to help 
researchers simultaneously explore whether events occur and if so, when” (Singer & 
Willett, 1991, p. 268-269). For this particular study, the “event” is treatment dropout. It is 
noted that for any given point in time during the study a participant needs to be included 
in one of the two groups and, similarly to the assumptions above, those groups must be 
mutually exclusive and exhaustive. In other words, each client is either in treatment or 
out of treatment. The null hypothesis that pretreatment client characteristics are not 
statistically significantly related to time to dropout was tested. The null hypothesis was 
rejected if p < .05.  
Finally, to determine which client characteristics are found to predict the number 
of treatment sessions attended (research question #3), another regression analysis was 
utilized. Originally, a Poisson regression analysis was going to be conducted. This type of 
analysis was going to be used since the dependent variable for this research question 
represents frequency counts, i.e., the number of times a participant attended a group 
session.  The Poisson model requires that the dependent variable mean be equal to its 
variance and this assumption is often violated in social science settings. Instead, it is 
often the case that the variance is either larger than the mean (i.e., overdispersion) or less 
than the mean (i.e., underdispersion).  In the event that the data are over or under 
dispersed, the analyses would have been run specifying a negative binomial error model. 
In fitting the negative binomial model, an additional scale parameter is estimated 
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allowing for adjustment due to over- or underdispersion (Regression models for count 
outcomes: Poisson, Negative Binomial, and Gamma, n.d.).  After examining the 
dependent variable number of treatment sessions attended it was discovered that this 
variable was normally distributed, no longer violating this assumption of Ordinary Least 
Squares Regression. Consequently, linear multiple regression analysis was utilized to 
address this research question.  Because considerable variability has been noted in the 
literature when relating client characteristics with treatment retention, the null hypothesis 
that pretreatment client characteristics are not related to the number of treatment sessions 
attended was tested. Like above, predictors were considered statistically significant if p < 
.05 (Wright, 1995). 
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Chapter IV: Results 
Overview 
The primary purpose of this chapter is to report the results of the statistical 
analyses conducted to address the research questions outlined in Chapter III. First, the 
manner with which missing data was investigated and managed is described. Next, the 
results of the analyses comparing the tested and non-tested subjects on basic demographic 
characteristics and service utilization variables are reported to address the degree of 
generalizability of the findings. Basic descriptive statistics on the sample are then 
reported. Corresponding tables outlining these results are also presented. The final 
section of this chapter is devoted to reporting the results of the three research questions 
described in Chapter III.  
Missing Data 
 When collecting data in treatment settings it is quite common for researchers to 
encounter missing data (Hair, Anderson, Tatham, & Black, 1998). Still, addressing 
missing data is essential since it can significantly bias results and negatively impact the 
generalizability of the findings if not handled properly. Typically, the method to address 
missing data involves first determining the underlying cause(s) that resulted in missing 
data, and secondly utilizing this cause to inform the approach used to rectify the issue of 
missing data (Hair et al., 1998). As such, an analysis to determine the basis of the missing 
data for this study was conducted so it could be properly addressed. The approach taken 
was twofold. First, any possible patterns to the missing data were examined to determine 
the extent of bias associated with the missing data (i.e., whether missing data was 
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associated with one particular assessor or assessment). Second, the potential implications 
of a decreased sample size on the proposed analyses were determined.  
The data set for this study was originally comprised of 298 participants. After 
reviewing all data points for the entire sample, it became evident that 13 of the 
participants were missing data from the InDUC and SOCRATES. It was determined that 
the responses of those 13 participants were lost electronically during a transitional phase 
of implementing an electronic data collection system (after eliminating the paper-pencil 
form) and these cases were not able to be recovered. Additionally, insufficient data 
collection on behalf of the assessors resulted in an inability to calculate summary scores 
on the Form 90, and determine M.I.N.I. diagnoses for 11 participants. It could not be 
determined if the insufficient data collection was resultant from a mistake by an assessor, 
or a refusal to answer a question by a participant. One additional case was missing a 
response on the race/ethnicity question of the ASI. Based upon this qualitative analysis, it 
was determined that the missing data took place at different points in time, across various 
variables, and as a result of different assessors. Consequently, the missing information 
was classified as missing completely at random (MCAR) (Hair et al., 1998). These 
authors suggest that one of the simplest approaches to dealing with MCAR data is to 
eliminate the cases with the missing data, provided this does not significantly 
compromise the statistical power of one’s sample. As such, listwise deletion was the 
chosen method to handle the missing data. Even though deletion of the cases resulted in a 
drop of the total sample size to 273 (an 8.4% reduction), this did not significantly reduce 
the power of the sample, nor was it believed that the cause of the missing data would bias 
the results.  
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One final issue of missing data emerged. There were a total of 15 cases missing 
ASI data resulting from a mishap during data collection where the computer that stored 
the ASI data electronically was accidently destroyed prior to the assessors running their 
regular back-up. As a result, 15 cases of data went missing because the computer data 
were not able to be retrieved. Some of the missing data was obtained by returning to the 
paper report that was generated for the counselors. However, only certain data points 
were able to be gathered this way, therefore some missing data remained from these 
individuals. For one of the analyses in this study, the binary logistic regression, there is a 
predictor variable that was included in the model that was one of the missing data points 
from those 15 ASI reports. Since the data was lost due to a computer being destroyed, it 
was determined that the data was again MCAR. Therefore, the approach used to address 
the missing data was to complete the logistic regression analysis only using observations 
with complete data. Although this did decrease the total sample size for this particular 
analysis from 273 to 258, this reduction was fairly minimal and did not significantly 
impact the power of the sample. This determination was based upon the 
recommendations put forth by Peduzzi, Concato, Kemper, Holford, and Feinstein (1996), 
that at least 10 events of (in this case) drop-out are needed for each predictor variable 
included in order to maintain adequate statistical power.  
Tested vs. Non-tested Clients 
 As noted in the Chapter III, a number of practical issues prevented all participants 
from being tested for the study (e.g., assessor availability, office space, client attendance). 
Consequently, there were approximately 171 program clients who were not assessed for 
this study, yet matriculated through the treatment program during the same time frame as 
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the data collection process. Basic demographic and treatment variables were collected on 
the non-tested participants in order to compare the two groups. To determine 
equivalency, comparative analyses were conducted to compare the study’s sample with 
the group of clients who were not tested for the study but matriculated through the 
program during the same time. Tested and non-tested participants were compared on 
gender, ethnicity, age, treatment duration, and treatment days grouped according to 
treatment completion and non-completion status so as to make a more accurate 
comparison between these two groups. Non-parametric tests were used because the 
continuous variables were not found to be normally distributed when the groups were 
split according to completion status. 
Completers 
 There were a total of 217 treatment completers in the tested (n =161) and untested 
(n = 56) group. Results indicated there were no statistically significant differences 
amongst the completers in the study as compared to the non-study group based on 
demographic characteristics, including gender, X2(1, N = 217) = .133, p  = .715, race, 
X2(5, N = 217) = 7.81, p  = .167, and age (U = 4124.5, p = .343). Additionally, no 
significant differences were found between the tested and non-tested treatment 
completers with respect to treatment variables including duration (U = 3803.5, p = .081) 
and number of treatment days (U = 4473.0, p = .931). 
Non-Completers 
 A total of 227 non-completers comprised the tested (n = 112) and non-tested 
group (n = 115). Results indicated no statistically significant differences among the non-
completers in the study vs. the non-study group based up gender X2(1, N = 227) = .001, p  
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= .981, race, X2(7, N = 227) = 9.191, p  = .239, and age (U = 6258.0, p = .713). 
Statistically significant differences were found to exist with regards to treatment duration 
and number of treatment days attended with the tested non-completers demonstrating 
longer treatment durations (U = 2493.00, p = .000) and more treatment days (U = 
2527.00, p = .000) than the non-completers not tested for the study. 
Descriptive Statistics of Study Sample 
 Descriptive statistics are reported on the entire sample and can be found in Tables 
2-5. Additionally, the tables are broken down according to completion status since this 
study looked to determine predictors of treatment completion and drop-out. Statistically 
significant differences between treatment completers and treatment drop-outs are noted in 
the Tables by asterisks. Statistically significant differences were determined by running 
chi-square analyses for categorical variables, and t-tests for continuous variables that 
were normally distributed and Mann-Whitney U tests for continuous variables without 
normal distributions. 
Client Demographic Characteristics 
 Basic client demographic information on the sample was collected through the 
ASI and is included in Table 2. The average age for the sample of 273 clients was 39.77 
years (SD = 11.80 years). The participant’s ages ranged from 18 to 77 years. The majority 
of the study sample was male (62.3%). Additionally, a large majority of the sample 
identified as Caucasian (86.4%). The sample completed an average of 13.62 years of 
education (SD=2.35), with a minimum of 8 years, to a maximum of 24 years. Almost half 
of the participants reported being married (44.7%) and 17.6% of the sample reported 
being divorced. A majority of the sample (65.9%) reported having a full-time 
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employment pattern (i.e., working 35+ hours/per week) for the three year period prior to 
entering this specific treatment episode. On the other hand, 7.7% of the sample reported 
being primarily unemployed for the three years prior to entering treatment. The average 
income generated 30 days prior to entering treatment was $1,977.73 (SD=2947.663), 
with a minimum income of $0, up to a maximum of $25,000. 
 Treatment completers and drop-outs demonstrated statistically significant 
differences in terms of age, marital status, and income earned in the 30 days prior to 
treatment entry. Treatment drop-outs were younger than treatment completers (t (271) = -
4.43, p = .000). Additionally, treatment drop-outs were found not to be married more 
often than treatment completers (X2(1, N = 258) = 10.433, p  = .001). Finally, treatment 
drop-outs were found to make less money during the month prior to treatment intake than 
treatment completers (t (271) = -2.17, p = .03). 
Table 2 
Demographic Characteristics at Intake 
     Treatment Completion Status   
     Completer Drop-out  Total Sample 
Demographic Characteristic  (n=161) (n=112)  (N=273) 
Age (Years)               42.32 (SD=11.0)   36.10 (SD=11.98)**  38.77 (SD=11.80) 
 
Gender (%)    
Male    63.4  60.7   62.3   
 Female   36.6  39.3   37.7 
 
Race (%)     
White    87.6  84.8   86.4 
 African American  8.7  8.0   8.4 
 Native American  1.2  1.8   1.5 
 Hispanic   2.5  4.5   3.3 
 Asian/Pacific Islander  0  0.9   0.4 
 
86 
 
Years of Education (%)     13.89 (SD=2.51)  13.24 (SD=2.03)      13.62 (SD=2.35) 
 
Marital Status (%)   
Married   52.8  33.0*   44.7 
 Never Married   26.1  44.6   33.7 
 Divorced   17.4  17.9   17.6 
 Separated   1.9  4.5   2.9 
 Widowed   1.9  0.0   1.1 
 
Employment Pattern (%)   
(Prior 3 three years) 
Full-time (35+ hours)  65.2  65.2   65.9  
 Part-time   12.5  12.5   12.5 
 Student   4.5  4.5   3.3 
 Retired/Disability  3.6  3.6   4.8 
 Unemployed   8.0  8.0   8.1 
 Missing   5.4  5.4   5.5 
 
Monthly Income ($)        2298 (SD=3483)    1517 (SD=1856)*    1977 (SD= 2947.66) 
* p < .05; ** p < .001 
Substance Use Characteristics 
 As outlined in Table 3, during the 30 days prior to being interviewed for the 
study, 74.1% of participants reported using alcohol to the point of intoxication, 30.8% 
used marijuana, 24.9% used cocaine, 10.3% used sedatives (not as prescribed by a 
physician), 5.9% used heroin, 3.7% used methadone, 1.5% used barbiturates, 2.2% used 
amphetamines, and 2.2% used hallucinogens. Approximately 45.4% used more than one 
substance during the 30 day period prior to being interviewed. As indicated, alcohol was 
the most commonly used substance. According to the Form 90 assessment, the average 
number of days that individuals spent consuming alcohol during the 90 days prior to 
abstaining was 40.77 (SD=33.57), with an average weekly standard drink consumption of 
44.49 (SD=59.91), and an average peak blood alcohol level of .26 (SD=.24).  
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 Treatment completers and drop-outs were found to statistically significantly differ 
in terms of their marijuana (U = 7077.5, p = .000), cocaine (U = 7322.0, p = .001), heroin 
(U = 8266.5, p = .004), and hallucinogen use (U = 8533.0, p = .003). Treatment drop-outs 
were found to use all four of these substances on more days during the 30 prior to 
treatment intake than treatment completers. 
Table 3 
Substance Use Characteristics 
     Treatment Completion Status   
     Completer Drop-out  Total Sample 
     (n=161) (n=112)  (N=273) 
Use 30 Days Prior to Intake Interview (%) 
 
Alcohol   68.3  75.9   74.1 
Marijuana   21.7  43.7**   30.8 
Cocaine   17.4  35.7*   24.9 
Sedatives   7.5  14.3   10.3 
Heroin    2.5  10.7*   5.9 
Methadone   0.9  6.2   3.7 
Barbiturates   0.6  2.7   1.5 
Amphetamines  1.9  2.7   2.2 
Hallucinogens   0.0  5.4*   2.2 
Inhalants   0.0  0.0   0.0 
 
Ave # of Drinking Days       43.64 (SD=33.73)  36.63 (SD=33.05) 40.77 (SD=33.57) 
in Previous 90 
 
Ave Weekly Drinks          45.44 (SD=52.64)   43.13 (SD=69.26) 44.48 (SD=59.91) 
 
Ave Peak BAC   .25 (SD=.22)      .27 (SD=.27) .26 (SD=.24) 
* p < .05; ** p < .001 
Clinical Characteristics at Intake 
 In addition to basic demographic and substance use information, diagnostic 
information about the participants was also collected through the use of M.I.N.I., and is 
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outlined in Table 4 below. The most common clinical syndrome found within the sample 
was Major Depressive Disorder, with 42.5% of the participants meeting diagnostic 
criteria. An anxiety disorder (e.g., panic disorder, social anxiety disorder, post-traumatic 
stress disorder, obsessive-compulsive disorder, generalized anxiety disorder) was also not 
uncommon with 28.6% of the sample meeting criteria for at least one of listed 
syndromes. These results indicated that having a co-morbid psychiatric diagnosis was 
high in this sample; indeed, 51.6% of the sample met the criteria for both a psychiatric 
and substance use disorder.  
Regarding substance use diagnoses (including substance abuse and substance 
dependence), 74% of the sample met criteria for an alcohol use disorder, and 49.1% met 
criteria for a drug use disorder. More specifically, 14.7% of the sample met criteria for a 
marijuana use disorder, 19.8% for an opiate use disorder, 22% for a cocaine use disorder, 
2.9% for a sedative use disorder, 1.1% for a hallucinogen disorder, and .4% for an 
amphetamine use disorder. Approximately 48.4% met criteria for only an alcohol use 
disorder, 23.4% for only a drug use disorder, and 25.6% for both an alcohol and drug use 
disorder. Over two-thirds of the sample (68.1%) reported having engaged in substance 
abuse treatment prior to the present treatment episode. 
Over half of the sample (60.8%) reported a history of sexual, physical, or 
emotional abuse over the course of their lifetime and taking psychiatric medication at 
some point in their life (64.5%). Having a history of suicidal thoughts and/or attempts 
was also not uncommon. At the time of treatment intake, approximately 33% reported a 
presence of suicidal ideation. 
89 
 
Treatment completers and treatment drop-outs were found to demonstrate 
statistically significant differences in terms of meeting criteria for an anxiety (X2(1, N = 
273) = 10.68, p  = .001), cocaine (X2(1, N = 273) = 11.443, p  = .001), or opiate disorder 
(X2(1, N = 273) = 4.47, p  = .03), whereby participants who met criteria for these 
disorders were more likely to drop-out of treatment. Additionally, participants who met 
criteria for only an alcohol disorder were more likely to complete treatment (X2(1, N = 
273) = 12.15, p  = .000), and those who met criteria for both an alcohol and drug disorder 
were more likely to drop out of treatment (X2(1, N = 273) = 8.40, p  = .004). Finally, 
treatment drop-outs were more likely to carry a dual diagnosis (X2(2, N = 273) = 7.74, p  
= .02) and have a positive history of psychiatric treatment than treatment completers 
(X2(1, N = 273) = 4.36, p  = .04). 
Table 4 
Axis I Diagnoses and Psychiatric Symptoms at Treatment Intake 
     Treatment Completion Status   
      Completer Drop-out  Total 
Sample     (n=161) (n=112)          (N=273)  
Major Depressive Disorder   37.9  49.1   42.5 
 
Anxiety (OCD, PTSD, Social Panic)  21.1  39.3*   28.6 
  
Alcohol Disorder    76.4  70.5   74 
 
Drug Disorder          
 Cocaine Disorder   14.9  32.1*   22 
 Opiate Disorder   15.5  25.9*   19.8 
 Marijuana Disorder   13.0  17   14.7 
 Sedative Disorder   2.5  3.6   2.9 
 Hallucinogen Disorder  0.6  1.8   1.1 
 Amphetamine Disorder  0.6  0.0   .4 
 
Alcohol-Only Disorder   57.1  35.7*   48.4 
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Drug-Only Disorder    20.5  27.7   23.4 
 
Alcohol and Drug Disorder   19.3  34.8*   25.6 
 
Previous AODA Treatment   67.7  68.8   68.1 
 
History of Abuse    59.6  62.5   60.8 
 Emotional Abuse   48.4  54.5   50.9 
 Physical Abuse   29.2  30.4   29.7 
 Sexual Abuse    24.2  21.4   23.1 
 
Suicidal Ideation    31.1  36.6   33.3 
 
Psych Treatment History   53.4  66.1*   58.6 
 
Psych Medication History   61.5  68.8   64.5 
 
Dual Diagnosis    44.7  61.6*   51.6 
* p < .05; ** p < .001 
Treatment Variables 
 For the purpose of this study, treatment variables were identified as the primary 
dependent variables and investigated as they potentially relate to treatment retention. 
There were three treatment variables included in this study: treatment completion/non-
completion status, treatment duration, and number of treatment sessions attended. The 
average treatment duration of the entire sample was 27 days (SD = 11.40). The average 
number of treatment sessions attended by participants was 14 (SD = 5.06). Based upon 
the criteria described in Chapter III, 41% of the participants were classified as treatment 
drop-outs and 59% were classified as treatment completers. Of those clients who dropped 
out of treatment, their average treatment duration lasted 20.46 days (SD = 10.65) and the 
average number of treatment days attended was 11.17 (SD = 5.40). On the other hand, for 
treatment completers, the average treatment duration lasted 31.63 days (SD = 9.52) and 
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the average number of treatment days attended was 16.29 (SD = 3.54). It needs to be 
stressed, however, that the 59% completion rate is based upon the 273 participants tested 
for this study. When the 171 clients who were not tested for this study are included, the 
completion rate decreases to 49% and the drop-out rate increases to 51%, which is a more 
accurate representation of the retention rates for all the clients who matriculated through 
the treatment program during the data collection process. 
Table 5 
Treatment Variables 
     Treatment Completion Status   
    Completer  Drop-out  Total Sample 
    (n=161)  (n=112)  (N=273)  
Treatment Duration     31.63 (SD=9.52)    20.46(SD=10.65)**        27.05(SD=11.40) 
Treatment Days     16.28 (SD=3.54)    11.17 (SD=5.40)**         14.19 (SD=5.06) 
* p < .05; ** p < .001 
Approach to Regression Analyses 
 The process utilized for the selection of covariates to be included in the regression 
analyses is an approach put forth by Hosmer and Lemeshow (2000). The type of 
approach used is one that is recommended for studies such as this one, which are 
primarily exploratory in nature. In order to determine the group of covariates that would 
be used in the regression models, a series of exploratory bivariate analyses (i.e., Chi-
square, t-tests, and correlations) were conducted. For each of the dependent variables to 
be used in the regression models (i.e., treatment duration, number of treatment days, and 
treatment completion status), exploratory analyses were run investigating the strength of 
the relationships between the potential covariates and dependent variables. Variables 
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found to be statistically significantly related to the dependent variable were retained for 
the regression analysis. A more liberal significance level cut-off was used of p = .10, to 
determine the initial group of covariates to be used in the regression models (Hosmer & 
Lemeshow, 2000). This liberal cut-off was utilized as a means to identify covariates that, 
by themselves, may not have been traditionally statistically significant (e.g., <.05) in the 
bivariate analyses, but could, as part of a more complex predictive model, contribute as a 
statistically significant predictor (Hosmer & Lemshow, 2000). 
Of the potential covariates examined, 32 were found to be statistically 
significantly related to treatment completion status. This final list was then broken down 
according to broad categories of the covariates (see Table 6) and again explored to 
determine which of the variables within each set were found to have the strongest 
relationship with the dependent variable. In order to cap the total number of predictor 
variables around 20-25 for the initial analysis, some of the variables were 
combined/collapsed. For example, instead of running recent drug use for each drug 
separately (e.g., heroin, cocaine, marijuana etc.) a new variable representing recent drug 
use spanning across type of drug was created. All the predictor variables listed in Table 6 
were found to have the strongest relationship to the dependent variable and hence were 
retained and included in the initial multivariate logistic model as predictors. The original 
logistic regression analysis included all the predictors listed in Table 6. The covariates 
that evidenced the weakest relationship to treatment completion status were removed and 
the analysis was run again. This approach to testing the significance of the coefficient(s) 
helps to address the following question: “Does the model that includes the variable in 
question tell us more about the outcome variable than a model that does not include that 
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variable?” (Hosmer & Lemeshow, 2000, p. 11). This approach was used iteratively until 
only the strongest and most parsimonious predictive model remained. This same method 
was utilized in the other two regression analyses and the tables with the corresponding 
significant predictors used in the initial analyses are listed accordingly. 
Table 6 
Covariates Included in Binary Logistic Regression Analyses 
Variable    Significance (p) Category 
Marital Status     .001   Demographics 
Years of Education    .013   Demographics 
Age     .000   Demographics 
Opiate Use Disorder    .034   Drug/Alcohol Disorder 
Cocaine Use Disorder   .001   Drug/Alcohol Disorder 
Drug use Disorder    .000   Drug/Alcohol Disorder 
Alcohol Only Disorder   .000   Drug/Alcohol Disorder 
Alcohol and Drug Disorder   .004   Drug/Alcohol Disorder 
ASI Drug Composite Score   .000   Drug/Alcohol Disorder 
Psych Treatment History   .037   Dual Diagnosis 
Depressive Disorder    .065   Dual Diagnosis 
Anxiety Disorder    .001   Dual Diagnosis 
Eating Disorder    .093   Dual Diagnosis 
Dual Diagnosis    .021   Dual Diagnosis 
Regularly take prescription med  .072   Health Problem 
for a physical problem 
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Lifetime Alcohol Use   .012   Alcohol/Drug Use 
Recent Drug Use   .010   Alcohol/Drug Use 
(30 days prior to intake) 
 
Historic Drug Use    .011   Alcohol/Drug Use 
 # of times treated for drug abuse .008   Alcohol/Drug Use 
Socrates D Total Score   .018   Motivation 
Socrates A Total Score   .004   Motivation  
 InDUC Responsibility   .028   Drug Use Consequences 
Admission prompted by  .071   Legal Problems 
legal system 
 
 Positive Legal History   .005   Legal Problems 
ASI Legal Composite Score  .03   Legal Problems 
 
Research Question 1 
 The first research question was to determine predictor variables associated with 
treatment completion status. It was hypothesized that pre-treatment client characteristic 
variables (e.g., age, marital status, drug and alcohol use) would help predict treatment 
completion and drop-out status. Logistic regression was utilized to examine this question 
since the dependent variable of treatment completion status is a dichotomous variable. As 
mentioned, Table 6 includes the predictor variables that were used in the initial logistic 
regression analyses. Based upon the significance level of each covariate within the 
model, those that contributed the least amount of variance, and had the lowest level of 
significance, were removed from the model one by one until the most parsimonious 
model with the strongest predictors were remaining (Hosmer & Lemeshow, 2000).  
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Like other regression analyses, logistic regression is susceptible to collinearity 
issues, whereby when two variables are highly correlated to one another it can make 
determining the unique contribution of each predictor variable, and thus any 
interpretation the meaning of the results, very difficult (Hair et al., 1998). To investigate 
any multicollinearity problems, collinearity diagnostics were run.  Both the tolerance and 
variance inflation factor (VIF) were examined for each variable. The recommended cut-
off is commonly a tolerance value of .10, which corresponds to a VIF value of above 10 
(Hair et al., 1998). The tolerance and VIF values were examined for each of the variables 
and all fell in the range demonstrating no multicollinearity problems, with no tolerance 
levels falling below .97 and no VIF values above 1.03.  
Table 7 depicts the final model utilized to address research question 1. The overall 
effect of the predictor variables upon the dependent variable of treatment completion 
status was statistically significant X2(4, N = 258) = 42.805, p  = .000.The model 
accurately classified treatment completion status for 70.2% of the participants, with 55% 
sensitivity and 81% specificity for treatment completion.  It demonstrated a 33% false 
positive rate and a 28% false negative rate at predicting treatment completion. Among the 
clients tested for this study, the documented rate of completion was 59%. Therefore, this 
model demonstrated an increase in correctly identifying treatment completion status from 
what would have been determined simply by “chance” by increasing this probability to 
70.2%. 
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Table 7 
Logistic Regression Model for Treatment Completion Status 
Variable        95% C.I for OR 
    B S.E. df Sig. OR Lower Upper 
Age    .046 .012 1 .000 1.047 1.022 1.073 
Anxiety Disorder  -.913 .296 1 .002 .401 .225 .718 
Cocaine Use Disorder  -.56 .172 1 .001 .571 .408 .801  
 
Admission prompted by -.856 .465 1 .07 .425 .171 1.057 
Legal system 
 
 As indicated by the inverting the adjusted odds ratios, for those clients who did 
not meet criteria for an anxiety disorder, there was a 2.5 increase in the odds of staying in 
treatment compared to those clients who were found to meet criteria for an anxiety 
disorder. Similarly, for those clients who did not meet criteria for a cocaine use disorder, 
there was a 1.75 increase in the odds of staying in treatment compared to those clients 
who were found to meet criteria for a cocaine disorder. Age was also found to be a 
statistically significant predictor. Because the adjusted odds ratio reported in the table 
indicates the change in odds with each one year increase in age, it was determined that a 
more meaningful indicator would be the change in odds with each decade increase in age 
(Norusis, 2003). The proper exponentiation was taken to calculate this more meaningful 
odds ratio. The resulting odds ratio demonstrated that the odds of staying in treatment 
increase by about 1 ½ times (OR = 1.58) for every decade increase in age. Although it 
was not statistically significant, by including the variable of “treatment prompted by the 
legal system”, the successful prediction of completion status increased by 3% (from 67% 
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to 70.2%). While there was not a substantial increase in the predictive power of the 
model, the slight increase, coupled with previous literature implicating legally prompted 
treatment as being related to retention, resulted in a decision to keep this variable in the 
model. Some of the participants in the study enrolled in treatment in large part because 
the legal system prompted them to do so (e.g., mandatory substance abuse treatment 
following a driving while intoxicated infraction). For those clients whose admission into 
treatment was prompted by the legal system, the odds of staying in treatment were 
slightly less than half when compared to those clients who were not prompted by the 
legal system. 
Research Question 2 
 The second research question examined if time to dropout could be predicted by 
various predictors. Survival analysis was used in order to describe the proportion of cases 
for which the event dropout occurred at various time points by assessing the relationship 
between survival time and a set of predictor variables. Survival analysis is utilized to 
investigate the occurrence of an event (in this case, treatment dropout) taking place and 
allows one to determine the point of time at which most individuals are most likely to 
drop out of treatment. Survival analysis is used to examine how covariates may change 
the odds of individuals dropping out of treatment (Norusis, 2005).  
Similar to the approach taken in the logistic regression model, exploratory 
analyses investigating the strength of the relationships between the potential covariates 
and the dependent variable (treatment duration) were conducted. All significant 
covariates that were then used in the initial survival analysis are listed below in Table 8. 
The Cox Proportional Hazards (PH) Model was the model chosen for the survival 
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analysis. It is considered a semiparametric approach as it does not require assumptions 
about the multivariate normality, linearity, or homoscedasticity (Norusis, 2005). On the 
other hand, the model does assume “that covariates are additive and linearly related to the 
log of the hazards function” (p. 137-138), known as the proportional hazards function. It 
is assumed that for all cases and across points in time, the shape of the survival function 
will essentially remain the same. The assumption of the proportional hazards function 
was tested and only predictors that did not violate this assumption were maintained in the 
analysis.  
Table 8 
Covariates Evaluated for Cox PH Model 
Variable    Significance  Category 
Marital Status     .019   Demographics 
Age     .000   Demographics 
Opiate Use Disorder    .031   Drug/Alcohol Disorder 
Cocaine Use Disorder   .077   Drug/Alcohol Disorder 
Drug use Disorder    .003   Drug/Alcohol Disorder 
Alcohol Only Disorder   .005   Drug/Alcohol Disorder 
Alcohol and Drug Disorder   .022   Drug/Alcohol Disorder 
ASI Drug Composite Score   .001   Drug/Alcohol Disorder 
Anxiety Disorder    .002   Dual Diagnosis 
Dual Diagnosis    .023   Dual Diagnosis 
Regularly take prescription med  .024   Health Problem 
for a physical problem 
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Recent Drug Use   .003   Alcohol/Drug Use 
(30 days prior to intake) 
 
Socrates D Total Score   .009   Motivation 
Socrates A Total Score   .10   Motivation 
 
The variables that were used for the analysis are listed in Table 9. Based upon 
recommendations put forth by Eliason (1993), when five or fewer covariates are used in a 
Cox regression analysis a sample size of at least 60 is required. Given these guidelines, a 
sample of 273 provides adequate statistical power to detect statistical effects. It should 
also be noted that like other types of regression analyses, Cox PH method is sensitive to 
high correlations between covariates. To address any issues of multicollinearity, 
collinearity diagnostics were conducted.  Both the tolerance and variance inflation factor 
(VIF) were examined for each variable. As previously indicated, the recommended cut-
off is commonly a tolerance value of .10, which corresponds to a VIF value of above 10 
(Hair et al., 1998). The tolerance and VIF values were examined for each of the 
predictors and all fell in the range demonstrating no multicollinearity problems, with no 
tolerance levels falling below .97 and no VIF values above 1.03.  
Table 9 
Covariates Used in the Cox PH Regression Analysis 
Variable    Category 
Age     Demographics 
Marital Status    Demographics 
Opiate Use Disorder   Drug Disorder 
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Cocaine Use Disorder   Drug Disorder 
Recent Drug Use   Alcohol/Drug Use 
SOCRATES A Total Score  Motivation 
 
Cox Regression Survival Analysis Final Model 
Table 10 depicts the final Cox regression model utilized to address research 
question 2. The overall effect of the predictor variables upon the dependent variable of 
treatment duration was statistically significant X2(3, N = 273) = 45.05, p  = .000. The 
table below provides additional information about the covariates that are statistically 
significant and how they relate to the dependent variable of treatment duration. If the 
odds ratios are less than 1.0 the direction of the effect is toward reducing the hazard rate. 
The hazard rate function represents the risk that exists for dropping out of treatment on 
that specific day and provides information on the average number of people who drop out 
of treatment over the course of the study period. When hazard rates are plotted over time 
it allows one to view the risk of dropping out over a specific duration and determine if 
there are any peaks or troughs in the graph indicating an increased or decreased risk of 
dropout for that period of time in treatment (Kleinbaum, & Klein, 2005). The survival 
function is also used to assess the point at which most people are likely to drop out. It is 
common for researchers to look at the time point when the survival function equals .50 
(i.e., the median lifetime) to make this determination.  
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Table 10 
Cox Regression Model for Time to Treatment Drop-out 
Variable        95% C.I for EXP(B) 
    B S.E. Wald df Sig. EXP(B) Lower Upper 
Anxiety Disorder  .713 .194 13.46 1 .000 2.04  1.394  2.99 
Cocaine Use Disorder  .594 .203 8.55 1 .000 1.81  1.217  2.7 
Age    -.043 .009 23.11 1 .000 .958  .942  .98 
 
As the results indicate, those individuals meeting criteria for an anxiety disorder 
have an increased risk of about 100% to drop-out compared to those without an anxiety 
disorder. Similarly, those clients meeting criteria for a cocaine disorder have an increased 
risk of drop-out of 81% compared to those clients who did not meet criteria for a cocaine 
disorder. Finally, for every year increase in age, the risk of drop-out was found to 
decrease by about 4%. As indicated earlier, 41% of the sample dropped out of treatment 
and 59% completed it, with 112 participants experiencing the event of drop-out and 161 
cases censored, since they were classified as treatment completers. The figure below 
depicts how the “survival” rate of hypothetical individuals with mean values on the 
covariates decreases over time, with survival time represented on the X axis. Note that 
the risk of drop-out tends to be fairly linear across the time span, as opposed to having 
any sharp peaks or troughs. 
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Figure 1 
Survival Function at Mean of Covariates  
 
Research Question 3 
 The third research question investigated whether any client characteristics at the 
point of treatment intake were statistically significant predictors of the number of 
treatment sessions attended. Originally a Poisson Regression analysis was going to be 
conducted since count data in the social sciences are not typically normally distributed, a 
violation of an assumption of the Ordinary Least Squares regression model (Licht, 1995). 
Upon investigating the data, it was discovered that number of treatment days attended 
was normally distributed, and as such, a linear multiple regression analysis was 
conducted. Prior to conducting the regression analysis, exploratory analyses were again 
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conducted, investigating the relationships between the dependent variable and various 
predictors. The initial list for the regression analysis can be found in Table 12. Prior to 
running the regression analysis, each continuous predictor was evaluated to ensure that it 
was linearly related to the dependent variable (Licht, 1995; Norusis, 2003). All predictors 
used were found to be linearly related to the dependent variable “treatment days”, barring 
four outliers in the ASI drug composite score and recent drug use. To ensure that the 
outliers were not skewing the results in anyway, the analyses were run both including and 
excluding the outliers and the results were not found to differ. 
Table 11 
IVs Included in Initial Multiple Regression Model 
Variable    Significance  Category 
Marital Status     .01   Demographics 
Age      .00   Demographics 
Opiate Use Disorder    .03   Drug/Alcohol Disorder 
Cocaine Use Disorder   .10   Drug/Alcohol Disorder 
Drug use Disorder    .01   Drug/Alcohol Disorder 
Alcohol only disorder   .01   Drug/Alcohol Disorder 
Alcohol and drug disorder    .06   Drug/Alcohol Disorder 
ASI Drug composite score   .01   Drug/Alcohol Disorder 
Years used alcohol regularly  .10   Drug/Alcohol Disorder 
Anxiety Disorder    .01   Dual Diagnosis 
Recent Drug use   .06   Alcohol/Drug Use 
(30 days prior to intake) 
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Socrates D Total Score   .01   Motivation 
Socrates A Total Score  .06   Motivation 
Socrates A Recognition Scale .02   Motivation 
 
Final Regression Model 
The final regression model resulted in a total of three statistically significant 
predictors. Before finalizing the model however, any potential problems of 
multicollinearity were assessed. To assess for any problems of multicollinearity both the 
tolerance and variance inflation factor (VIF) was examined for each variable. The 
recommended cut-off is commonly a tolerance value of .10, which corresponds to a VIF 
value of above 10 (Hair et al., 1998). The tolerance and VIF values were examined for 
each of the variables and all fell in the range demonstrating no multicollinearity 
problems, with no tolerance levels falling below .61 and no VIF values above 1.6.  
The final regression model was found to be statistically significant F(3, N = 273) 
= 11.58, p  = .000, with the predictor variables accounting for approximately 35% of the 
variance. The beta weights and statistical significance for each predictor variable can be 
found below in Table 12. The results indicate that age is positively associated with the 
number of days in treatment, meaning, older clients were found to attend more treatment 
days than their younger counterparts. Both having an anxiety disorder and total number 
of years using alcohol were negatively related to number of treatment days attended. 
Clients diagnosed with an anxiety disorder spent less time in treatment than those without 
that disorder. Finally, those clients who used alcohol regularly for more years over the 
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course of their lifetime attended fewer treatment days than those who used alcohol 
regularly for fewer years.  
Table 12 
Multiple Regression Model for Number of Treatment Sessions Attended 
Variable        95% C.I for B 
    B S.E. β t Sig. Lower Upper 
Age    .160 .032 .378 5.053 .00 .097 .222 
Anxiety Disorder  -1.532 .651 -.139 -2.352 .019 -2.814 -.249 
Years of Alcohol Use  -.074 .031 -.177 -2.376 .018 -.135 -.013 
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Chapter V: Discussion 
Overview 
 The purpose of this chapter is to discuss and integrate the findings reported in 
Chapter IV with the existing substance abuse treatment retention literature. Each research 
question is reviewed and the corresponding results are discussed. The clinical 
implications of the findings are presented, as well as this study’s limitations. 
Recommendations for future research and closing remarks are included. This chapter 
concludes with Table 13, which is a summarization of the statistically significant findings 
and interpretation of these results. This table can be found at the end of the chapter along 
with a summary of the clinical implications and how the findings fit with existing 
literature.  
Rationale for the Study 
This study set out to investigate how client characteristics, at the point of 
treatment intake, are related to retention at a local substance abuse treatment program. 
The purpose of this study was two-fold. First, a variety of client characteristics were 
examined to investigate whether they could help predict drop-out of treatment. The 
clinical implications of these findings will be shared with the treatment program with the 
goal of increasing the program’s retention rates. Retention has been linked to client 
attributes that are amenable to change through the therapeutic process. Although “static” 
demographic characteristics (i.e., gender, age, and ethnicity) appear to be related to 
treatment retention and outcomes, other “dynamic” client characteristics that can be 
impacted in the therapeutic milieu (i.e., psychiatric distress, social support, and 
employment problems) are also directly linked (Klag et al., 2004). Importantly, whether 
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dynamic or static client characteristics are identified as being related to retention, the 
treatment program could look to alter their treatment approach to help improve drop-out 
rates (i.e., offering mentoring to younger clients in an effort to help keep them engaged in 
treatment). Therefore, the results of this investigation could be used by the treatment 
program to develop an intake “at risk” screen for new clients entering their program, and 
in response, possibly tailor treatment to help improve the retention rates of those more 
prone to drop-out. Second, this study also sought to investigate how well the existing 
literature base “fits” with the findings associated with the treatment program utilized for 
this investigation, since there have been such conflicting results reported in substance 
abuse treatment retention literature.  
Research Questions 
The research questions and the results of those questions will be briefly reviewed 
in this section. As indicated in Chapter IV, there was a fair amount of overlap in the 
statistically significant predictors associated with all three research questions. Two of the 
variables, age and meeting criteria for an anxiety disorder, were statistically significant 
predictors in all three regression models. One variable, meeting criteria for a cocaine 
disorder, was a statistically significant predictor in two of the three models. Therefore, 
instead of including an in-depth discussion of the statistically significant variables when 
describing the results of each research question, each statistically significant variable will 
be discussed in separate subsequent sections to avoid redundancy. 
Completers Compared to Non-Completers 
 Before the main research questions were investigated, analyses were run 
comparing treatment completers and non-completers on demographic, psychiatric, and 
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substance use characteristics. Statistically significant differences were found to exist 
between completers and non-completers in terms of: age, marital status, income, drug use 
just prior to treatment entry, meeting criteria for an anxiety disorder, having a dual 
diagnosis, meeting criteria for a cocaine or opiate disorder, and being diagnosed with 
only an alcohol disorder. Compared to treatment completers, treatment drop-outs were 
more likely to be younger; unmarried; report lower incomes; use drugs more prior to 
intake; have met criteria for an anxiety, cocaine, or opiate disorder; and have a dual 
diagnosis. Treatment completers were more likely to be diagnosed with an alcohol-only 
disorder than treatment drop-outs. Each of these statistically significant variables will be 
discussed in the subsequent section after the results of the research question are reviewed. 
Research Question 1 
The first research question investigated whether client characteristics could help 
predict treatment completion status. The results indicated that younger age and meeting 
criteria for an anxiety disorder and/or a cocaine disorder were statistically significant 
predictors of treatment drop out. The final logistic regression model was found to 
accurately predict treatment completion status about 70% of the time. Although the 
predictive ability of the model was found to be better than chance (59%), it still did not 
demonstrate excellent predictive ability of treatment completion status among this 
sample. This may have been the result of the fact that only client characteristics were 
included as variables. Had treatment variables (i.e., therapeutic alliance, intensity of 
service allotment) also been included in this study, the predictive power of the model 
may have improved. This hypothesis is based on previous literature which has implicated 
program factors as impacting client retention (Broome et al., 1999; Chou et al, 1998; 
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Marrero et al., 2005). Still, the clinical implications of the model can help to inform 
current treatment practices, as well as future research investigations that could take place 
as a follow-up to this study.  
 At the very least, this program is now aware that, at the point of treatment intake, 
younger clients and those with an anxiety and/or cocaine disorder are at an increased risk 
for dropping out of treatment. One way to utilize this information is for counselors and 
intake workers to be aware of these risk factors and use them as an alert system to more 
closely work with such clients. For example, clinicians may meet with these “at risk” 
clients and employ a brief motivational intervention to help solidly engage them in 
treatment early on. In fact, if such a method is useful with those at risk for drop-out it 
may also be helpful with other client presentations as well. Additionally, employing 
treatment approaches specifically designed to address cocaine disorders may also help to 
decrease the risk of drop out. Motivational enhancement strategies have been found to be 
useful with this type of population and can be easily implemented into existing 
approaches (Bernstein et al., 2005; Secades-Villa et al., 2004). Finally, working to 
provide more holistic or integrated treatment to clients with co-morbid anxiety disorders 
could also help to decrease the risk of drop-out (Hesse, 2009). These recommendations 
will be expanded on in subsequent sessions discussing the individual variables. 
 It should also be noted that although the model did not demonstrate promising 
sensitivity (true positive) for treatment completion, it demonstrated much higher 
specificity (true negative). This suggests that the treatment program can be more 
confident in predicting who is going to drop-out of treatment as opposed to who is going 
to complete it. This has positive clinical implications as treatment adjustments can be 
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targeted at these specific characteristics. In other words, there does not appear to be a 
down side to adjusting treatment based on some of the recommendations found here even 
for those clients who would end up completing treatment without such adjustments. For 
example, employing a brief motivational interviewing intervention early on in treatment 
at the very least would not hurt any of the clients and in fact, may be found to improve 
retention rates among those at-risk. 
Future investigations could look to improve the predictive accuracy of the model 
by including both the statistically significant variables from this study, while 
incorporating additional variables such as program factors and other client characteristics 
not measured in this study. By doing so, the predicative power of the logistic regression 
model could improve, providing a more illustrative picture of those at-risk for drop-out. 
Ultimately by improving the predictive model the treatment program would be able to 
develop an at-risk screen that could identify those clients at greatest risk of dropping out. 
Altering treatment approaches to improve retention rates of these clients could be an 
ensuing step in research. 
Research Question 2 
 The second research question investigated whether client characteristics could 
predict time to drop out. Mirroring the results of the first research question, younger age 
and meeting criteria for an anxiety and/or cocaine disorder were found to predict shorter 
stays in treatment. Treatment drop out was found to take place gradually over time, 
without what appears to be any specific periods of increased risk. Previous research 
identifies the beginning of treatment as a particularly vulnerable time for drop out (Justus 
et al., 2006; Sayre et al., 2002; Siqueland et al., 2002; Veach et al., 2000); however, the 
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sample utilized for this investigation does not  support that finding. Still, it should be 
noted that the group of clients who were not tested for this study may have impacted this 
result. A variety of practical issues were found to impact the number of clients tested, 
including early drop-out. Some clients did not return for treatment after intake and 
therefore were not assessed for this project. The average duration of time from treatment 
entry to assessment appointment was five calendar days. There were a number of clients 
that dropped out of treatment between the point of intake and when they were to be 
tested. As such, data on these clients are not represented in these results. Consequently, 
there is a possibility that the results of this research question may be underestimating the 
risk of early drop-out since a number of clients who dropped out early were not included 
in the survival analysis. 
Research Question 3 
 The third research question investigated if client characteristics could predict the 
number of treatment sessions attended. Results indicated that younger age, meeting 
criteria for an anxiety disorder, and greater number of years using alcohol regularly were 
statistically significant predictors of fewer treatment sessions attended. The next section 
will look more closely at the statistically significant variables and discuss possible 
interpretations of the results. 
Treatment Completers versus Non-completers 
Demographic Characteristics 
 In terms of demographic characteristics, younger clients, those not married, and 
those with lower incomes were more likely to drop out of treatment than clients who 
were older, those married, and those with higher incomes. Similar findings are found in 
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the existing literature base. In fact, one of the most robust findings in the treatment 
retention literature is the positive relationship between age and treatment drop-out (Chou 
et al., 1998; Green et al., 2002; Kavanagh et al., 1996; Mammo & Weinbaum, 1993; 
Mitchell-Hampton, 2006; Roffman et al., 1993; Rowan-Szal et al., 2000; Satre et al., 
2004; Stark, 1992). Considering that age was also a statistically significant predictor in 
each of the three regression analyses, the subject of age and retention will be expanded 
upon in the section specifically devoted to discussing the statistically significant 
predictors that held up in the regression models to avoid redundancy. The statistically 
significant client characteristics associated with the bivariate analyses that were not found 
to hold up in the regression models will be discussed in this section.  
 Although much research has been conducted on age, a more limited number of 
studies have implicated marital status as being related to treatment retention. Siqueland et 
al. (2002) reported that among their Caucasian participants, those who were married or 
lived with a significant other were found to remain in treatment for a longer period. Other 
studies have replicated this finding that not being married is associated with treatment 
drop-out (Broome et. al., 1999; Curran, Stecker, Han, & Booth, 2009). Theories put forth 
explaining this relationship include the notion that clients may be more likely to remain 
in treatment if there is a supportive partner at home reinforcing the engagement in 
treatment. Related, spouses may put significant pressure on their partners to attend 
treatment and threaten to leave if treatment is not completed. This type of “external 
motivation” has been found to prompt initial attendance in substance abuse treatment 
(DiClemente et al., 1999; Weisner et al., 2001). Also related, those clients who are 
unmarried adults may have fewer people to whom they are held accountable to, including 
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children, which also could impact treatment retention. For example, a client could be 
more committed to a treatment regimen if s/he has young children at home who depend 
on him/her. A phenomenon coined role incompatibility illustrates the conflict between 
certain social roles (e.g., parenting) and certain types of behavior (e.g., heavy drinking 
resulting in the role of heavy drinker). These types of role incompatibilities could act at 
as strong motivators to keep clients in treatment. Typically speaking, younger and 
unmarried clients tend to have fewer role incompatibilities as it relates to their substance 
use (Littlefield, Sher, & Wood, 2009), hence possibly making it less difficult to drop-out 
of treatment and continue using. 
 Finally, clients who reported receiving lower monthly incomes were more likely 
to drop out of treatment. This positive relationship has been replicated in the literature 
across samples (Roffman et al.,1993; Siqueland, 2002), as well as specifically with 
female clients (Green et al., 2002; Mertens & Weisner, 2000; Weisner et al., 2001). 
Explanations for this phenomenon may include that individuals with higher incomes 
generally have greater access to resources that individuals with lower incomes may not 
be able to afford. For example, those clients with higher incomes may also be able to pay 
for a psychotherapeutic add-on if co-morbid psychiatric distress was an issue, or cover 
child-care costs in order to attend treatment. Similarly, if insurance only allots for a 
limited number of sessions, individuals with higher incomes may have more latitude to 
select to pay out of pocket for additional sessions in order to complete the treatment they 
started. On the flip side, those clients with lower incomes may not be in a position to miss 
numerous days of work to attend treatment, especially intensive outpatient treatment that 
meets every (or almost every) day of the week. 
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 The clinical implications of these findings suggest that when this treatment 
program enrolls clients who are young, not married, and/or have lower incomes they 
could be at an increased risk of dropping out of treatment. One useful strategy may be to 
work with those clients who are not married to identify motivating factors to remain in 
treatment. This could include identifying someone close to them who supports their 
sobriety to act as the accountability factor typically associated with a spouse. 
Additionally, clients who present with lower incomes may benefit from meeting with a 
social worker on staff to learn about financial assistance or other types of community 
programs (e.g., affordable child care, employment placement) that might assist them in 
managing the additional stressors outside of their recovery process. 
Recent Drug Use and Type of Drug Disorder 
 In addition to demographic characteristics, drug use just prior to treatment intake 
was  associated more often among those clients who dropped out of treatment. More 
specifically, treatment drop-outs were found to have used marijuana, cocaine, heroin, and 
hallucinogens more in the 30 days prior to intake than those clients who completed 
treatment. Heavier drug use has been implicated as being related to retention in previous 
research as well. For example, Stark (1992) has claimed that “the fact that clients who 
use more drugs have higher attrition rates is true almost by definition and is 
overwhelmingly confirmed by the evidence” (p. 102). Drug use close to the point of 
intake can be indicative of both the severity and intensity of clients’ substance use, higher 
degrees of which have been found to negatively impact retention in treatment (Alterman 
et al., 1996; Lang & Belenko, 2000; Maglione et al., 2000b; Marrero et al., 2005; Mertens 
& Weisner, 2000; Westreich et al., 1997). Additionally, entering treatment when one is 
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using both alcohol and drugs has been associated with increased rates of drop-out (Easton 
et. al., 2007). Other studies have supported the finding that when clients are using drugs 
directly around, or 30 days before, treatment intake, they are less likely to remain in 
treatment (Alterman et al., 1996; Paraherakis et al., 2000; White et al., 1998). 
 Using drugs close to the point of treatment intake may negatively impact retention 
for a variety of reasons. As previously stated, the variability in treatment approaches is 
the rule rather than the exception and some treatment approaches may not be addressing 
the needs of those using drugs. For example, the treatment program associated with this 
study is based upon tenets of the Minnesota Model of treatment, including the 
incorporation of  a 12-step approach rooted in the treatment of alcohol dependence 
(Owen, 2003). Clients who enter treatment with recent drug use may have idiosyncratic 
treatment needs not associated with those who only use alcohol. For example, before 
treating clients who are addicted to opiates, it has been suggested that first such clients 
may benefit from stabilizing on methadone and then subsequently being exposed to more 
traditional substance abuse treatment. Still, a call for alternative interventions for specific 
drug using populations has been recommended (Paraherakis et al., 2000). Further 
complicating matters may be that clients who are using illicit drugs just prior to and 
around treatment intake are not necessarily functioning at an optimal cognitive level. 
Decision making and judgment is often impaired, which has implications for engaging 
and remaining in treatment (Stark, 1992). Additionally, if a client is having a difficult 
time abstaining from their use of drugs in a program that requires absolute abstinence in 
order to participate, such a client may simply make a decision to leave before being 
discharged due to violating treatment rules. The treatment program associated with this 
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study employs an abstinence-based treatment approach such that if abstinence is broken 
clients are mandatorily discharged from the program. 
 Research has also suggested that type of drug used can negatively impact 
treatment retention; cocaine and opiate use being cited in numerous studies for the 
adverse relationship it appears to have with treatment retention (Fletcher et al., 1997; 
Paraherakis, et al., 2000; Sapadin, 2006; Sinqueland et al., 2002; Veach et al., 2000). In 
this study, in addition to recent use of cocaine and heroin, meeting criteria for a cocaine 
or opiate disorder was also associated with higher treatment drop-out. In this study, 
meeting criteria for a cocaine disorder was found to be a statistically significant predictor 
of treatment drop-out and time spent in treatment; therefore, this topic will be expanded 
upon when the statistically significant predictors of the regression analyses are discussed. 
However, since opiate use was not implicated in the regression analyses it will be 
covered in this section. 
Individuals addicted to opiates have been found to demonstrate higher levels of 
cognitive impairment than clients who enter treatment using other types of drugs 
(Paraherakis et al., 2000). Cognitive impairment, especially its potential effect on a 
client’s ability to attend, has been found to impact retention, whereby greater impairment 
is related to increased risk of drop-out (Aharonovich, et al., 2006). Furthermore, 
Paraherakis et al., (2000) reported that when comparing clients according to alcohol, 
cocaine, and opiate use, those clients addicted to opiates were found to attend treatment 
sessions less often and demonstrated lower abstinence rates. It is difficult to ascertain 
exactly why one addicted to opiates might demonstrate lower retention rates. It may be, 
again, idiosyncratic treatment needs associated with such a population. It may be related 
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to the cognitive impairment associated with opiate use which was cited earlier. Finally, 
the lower rates of retention associated with opiate use may be related to the fact that 
younger clients have been found to use opiates a higher rates than their older counterparts 
(Paraherakis et al., 2000). Seen this way, since age is implicated consistently in retention, 
opiate use may simply be a confounding variable. Still, when clients present with an 
opiate disorder or at the very least, use opiates just prior to treatment, this can be an 
indicator of a risk for drop-out. 
Interestingly, in the present study, treatment completers demonstrated higher rates 
of an alcohol-only disorder. Similar findings have been shown in previous research which 
has suggested that when clients present for treatment with only alcohol use, their 
retention rates have been found to be higher than for clients who present with a co-
morbid drug disorder or a single drug disorder (Joe et al., 1999; McKellar et al., 2006). 
There are a few potential explanations of this finding. One explanation may be related to 
the treatment philosophy employed by the program. As mentioned, the treatment program 
associated with this study is based upon the Minnesota Model of treatment; one that has a 
history of, and roots in, the treatment of alcoholism. It would seem logical to conclude 
that this program likely meets the treatment needs of those clients addicted to alcohol, 
perhaps contributing to such clients demonstrating higher retention rates. Similarly, if a 
client presents with a co-morbid drug use disorder this may be indicative of more severe 
substance abuse. This more severe pattern of use, coupled with a treatment program that 
may not be tailored for such individuals, could result in higher drop-out rates for such 
clients.  
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Dual Diagnosis 
 Treatment completers and non-completers were found to demonstrate statistically 
significant differences based on psychiatric distress and diagnoses. Treatment non-
completers demonstrated higher rates of meeting criteria for an anxiety disorder, being 
dually diagnosed, and having a history of psychiatric treatment. Because meeting criteria 
for an anxiety disorder was a statistically significant predictor in each of the regression 
analyses, the discussion around this finding will be expanded upon in the subsequent 
section.  
 Substance abuse treatment clients presenting with a dual diagnosis are a common 
occurrence with documented rates around 63-69% (Castel et al., 2006; Chareny et al., 
2005). Slightly more than half (51.6%) of the total sample of this study met criteria for 
both a substance abuse and other psychiatric disorder, but a higher rate was demonstrated 
specifically among treatment drop-outs (61%). Although this rate is slightly below what 
has been reported in the literature, it still indicates high levels of dual diagnosis. This is a 
noteworthy finding considering clients with a co-morbid psychiatric diagnosis also have 
been found to demonstrate more severe substance use disorders (Kessler et al., 1996). Co-
morbid psychiatric problems among substance abuse treatment populations are an 
important area of study as this population continues to grow (Osher, 2000), and yet, it 
remains a significant challenge to dissect the etiology and relationship between substance 
use disorders and co-morbid psychiatric disorders (Gossop, Marsden, & Stewart, 2006).  
In the present study, it was not investigated whether the clients with a dual 
diagnosis demonstrated more severe substance abuse problems, but it is not uncommon 
for individuals with psychiatric distress to cope with such symptoms by using drugs or 
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alcohol. In turn, the use of such substances often exacerbates the psychiatric distress they 
are attempting to manage. It would not seem unlikely then, that the substance use also 
decreases one’s ability to manage both the withdrawal effects of the substance and the 
psychiatric distress, resulting in a more severe substance use disorder. Such clients might 
be more difficult to retain for a variety of reasons. First, clients with co-morbid 
psychiatric diagnoses are typically not provided specialized substance use treatment that 
also incorporates the treatment of the psychiatric disorder (Hesse, 2009; Petrakis et al., 
2002). Such individuals likely have unique treatment needs that may not be met when 
substance abuse and psychiatric treatment remain distinct (Charney, Paraherakis, & Gill, 
2001). The finding that clients with histories of psychiatric treatment were more likely to 
drop-out of treatment is not entirely surprising. Having a history of psychiatric treatment 
suggests that such clients have struggled with both substance use and other psychiatric 
disorders; again, relating to the hypotheses postulated above that having such a history 
could increase one’s risk of drop-out. 
The explanation for higher attrition rates among those who present for treatment 
with a dual diagnosis is likely due to a constellation of factors. The factors may be 
related, but not limited to some of the following. When clients are focused on alleviating 
intense psychological distress they may be less engaged and/or invested in substance use 
treatment. Further exacerbating this problem is the fact that people often abuse 
substances in an effort to alleviate psychological distress (albeit temporarily). Engaging 
in substance abuse treatment, abstaining from substance use, and identifying the reasons 
underlying one’s use can be a stressful undertaking. Additionally, if the psychiatric 
distress is intense a client may be less apt to remain in treatment as it may simply feel too 
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overwhelming to manage severe psychiatric distress while attempting to abstain from 
substance use. In fact, previous research has demonstrated that more severe psychiatric 
distress can negatively impact retention (Haller et al., 2002; Mertens & Weisner, 2000).  
Furthermore, psychological symptoms may interfere with a client’s ability to self-
regulate their behavior thereby making it more difficult to both remain in treatment and 
abstain from using substances. Finally, if the treatment program itself does not formally 
address a client’s co-morbid psychiatric distress they may be dissatisfied and drop out 
feeling as though their treatment needs were not adequately addressed. Indeed, clients 
who met criteria for a dual diagnosis in the treatment program for this study may not have 
fared well, in part, due to the Minnesota model employed. This model has been contra-
indicated for clients who present with a dual diagnosis when the psychiatric distress has 
not been stabilized (Owen, 2003). When a client presents with active co-morbid 
psychiatric distress it might therefore be useful to immediately refer them to another 
department for add-on psychotherapeutic treatment of the co-morbid psychiatric distress 
while also utilizing the addictionologist on staff to remediate symptoms more rapidly, if 
possible, through the use of pharmacology. This way, three treatments could be taking 
place simultaneously, more holistically treating the client, while also potentially 
contributing to increased treatment retention if symptom remediation is successful. 
Significant Predictors in Regression Analyses 
 There were two predictors, age and anxiety disorder, that were found to be 
statistically significant predictors in all three regression analyses. One predictor, meeting 
criteria for a cocaine disorder, was a statistically significant predictor in the logistic 
regression and survival analyses. One final predicator, total years of consistent alcohol 
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use, was a significant predictor in the multiple regression analysis. As was previously 
stated, due to the considerable overlap in findings, each predictor will be examined in 
subsequent sections based upon how they may relate to time spent in treatment. The 
findings, as they apply specifically to the treatment program associated with this study, 
will be discussed in each of the following sections as well. 
Age and Treatment Drop-out 
 Age was found to be a statistically significant predictor as it relates to treatment 
completion status, number of treatment days attended, and treatment duration. More 
specifically, it was found that with each decade increase in age the odds of dropping out 
of treatment dropped by about 1 ½ times. This is a significant finding when one considers 
that there was a 6 decade range among the sample. Similar findings have been reported in 
other studies. For example, one study indicated that in regards to age, “for each one-year 
increase in age, there was a 2.8% increase in the likelihood of completing treatment” 
(Siqueland at al., 2002, p. 29). A similar, decrease in risk was associated with this 
sample, in that with every year increase in age the risk of drop-out fell by 4%. These 
results suggest that the sample for this study is similar to the population in that younger 
age represents an increased risk for drop-out. 
 With people continuing to live longer, there will likely be a wider range of ages 
represented in substance abuse treatment; therefore, being aware of retention patterns 
related to age is important (Satre et al., 2004). The positive relationship between age and 
time spent in treatment has been one of the most robust findings in substance abuse 
treatment literature. Consistent with the findings of this study, older clients are found to 
be retained in treatment for statistically significantly longer periods and prematurely 
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dropout of treatment less frequently than younger clients, regardless of the treatment 
modality (Chou et al., 1998; Green et al., 2002; Kavanagh et al., 1996; Mammo & 
Weinbaum, 1993; Mitchell-Hampton, 2006; Roffman et al., 1993; Rowan-Szal et al., 
2000; Satre et al., 2004; Stark, 1992).  
 There are a number of possible explanations for younger clients being at an 
increased risk of dropping out of this treatment program. First, younger individuals have 
been found to use more substances, use a wider variety of substances, are less likely to 
have children who rely on them, and often are thought to possess a behavioral impulsivity 
not typically associated with more mature populations (Satre et al., 2004; Stark, 1992). 
Additionally, younger individuals may not have experienced as many problems as a 
result of their drug and alcohol use, and therefore may not see their use as a chronic 
problem (McKellar et. al, 2006). Being surrounded by many young people who also use 
alcohol and drugs would likely only exacerbate this perception. Conversely, older 
individuals who have demonstrated chronicity of substance use may be more aware of the 
toll that drug and alcohol use can have on one’s life by likely having experienced such 
effects, reinforcing the messages heard in treatment about consequences of use. 
Furthermore, older individuals may be more aware of the potential risks associated with 
relapse from having more recovery attempts than their younger counterparts (Bishop, 
Jason, Ferrari, & Chen-Fang, 1998). One noteworthy conclusion regarding age and 
retention is the positive concept that older adults are more likely to be retained. And 
although older adults are likely to represent a smaller percentage of substance abuse 
treatment clients (Satre et al., 2004), their presence in the therapeutic milieu could be 
used as a positive model for their younger counterparts. A real-world application of this 
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conclusion is that the treatment program could implement a mentoring program as a way 
for older clients to work closely with younger clients and model more favorable treatment 
attendance patterns.  
In summary, the positive relationship between age and retention appears to be a 
generalizable finding across populations and treatment centers, and has been coined the 
“indisputable factor” related to substance abuse retention (Saarnio & Knuuttila, 2003). 
Consequently, the relationship between age and treatment drop-out has noteworthy 
clinical implications. The results of this study (and others) suggest that this treatment 
program can be fairly confident in assuming that when younger clients present for 
treatment they are automatically at an increased risk for dropping out of treatment. 
Incorporating a mentoring approach with some of the older clients in treatment could 
assist younger individuals in engaging and remaining in treatment. Additionally, 
following up with younger clients who dropped out of treatment could provide some 
useful information as to the reasons behind it. No literature could be found on specific 
treatment approaches geared towards younger populations. Studying and developing a 
unique treatment approach for younger substance abusing populations could have a 
significant directional impact on the future of substance abuse treatment.  
Moreover, future research could look to compare and contrast effective substance 
abuse treatment approaches for adolescents and adults to inform the development of a 
specific approach with young adults. Working with younger clients to retain them in 
treatment could have far-reaching positive effects. Improved retention rates for younger 
clients should improve the outcomes associated with the treatment episodes. Improved 
treatment outcomes earlier in the clients’ lives will mitigate the ill effects of long-term 
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substance abuse. A good starting point in this approach would be to identify methods for 
establishing a solid therapeutic alliance as early as possible with younger clients. 
Additionally, linking younger clients with community support could also be beneficial. 
Historically, AA and NA support groups have been attended by older populations 
(Saarnio & Knuuttila, 2003). It may be beneficial to determine an approach for engaging 
younger clients in these groups so as to provide an additional protective factor for 
recovery (Saarnio & Knuuttila, 2003). A potential positive shift is that it appears as 
though younger individuals are beginning to tap into community 12-step programs at 
higher rates. For example, Narcotics Anonymous reported that most of their attendants 
are between the ages of 30-50 (NA World Services, 2007), however, it has also been 
reported that the median age of its members is decreasing (South Coast Recovery, 2008). 
Identifying community support options that attract younger members could help keep 
them engaged in the recovery process. Indeed, this recommendation aligns particularly 
well with the guiding principles of the treatment program associated with this study since 
it encourages the seeking out and attending of AA and other community support groups.  
Anxiety and Treatment Drop-out 
Being diagnosed with an anxiety disorder was found to be predictive of treatment 
drop-out, fewer treatment sessions attended, and a shorter duration of treatment. These 
results suggest that having an anxiety disorder is a significant risk factor for clients 
seeking treatment at the program utilized for this study. Although a fair amount of 
research has been conducted on co-occurring substance use and psychiatric disorders, a 
substantial portion of this research has focused primarily on depressive disorders coupled 
with substance use disorders (Gossop et al., 2006). This largely singular focus on 
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depression has persisted despite the fact that substance abuse treatment populations 
commonly demonstrate anxiety disorders, paranoid ideation, and even psychoticism 
(Gossop et al., 2006). And although a high percentage of clients in this sample met 
criteria for a depressive disorder, this was not found to be related to treatment duration or 
drop-out. On the other hand, those who met criteria for an anxiety disorder demonstrated 
statistically significantly shorter stays and were more likely to drop out.  
Anxiety is commonly reported among substance abuse treatment populations as it 
has been found to be related to both alcohol and cocaine use. For example, the National 
Epidemiologic Survey on Alcohol and Related Conditions (2006) indicated that about 
20% of Americans with a current anxiety disorder also have a current alcohol or other 
substance use disorder. Co-morbid anxiety was common in this sample as well. Almost a 
third (29.6%) of the total sample for this study met criteria for an anxiety disorder and 
almost two-fifths (39.3%) of those who dropped out of treatment met criteria for an 
anxiety disorder. The common affiliation of anxiety and substance use is perhaps due in 
part to the “bidirectional” relationship that exists between the two. For example, alcohol 
is commonly used to manage anxiety symptoms and then in turn results in additional 
anxiety symptoms during periods of withdrawal (Brady, Tolliver, & Verduin, 2007). 
Even though fewer studies have been conducted investigating anxiety and treatment 
retention, other studies have found anxiety to be related to time spent in treatment. For 
example, Doumas, Blasy, and Thacker (2005) reported that clients in an intensive 
outpatient program with co-morbid anxiety were more likely to drop out of treatment 
than those clients free of anxiety. Other studies have reported different findings whereby 
a diagnosis of an anxiety disorder was associated with longer treatment episodes and 
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treatment completion (Curran, et. al., 2002). Despite limited research being conducted on 
anxiety and retention, this study suggests that anxiety and participation in substance use 
treatment are tied. At the very least it can be assumed that the anxiety often triggered or 
exacerbated by the ceasing of regular substance use could in turn result in avoidance 
strategies (i.e., leaving treatment), especially when a common requirement of treatment is 
abstinence. 
An additional explanation of this finding may be related to the treatment modality 
employed at the treatment center. As was noted, all treatment takes place in group format, 
often in the upwards of 10-12 members per meeting (depending on census). If a client is 
struggling with symptoms of anxiety, being in a group setting may only exacerbate this. 
Further, symptoms of anxiety are generally much higher during the early phase of 
abstinence (Brady et al., 2007). This increase in symptoms, coupled with entering a group 
before rapport can be built, would likely only aggravate the anxiety disorder while also 
negatively impacting treatment effect. For example, if a client is struggling to manage 
acute anxiety symptoms s/he will not be able to focus appropriately on group content 
compromising positive treatment effects. 
Still, some of the difficulty in deciphering the meaning behind the lower retention 
rates among the sample for this study may be due to the variety of anxiety disorders 
represented by this variable (e.g., OCD, PTSD, Panic Disorder, and Social Anxiety). It is 
unknown if clients with a particular anxiety disorder were more likely to drop-out than 
those with a different anxiety disorder. It would not seem unreasonable to assume that 
clients who present with a co-morbid PTSD disorder may likely have distinct treatment 
needs from another client who presented with co-morbid social anxiety. Related, because 
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the treatments of different anxiety disorders are often distinct, such clients are not likely 
to receive this type of treatment in an intensive outpatient substance abuse program. If 
these clients do not also seek out a psychotherapeutic add-on treatment, removing the 
substance use, which is likely a primary coping mechanism, might only exacerbate the 
anxiety disorders symptoms; in turn they may cope by avoiding treatment, putting them 
at risk for drop-out. The finding that meeting criteria for an anxiety disorder is predictive 
of shorter stays in treatment has applied value for the treatment program as this can be 
viewed as a risk factor indicating possible premature treatment drop-out. At the very 
least, this information can be used by clinicians to assist their clients in developing a plan 
to address both their substance use and anxiety. 
It should be noted that the best treatment approach for co-occurring substance use 
and mood and anxiety disorders has yet to be determined. The industry has seen a 
forward movement to integrate substance abuse and psychiatric treatment, as opposed to 
keeping them distinct as historically has been the case (Hesse, 2009). This is in part due 
to the fact that substance abuse treatment seeking individuals fare better when substance 
abuse treatment addresses underlying psychiatric disturbance that does not remit when 
abstinence is achieved (Rounsaville & Kleber, 1985; Woody et al., 1984). Furthermore, 
as was indicated in Chapter 3, the treatment program utilized for this study employs an 
abstinence based program adopting components of the Minnesota Model of treatment. 
The Minnesota Model treats chemical dependency as the primary problem (Winters, 
Stinchfield, Opland, Weller, & Latimer, 2000). Not surprisingly, this treatment program 
also treats the substance use disorder as the primary problem. Although it is certainly 
understandable that a substance abuse treatment program would consider the SUD as the 
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primary issue to address, this does not mean that co-morbid psychiatric distress will not 
interrupt this process. Indeed this hypothesis may be why the Minnesota Model of 
treatment has been contraindicated for individuals with un-stabilized co-morbid 
psychiatric distress (Owen, 2003). This notion, coupled with  this study’s finding of the 
relationship between anxiety and dropout suggests that the  program may want to 
consider altering components of their treatment approach. If the program has sufficient 
resources available to provide integrated treatment, it is hypothesized that it could be 
extremely beneficial for clients. If resources are not available to facilitate integrated 
treatment, the program could still make efforts to ensure that clients with a co-morbid 
anxiety disorder have a psychotherapeutic add-on treatment. Considering the treatment 
program associated with this study has on-site departments that treat other types of 
psychiatric disorders, it may be beneficial to refer clients with a co-occurring anxiety 
disorder to another department in the hospital. This way, even if the treatment itself is not 
integrated, staff could consult and work together in the planning and delivering of 
treatment to such clients.  
Finally, an additional useful pursuit may be working with clients to tolerate the 
distress often associated with anxiety. Clients in general could benefit from learning 
behavioral techniques that have been found to assist with distress tolerance, which might 
also be a useful skill in relapse prevention. For example, individuals with lower levels of 
distress tolerance have been found to demonstrate shorter periods of abstinence from 
cigarettes (Brown, Lejuez, Kahler, & Strong, 2002). If the primary coping strategy of 
substance use is taken away, a new coping strategy is not provided, and distress tolerance 
training is not implemented, then individuals experiencing symptoms of anxiety may 
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begin to avoid treatment. This is noteworthy as when substance abusing individuals 
demonstrate avoidant coping strategies it has been found to predict negative outcomes 
(Ireland, McMahon, Malow, & Kouzekanani, 1994). Assisting clients by both (1) 
replacing the unhealthy coping strategy of substance use with an alternative, while (2) 
also teaching them to tolerate stressful and uncomfortable emotions could be helpful. 
Clients suffering from anxiety disorders may particularly benefit from distress tolerance 
training due to the bidirectional mechanism associated with anxiety and substance use 
described earlier. Teaching distress tolerance to clients may improve retention. 
Individuals who demonstrate higher degrees of distress tolerance have been found to 
persist in treatment for longer periods than those demonstrating lower distress tolerance 
(Daughters et al., 2005). 
Cocaine Disorder and Risk of Drop-out 
 In the sample for this study, meeting criteria for a cocaine disorder was found to 
be predictive of treatment drop-out status and a shorter time spent in treatment. This 
finding has emerged in previous research, which has suggested that having a cocaine 
addiction is related to decreased retention (Alterman et al., 1996; Fletcher et al., 1997; 
Sapadin, 2006; Veach et al., 2000; White, Winn, & Young, 1998). It may not just be the 
type of drug disorder, but the type of treatment program attended by people with distinct 
drugs of choice that impacts retention. For example, research has indicated that clients 
engaged in intensive inpatient substance abuse treatment, whose primary substance of 
abuse was not alcohol, were statistically significantly more likely to drop out of treatment 
than those clients with alcohol as their primary drug of choice (Wickizer, et al., 1994).  
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The reasons behind why clients in this sample who met criteria for a cocaine 
disorder were at an increased risk of drop-out remain elusive. Explanations of this 
phenomenon in other treatment populations have focused primarily on treatment 
approaches that are deeply rooted in the AA model, which is associated with a large 
number of substance abuse treatment centers in the United States (Sapadin, 2006; Veach 
et al., 2000). Although a large number of centers, like the one utilized for this study, 
employ treatment models that are grounded in AA theory and approach, they still treat 
clients with drug disorders, expanding the model to include illicit drugs. Individuals with 
cocaine disorders may very well have specific treatment needs that are distinct from those 
individuals only addicted to alcohol. For example, it may be that the impulsivity often 
linked to cocaine use impacts one’s ability to remain focused in treatment. Addressing a 
unique characteristic such as impulsivity might improve their retention rates. The theory 
that retention can be impacted by exposing clients with drug disorders to a treatment 
approach not specifically designed to treat such clients could apply to the sample of this 
study since the treatment method is rooted in the principles of AA. Not surprising, AA 
principles were designed to specifically treat alcohol use disorders, therefore, they may 
not be automatically applicable to individuals with a drug use disorder. . Indeed, alcohol 
dependent individuals have been found to be retained for longer periods than drug 
dependent individuals when a Minnesota Model of treatment (an approach based on 
principles of AA) was employed (Veach et al., 2000). A similar finding was uncovered in 
this study whereby those clients who were diagnosed with only an alcohol disorder were 
more likely to complete treatment Again, this supports the hypothesis that treatment 
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programs rooted in AA may meet the treatment needs of those clients who present with 
an alcohol use disorder better than those with a drug use disorder. 
Furthermore, a majority of the clients in this sample met criteria for an alcohol 
disorder (74%) and a minority for a cocaine addiction (22%). Being in the minority, those 
clients with a cocaine disorder may find it challenging to identify with other clients in the 
treatment program who struggle with an alcohol addiction. This lack of universality 
among cocaine dependent individuals, coupled with a treatment approach rooted in 
treated alcohol disorders, could potentially relate to their increased risk of drop-out. 
Finally, considering that cocaine use is illegal, it may be that those individuals who met 
criteria for a cocaine disorder lead a more antisocial lifestyle than clients addicted to 
alcohol. Antisocial personality traits and/or lifestyle characteristics are not likely to mesh 
well with the regimented treatment approach associated with most centers (White et al., 
1998). Antisocial personality disorder has been found to be linked to lower treatment 
completion rates (Mueller & Wyman, 1997). This is not to say that someone with a 
cocaine disorder will automatically have an antisocial personality or traits, but using an 
illicit substance does demonstrate a tendency to operate outside of accepted social norms, 
in this case legal boundaries. Seen this way, such individuals may have a more difficult 
time “buying into” a treatment process that they perceive is based upon a misplaced 
cultural value that the use of illicit substances is inappropriate. 
Treatment implications of these findings suggest that it may be useful to link 
clients up with others who use and are addicted to similar substances for support. The 
finding that clients who met criteria for an opiate disorder were more likely to drop-out of 
treatment may also support this recommendation. It may be useful to provide periodic 
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brief motivational interviewing interventions with clients who meet criteria for a cocaine 
and/or opiate disorder. Such a brief approach has been found to improve drug use rates 
among cocaine and heroin addicted individuals (Bernstein et al., 2005), and could assist 
with treatment retention efforts. Additionally, reinforcing the importance of attending NA 
or CA (Cocaine Anonymous) meetings outside of the regular treatment meetings may 
help individuals with cocaine addictions to connect with a larger community of those in 
recovery that may be more similar to themselves. Talking with individuals who meet 
criteria for a cocaine disorder about their treatment needs may also be helpful, especially 
during times when such clients might feel as though their treatment needs are not being 
met. “Resistant behaviors” might be indicative of clients feeling as though treatment is 
not working for them (Teyber, 2005). This type of behavior could include sporadic 
attendance or decreased contribution and engagement during group session. When 
clinicians note such behaviors, an individual session could be scheduled with the client to 
discuss potential concerns. A useful client-centered approach to explore such concerns 
would be motivational interviewing, as a way to both gain information while also 
minimizing defensive reactions from clients. Any identified themes derived from such 
interviews could be implemented into practice if feasible. 
Years of Alcohol Use and Drop-out 
 The total number of years that individuals used alcohol regularly (i.e., 3 or more 
days per week for at least 6 months out of the year), was found to be negatively 
associated with the number of days spent in treatment. Previous research has also 
indicated a negative relationship between chronic use of substances and retention in 
treatment (Alterman et al., 1996; Lang & Belenko, 2000; Maglione et al., 2000b; Marrero 
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et al., 2005; Mertens & Weisner, 2000; Westreich et al., 1997). There are a number of 
speculations that could be made about the link between long-term alcohol use and 
decreased retention. First, it would not seem unreasonable to assume that the more years 
spent drinking, the more chronic the drinking problem. The more chronic the drinking 
problem, the greater the difficulty in remaining abstinent from the drug, and in turn, the 
greater challenge inherent in remaining engaged in treatment. Chronic and persistent 
alcohol use, especially among individuals with previous substance use treatment 
histories, may represent a subgroup of treatment resistant alcohol dependent clients. 
Substance abuse treatment populations have long been associated with words like 
“unmotivated” and “in denial”, connoting a theme that such populations, in general, are 
difficult to treat. Despite this stereotype, there may very well be pockets of substance 
users that do not respond to treatment as favorably as we might like. An analogy in the 
general psychiatric treatment realm might be treatment resistant depression. Chronic 
alcoholics seeking treatment have been described as treatment resistant when 
demonstrating decreased treatment responsiveness (Ehrenreich et al., 1997). 
 It is possible that the subgroup of individuals who used alcohol more chronically 
and spent fewer days in treatment demonstrated less treatment responsiveness. Similar 
hypotheses have been tested before with opiate abusing clients, indicating that multiple 
previous opiate detoxifications are associated with less treatment responsiveness 
(Malcolm, Roberts, Wang, Myrick, & Anton, 2000). The reasoning behind this possible 
decreased treatment responsiveness is unknown. Again, working with clients who present 
with histories of chronic alcohol use may help clinicians gain a better understanding of 
why previous treatment episodes were unsuccessful. Additionally, it is likely that some 
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components of treatment appeal to these individuals, or they would not be initiating 
treatment in the first place. As such, gaining a better understanding of what has also 
worked well during previous treatment episodes might be useful. A unique treatment 
approach that spans a two-year period moving from daily individual treatment doses to 
one weekly group exposure has been found to work well with treatment resistant 
alcoholics. By employing such an approach, 60% of the clients were retained and 
abstinent throughout the two-year period (Ehrenreich et al., 1997). Although a number of 
practical issues may prevent clients from remaining in treatment for a two-year period 
(e.g., insurance coverage, counselor availability), it may prove useful to intensify 
treatment early on by supplementing with individual therapy sessions. 
 The concept of sustained brain damage contributes to another hypothesis 
regarding why clients with more chronic alcohol histories demonstrated shorter stays in 
treatment. Cognitive impairment secondary to substance abuse cannot be ruled out as a 
possible implicating factor of this finding. It is well known that the longer one uses 
alcohol and/or drugs, the greater the negative impact on the brain and cognitive 
functioning. The importance of being able to attend during substance abuse treatment was 
described earlier, and can also be applied here. Chronic alcohol use has been found to 
impact one’s ability to attend to, store, and recall information (National Institute on 
Alcohol Abuse and Alcoholism, 2001). Further, cognitive impairment has been found to 
be most severe during the first couple weeks of abstinence (National Institute on Alcohol 
Abuse and Alcoholism, 2001). For those individuals demonstrating chronic alcohol use, 
the biological impact of doing so could negatively impact their ability to pay attention 
during sessions, store the information shared, and recall it after treatment sessions end. 
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These difficulties, coupled with the increased risk of experiencing such symptoms during 
the first two weeks of abstinence, could easily put such individuals at an increased risk of 
attending fewer treatment sessions. The clinical implications of cognitive decline among 
substance abusing treatment populations has not received much attention in the literature 
and yet it remains an important area of future study due to the far reaching effects it may 
have on treatment engagement and retention (Aharonovich, et al., 2006) 
Variance Not Accounted For 
 Despite the findings that age, meeting criteria for a cocaine or anxiety disorder, 
and years of alcohol use were all predictors of treatment drop-out, there is a significant 
amount of variance that was not accounted for with the variable set utilized for this study. 
The rather limited amount of variance accounted for was surprising when one considers 
the wide array of client variables included, many of which have been implicated in 
previous research as being related to retention. For example, client motivation has 
consistently been implicated as being positively related to retention and time spent in 
treatment (Brocato, 2004; Broome et al., 1999; Simpson & Joe, 2004; Simpson et al., 
1997). And although there are a variety of ways in which motivation is defined (i.e., 
external vs. internal), this study included a motivation measure of “readiness for change”, 
which was not found to be predictive of treatment drop-out. This then begs the question: 
what else is predictive of individuals dropping out of treatment that the current variable 
set is not revealing? There are a number of possibilities and few of the potential factors 
will be described below. 
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Program Factors 
First, an unknown in this study is the impact of treatment variables on client 
retention. Program specific and treatment specific factors have recently gained attention 
in research efforts as potentially relating to client retention. The link appears clear: if 
clients are not satisfied with the treatment program in which they are engaged, they are 
not likely to continue with treatment. Certainly client satisfaction with service offerings 
can impact premature drop-out. In fact, Hser et al. (2004) reported strong relationships 
between treatment intensity, client satisfaction and, in turn, treatment retention. 
Interestingly, clients who entered treatment with greater problem severity reported 
greater satisfaction with treatment services rendered. The authors hypothesized that this 
increased satisfaction was directly related to the fact that clients with greater problem 
severity received more services; when clients were offered and utilized more services, 
they reported greater satisfaction with treatment.  
Intensity of service offerings and satisfaction with treatment services has also 
been investigated among injection drug users. Marrero et al. (2005) discovered that those 
clients who received more intensive comprehensive services (i.e., two or more kinds of 
treatment services) were statically significantly more likely to remain in treatment than 
clients who did not receive such comprehensive services. Furthermore, when clients 
reported a low level of satisfaction with the services received, they were two and half 
times more likely to prematurely drop out of treatment (Marrero et al., 2005). Related, 
when clients were more actively engaged in treatment (i.e., demonstrated more consistent 
attendance in treatment) they reported a greater commitment to treatment three months 
after treatment began (Broome et al., 1999). These results point to the importance of 
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programs offering treatment that is both high in quality and quantity to help retain clients 
and improve their outcomes. These types of treatment factors were not investigated in 
this study, but may very well have accounted for some of variance associated with time 
spent in treatment. 
Therapeutic Alliance 
As other psychotherapeutic research has demonstrated (Martin, Garske & Davis, 
2000), the therapeutic alliance is important in improving treatment retention and 
outcomes. Meier, Donmall, McElduff, Barrowclough, and Heller (2006) reported that 
substance abuse treatment clients often leave treatment prematurely and outcomes suffer 
when they are unable to establish a solid therapeutic relationship early on with their 
therapists. Meier et al. (2006) determined that clients who had weaker alliance ratings 
with their counselor were more likely to prematurely drop out of treatment than those 
clients who rated their alliance as strong. Furthermore, the counselors’ rating of the 
therapeutic alliance was found to be the strongest predictor of treatment drop-out.  Meier, 
Barrowclough, and Donmall’s (2005) review of the literature on the role of the 
therapeutic alliance in drug treatment found moderate effect sizes of the alliance 
(accounting for 5%-15% of the variance) in predicting retention. It appears that the 
therapeutic alliance is a particularly important component of drug treatment when the 
client enters treatment while experiencing psychiatric distress. When clients entered 
treatment with no or minimal psychiatric distress the therapeutic alliance did not appear 
to be related to treatment completion. On the other hand, when clients entered treatment 
with moderate or severe psychiatric symptoms, those who had a good alliance with their 
counselor were retained until completion 75% of the time versus 25% of the time for 
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those with weak alliances. Even when the therapeutic alliance has not been found to be a 
direct predictor of retention, studies have suggested that it plays a mediating role 
impacting clients’ motivation to change, which in turn is positively related to retention 
(Brocato & Wagner, 2008). The aforementioned findings may be particularly noteworthy 
as they relate to this sample considering such a large percentage of the clients were dually 
diagnosed and/or met criteria for an anxiety disorder, which was consistently linked to 
treatment dropout. 
These studies point to the importance of offering treatment program services that 
are perceived as helpful by clients. When clients are satisfied with the services they 
receive, it can directly impact a program’s ability to retain them. After all, substance 
abuse treatment is a service provided to consumers, and if the consumers are not satisfied 
with that service they are not likely to continue participating in it. Programs that offer 
services that adequately address the needs of clients by reducing distress and improving 
functioning stand to improve retention rates. One way in which programs can focus on 
improving client retention and possibly program satisfaction is by utilizing counselors 
who are able to establish solid, positive therapeutic alliances with their clients. This is an 
area of future research that warrants additional study. 
Interactions of Client and Program Factors  
It is evident from the cited literature in this section that client and program factors 
are both related to retention. It is important to note, however, that neither exists in a 
vacuum; different program characteristics will likely impact clients differently. 
Unfortunately, little research has examined this interaction. Chou et al. (1998) 
investigated how client and program characteristics interact to impact overall retention. 
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They included three client attributes (e.g., gender, age, drug use level) and three program 
characteristics (e.g., service provision, funding, staff-client gender matching). Results 
demonstrated that younger male clients with increased drug severity were more likely to 
prematurely drop out of drug-free outpatient treatment. Additionally, female clients were 
more likely to remain in programs that accepted both public and private funding (versus 
simply public funding). These results imply that the interactions between client and 
program characteristics that are linked to retention are complex and, as the authors 
suggest, future research should look to include more variables since this is a significantly 
understudied area. 
Readiness for Treatment 
Although this study investigated motivation as it relates to readiness to change, 
readiness for treatment was not investigated. A large portion of previous research has 
focused on readiness for treatment rather than readiness to change, and although these 
two constructs are likely related, they remain distinct (DiClemente et al., 1999). For 
example, a client may want to change a specific behavior but may not be open to the idea 
of treatment assisting in that process. Although the way in which motivation was 
measured for this study was not found to be predictive, it does not mean that motivation 
is not related to retention among the sample used for this study. It may be helpful for 
future research to investigate if both readiness for treatment and readiness for change are 
related to substance abuse treatment retention. 
Cognitive Functioning 
 Another area that was not assessed in this study was the cognitive functioning of 
the clients in the program. Research has consistently documented the negative impact 
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substance use can have on the brain. Clients who demonstrate more impaired cognitive 
functioning especially as it relates to their ability to attend are more likely to drop-out of 
substance abuse treatment (Aharonovich, et al., 2006). This could be a particularly 
interesting area for future study, especially in intensive outpatient programs like the one 
utilized for this study. Intensive outpatient programs that have adapted the Minnesota 
Model to fit outpatient settings tend to offer primarily group treatment, which meets for a 
few hours at a time. If clients are struggling to attend, this could be exacerbated by a 
format that includes numerous people meeting for an extended period of time. 
Furthermore, if individuals are struggling to attend it could be perceived by treatment 
staff as if they are unmotivated or not engaged in the treatment program; such tensions 
could likely contribute to early drop-out. 
Client Impulsivity 
 Impulsivity has been defined as “a predisposition towards rapid, unplanned 
reactions to internal or external stimuli with diminished regard to the negative 
consequences of these reactions to the impulsive individual or others” (Moeller, Barratt, 
Dougherty, Schmitz, & Swann, 2001, p. 1783). Impulsivity has been linked to substance 
abuse in the literature, and is believed to be both a facilitator and result of drug use 
(DeWit, 2009). The link between impulsivity and substance abuse treatment retention is 
less clear however. Nonetheless, impulsivity has increasingly become a focus in the 
general arena of substance abuse and may very well be related to length of stay in 
treatment. At the very least, impulsivity has been found to be associated with chronic 
substance use and a contributor to relapse (Ersche, Roiser, Robbins, & Sahakian, 2008; 
Perry & Carroll, 2008). 
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Further, impulsivity has been found to be related to age; the younger individuals 
are, the more impulsive they tend to be, which has been found to predict alcohol use 
disorders (Littlefield et al., 2009). Impulsivity has also been implicated as a risk factor 
associated with developing a cocaine addiction (Lejuez, Bornovalova, Reyonlds, 
Daughters, & Curtin, 2007). Exacerbating the problem, the earlier one develops a cocaine 
disorder and the more chronic their use, the more impulsive such individuals tends to be, 
and the more intense withdrawal effects they tend to experience (Ahmadi, Kampman, 
Dackis, Sparkman, & Pettinati, 2008). The link seems reasonable; if younger clients and 
those who met criteria for a cocaine disorder are found to be more impulsive, relapse 
becomes more probable and therefore, so does treatment drop-out. Individuals with 
higher levels of impulsivity may simply decide that treatment is no longer necessary and 
are more likely to relapse. Younger impulsive clients may struggle with sobriety, 
especially when surrounded by peers, who are also using, increasing the likelihood of 
dropping out of treatment. The bottom line is that for a younger individual addicted to 
cocaine, the rewards associated with substance abuse treatment may appear insignificant 
when compared to the immediate gratification associated with cocaine use (Potenza, 
2007). Perhaps exacerbating the problem, cocaine use has also been found to result in 
enduring impulsive decision making even after the drug is no longer being used (Simon, 
Mendez, & Setlow, 2007). This suggests that even clients with only historical use of 
cocaine could still be presently at-risk for making impulsive decisions about remaining in 
treatment. 
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Limitations 
 There were a number of limitations associated with this project. First, the 
percentage of clients that dropped out of treatment (41%) is lower than what has 
generally been reported in the literature for outpatient treatment, which has been found to 
range from around 60% to 75% (Justus et al., 2006; Sayre et al., 2002; Siqueland et al., 
2002; Wickizer et al., 1994). Even though some investigations have reported retention 
rates of around 50%, this is a minority of the literature focused on intensive outpatient 
populations (Dobkin, De Civita, Paraherakis, & Gill, 2002; Green et al., 2002; Mammo & 
Weinbaum, 1991). It should also be reiterated however, that the 444 clients who 
matriculated through the program during the data collection process (i.e., those tested and 
not tested for the study) demonstrated an overall drop-out rate of 51%. This percentage is 
closer to the cited averages found above, but again, still lower than what is generally 
associated with outpatient treatment.  
The lower rate of drop-out in this sample may be resultant from a variety of 
factors. First, it could be that the lower rates of drop-out among those tested were simply 
an artifact of early client attrition prior to being tested. In fact, 67% of the non-tested 
clients drop-out of treatment. Treatment investigations rely on adequate recruitment of 
participants and also retention of those participants throughout the course of the 
investigation to achieve reliable and valid results. It is not uncommon for research efforts 
to lose participants when they prematurely drop out of treatment (Vaughn, Sarrazin, 
Saleh, Huber, & Hall, 2002). Another hypothesis that should be noted, however, is that 
the higher rates of treatment completion could be related to having undergone the testing 
process itself. A number of clients reported to assessors that the assessment procedure 
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was quite helpful in gaining a better understanding of their substance use patterns, and 
saw the opportunity to meet one on one with an assessor as therapeutic.  
The fact that those clients who were not tested for this study demonstrated higher 
rates of drop-out does limit the generalizability of the findings. The interpretation of the 
results should be done with this in mind. Also compromising the generalizability of the 
findings is the issue of “overfitting” of the regression models – this is a common issue 
with regression analyses as “usually, the model will fit the sample from which it is 
estimated better than it will fit the population from which the sample is selected. Another 
sample from the same population will often result in a different model” (Norusis, 2003, p. 
157).  
 A further limitation of this study may be the manner with which the data was 
collected. All information was gathered based upon client report/recall and there have 
been limitations noted with such an approach. Inherent within the method of self-report is 
an assumption that participants’ recall is accurate, and yet researchers have noted that 
recall bias can negatively influence the accuracy with which clients report their substance 
use (Caldwell, Rodgers, Power, Clark, & Stansfeld, 2006, as cited in Keyes et al., 2008; 
Moyer, Finney, & Swearingen 2002). Theoretically, recall bias and inaccurate reporting 
of substance use can come from a variety of sources. For example, brain damage as a 
result of consistent substance abuse can impact the ability with which participants can 
recall substance use patterns. But it is not just past use that can impact recall. At the time 
that self-reported data is requested clients may be under the influence of alcohol or drugs, 
significantly impairing their ability to access memories accurately. Furthermore, 
mandated clients may falsely report data for fear of significant legal consequences 
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(Brocato & Wagner, 2008). Although the accuracy of self-report data has been 
questioned, some authors maintain that self-report information tends to be a valid source 
of data especially when obtained independently of the treatment providers coupled with 
assurances of confidentiality, which is consonant with the approach used for this 
investigation (Moos & Moos, 2003). 
 Another limitation associated with this study was the dichotomization of the 
dependent variable, treatment completion. Although such a dichotomization is a common 
approach in retention studies, what constitutes a treatment completer has been found to 
vary considerably (Wickizer, et al., 1994). Even though more than half of this sample 
completed treatment, how well they were engaged and performed throughout their tenure 
was not assessed. Being labeled a “treatment completer” only indicates who has remained 
in treatment through completion; it does not provide a very illustrative picture of how 
well one was engaged in and devoted to the treatment process. A useful analogy may be 
that even though a group of students all passed a course, their understanding of the 
material and what they took away from the course cannot necessarily be determined 
through simply a pass/fail model. A possible solution to this limitation is for studies to 
more broadly define treatment retention by avoiding a simple dichotomization. 
 A final limitation of this study was the lack of programmatic variables 
investigated, which was expanded upon in the section hypothesizing about variance 
unaccounted for. Although historically only client characteristics were thought to be 
related to retention, there was a shift in perspective a few years ago indicating that 
programmatic factors also likely play a large role (Brocato & Wagner, 2008; Simpson, 
2001). Clearly client factors are not the only contributor to premature drop-out. As 
145 
 
previously stated, the limited variance that was accounted for in this study is likely 
related to the fact that programmatic factors were not measured and included in the 
analysis. Future retention research would benefit from including both client and program 
factors. 
Future Directions 
 Despite the fact that a substantial amount of research has been conducted on 
substance abuse treatment retention, there is still much that is unknown. The conflicting 
findings associated with this research area have simply led to more questions than 
answers, and suggest that there is much heterogeneity among treatment programs and 
clientele. As such, substance abuse treatment retention remains a promising area of study. 
By improving retention rates, programs can help improve their clients’ outcomes while 
also making their program more attractive to potential clients. Although a fair amount of 
previous research focused on how client characteristics might be related to treatment 
retention, there has been a growing movement to include programmatic factors in 
retention research. This movement could be an important step towards gaining a better 
understanding of the predictors of treatment retention, while also possibly helping to 
provide a more complete picture of the phenomenon of substance treatment drop-out. As 
was demonstrated in this study, a limited amount of variance predicting treatment drop-
out was accounted for by only using client characteristics. If programmatic factors had 
also been included they likely would have helped account for more of the variance in the 
predictive models.  
Still, a research challenge exists to begin to tease out how program and client 
characteristics interact to impact retention within specific programs. For example, 
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employed, alcohol-dependent clients with increased problem severity have been found to 
be retained for longer periods than other clients in a Minnesota Model-based intensive 
outpatient program (Veach et al., 2000). Clearly not all programs are intensive outpatient 
and further, not all treatment programs are based upon the Minnesota Model; it begs the 
questions: Does the Minnesota Model simply work well for that specific subgroup of 
clients? Perhaps outpatient programs are more sensitive to the needs of employed clients? 
Or perhaps employed clients are more motivated to engage in treatment since they may 
have more reasons to achieve and maintain sobriety? Do different interventions work 
better with, and therefore improve the retention of, a different subset of clients? These 
questions help support the idea for treatment programs to conduct in-house investigations 
to help uncover the idiosyncratic retention dynamics taking place in their treatment 
program. For example, this investigation helped to shed light on the hypothesis that the 
Minnesota Model may not be the ideal treatment approach for a pocket of drug users. 
Future research can also look to include client and program factors that have not 
been investigated as thoroughly in previous research. For example, very limited research 
has been conducted on how a client’s cognitive functioning might impact retention. 
Further investigations including this variable could be useful since cognitive impairment 
is typically associated with substance use. Additionally, although research has linked 
impulsivity and substance use, the relationship between impulsivity and treatment 
retention has not been investigated. Finally, since age has been found to be one of the 
most findings in the retention literature, future research efforts could look to implement 
programmatic or therapeutic approaches targeted at younger clients.  
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It should also be noted that there is a paucity of qualitative investigations in the 
area of substance abuse treatment retention. Although qualitative investigations have had 
a prominent existence in social science and anthropological research, they have been 
much less pronounced in the field of addictions research. For example, of 291 
investigations published between 1995-1996 in the journals Addiction, Drug and Alcohol 
Review, and Addiction Research, only 6% (17) cited studies that at least partially utilized 
qualitative methods and only three qualitative studies were published by the journal 
Addiction (Neale, Allen, & Coombes, 2005). Still, qualitative studies, which attempt to 
study phenomena in their natural environments, have a place in retention research. 
Employing a qualitative component to a quantitative investigation could prove quite 
useful in determining factors related to retention. For example, by interviewing clients 
who prematurely drop-out of treatment programs could gain to better understand where in 
the treatment process things begin to break down for their clients increasing the risk of 
them leaving before treatment is completed. 
Conclusions 
 The results of this investigation indicate that some clients of the associated 
treatment program are at an increased risk of dropping out of treatment based upon 
characteristics demonstrated at the point of treatment intake. Meeting criteria for an 
anxiety and/or cocaine disorder and being younger were consistently implicated as 
placing someone at an increased risk for leaving treatment. Armed with this knowledge, 
the treatment program can look to identify new clients who share these at-risk 
characteristics and work closely with them to help improve retention perhaps through 
some of the suggestions presented earlier. The results of this study also point to the 
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feasibility of conducting research at the program level, which has many benefits 
including contributing to the larger research base, while also gaining knowledge about 
the unique characteristics and challenges associated with a specific treatment program.  
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Table 13 
Statistically Significant Results, Clinical Implications and Fit with Literature 
Statistically 
Significant Variables Findings 
Clinical Implications and 
Recommendations 
“Fit” with Previous 
Research 
Demographic Characteristics 
Age Younger clients 
dropped out of 
treatment more 
than older 
clients. Age was 
a positive 
predictor of 
treatment 
completion 
status, number of 
treatment days 
attended, and 
total duration in 
treatment. 
The treatment program can 
be quite confident that young 
clients are at increased risk 
of drop-out. 
Meet with young adults early 
on one-on-one to establish 
strong working alliance.  
Establish a mentoring 
approach in treatment 
whereby younger clients are 
paired up with older adults 
who have demonstrated 
abstinence and treatment 
commitment. 
The positive 
relationship between 
age and treatment 
duration is one of the 
most robust findings in 
substance abuse 
treatment retention 
literature (Chou et al., 
1998; Green et al., 
2002; Kavanagh et al., 
1996; Mammo & 
Weinbaum, 1993; 
Mitchell-Hampton, 
2006; Roffman et al., 
1993; Rowan-Szal et 
al., 2000; Satre et al., 
2004; Stark, 1992). 
Marital Status Unmarried 
clients dropped 
out of treatment 
more often than 
married clients. 
Help unmarried clients 
identify a supportive person 
in their life that can act as an 
accountability source. For 
example, a spouse could act 
as a motivational source to 
stay in treatment. 
Being married has been 
associated with better 
retention in previous 
research (Broome et. 
al., 1999; Curran et al., 
2007; Siqueland et al.). 
Income Clients with 
lower incomes 
(30 days prior to 
intake) dropped 
out of treatment 
more often than 
clients with 
higher incomes. 
Clients with lower incomes 
may not be able to miss work 
to attend an intensive 
outpatient program regularly. 
Similarly, such clients may 
not have enough income to 
supplement treatment or pay 
for things like child care. 
Setting up lower income 
clients with a staff social 
worker could assist with 
peripheral planning. 
Income has been found 
to be positively related 
to time spent in 
treatment in other 
research efforts (Green 
et al., 2002; Mertens & 
Weisner, 2000; 
Roffman et al.,1993; 
Siqueland, 2002; 
Weisner et al., 2001). 
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Statistically 
Significant Variables Findings 
Clinical Implications and 
Recommendations 
“Fit” with Previous 
Research 
Recent Drug Use 
Recent Use of: 
• Marijuana 
• Cocaine 
• Hallucinogens 
• Heroin 
Clients who used 
marijuana, 
cocaine, 
hallucinogens, or 
heroin during the 
30 days prior to 
treatment were 
more likely to 
drop out of 
treatment than 
those who did 
not use those 
drugs. 
Recent drug use could 
indicate a more severe 
disorder. Increased drop-out 
might be related to 
Minnesota treatment model 
employed. Connecting new 
clients who use drugs with 
other drug using clients who 
have demonstrated good 
attendance could help 
increase universality with 
this minority group. 
Drug use close to the 
point of treatment intake 
has been found to 
negatively impact client 
retention (Alterman et 
al., 1996; Paraherakis et 
al., 2000; White, Winn, 
& Young, 1998). 
Alcohol Use 
Years of Regular 
Alcohol Use 
Years of regular 
alcohol use was 
negatively 
predictive of 
number of 
treatment 
sessions 
attended. 
Chronic alcohol use can 
impair cognitive functioning 
perhaps resulting in 
decreased ability to attend. 
The group may also represent 
a “treatment resistant” group 
that does not respond as 
favorably to treatment. 
Literature confirms that 
chronic substance use 
has been found to be 
negatively related to 
time spent in treatment 
(Alterman, McKay, 
Mulvaney & McLellan, 
1996; Lang & Belenko, 
2000; Maglione et al., 
2000b; Marrero et al., 
2005; Mertens & 
Weisner, 2000; 
Westreich, Heitnre, 
Cooper, Galanter & 
Gued, 1997). 
Drug Use Disorder 
Cocaine or Opiate 
Disorder 
Meeting criteria 
for a cocaine or 
opiate disorder 
was associated 
with increased 
risk of drop-out 
and shorter stays 
in treatment. 
Increased drop out might be 
related to the treatment 
program’s philosophy. 
Clients with a cocaine or 
opiate disorder may 
demonstrate cognitive 
impairment or increased 
impulsivity, which may 
impact drop-out. Clients who 
meet criteria for a drug use 
disorder might benefit from 
motivational interviewing 
strategies. 
Cocaine and Opiate use 
disorders have been 
indicated as negatively 
influencing time spent in 
treatment (Fletcher et al., 
1997; Paraherakis, et al., 
2000; Sapadin, 2006; 
Sinqueland et al., 2002; 
Veach et al., 2000). 
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Statistically 
Significant Variables Findings 
Clinical Implications and 
Recommendations 
“Fit” with Previous 
Research 
Psychiatric Co-Morbidity 
Dual-Diagnosis 
 
 
 
 
 
 
Clients who met 
criteria for a dual 
diagnosis were 
more likely to 
drop out of 
treatment. 
Dual diagnosis could impact 
retention if the psychiatric 
symptoms are not stabilized 
or treated concurrently with 
the substance use disorder. 
If integrated treatment 
cannot be offered, retention 
may be improved by: (1) 
referring clients to other 
departments at the hospital 
(2) have such clients meet 
with the addictionologist on 
staff for pharmacology add-
on. 
Previous research 
demonstrates conflicting 
results, with some 
researchers finding 
decreased retention rates 
among dually diagnosed 
clients (Curran et al., 
2002) and other studies 
reporting higher 
retention/completion 
rates among those dually 
diagnosed (Broome et 
al., 1999; Justus et al., 
2006). 
Anxiety Disorder Meeting criteria 
for an anxiety 
disorder was 
predictive of 
treatment drop-
out, shorter 
treatment stays, 
and fewer 
treatment days 
attended. 
Anxiety and substance use 
have a bidirectional 
relationship whereby one 
negatively influences the 
other. Treatments that ID 
the SUD as the primary 
problem have been 
contraindicated for dually 
diagnosed clients if 
psychiatric distress is not 
stabilized. This suggests 
that integrated treatment 
may be a positive future 
direction this treatment 
program could consider. 
Previous research has 
demonstrated conflicting 
results suggesting that 
having an anxiety 
disorder is associated 
with shorter (Doumas et 
al., 2005), and longer 
stays (Curran et al., 
2007) in treatment. More 
research has been 
conducted on substance 
abuse treatment 
retention and co-morbid 
depressive disorder. 
History of Psychiatric 
Treatment 
Clients with a 
positive history of 
psychiatric 
treatment were 
more likely to 
drop out of 
treatment. 
Having a history of 
psychiatric treatment 
suggests that these clients 
may also be at-risk of co-
morbid psychiatric distress 
which could negatively 
impact treatment retention. 
Additionally, individuals 
with psychological distress 
also tend to demonstrate 
more severe substance use 
disorders, which could be 
related to the increased risk 
of such clients dropping out. 
No literature could be 
found linking previous 
psychiatric treatment to 
retention problems, but 
the literature listed 
previously in the dual 
diagnosis and anxiety 
sections likely also apply 
here since having a 
history of psychiatric 
treatment could likely be 
linked to dual diagnosis 
issues. 
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Comprehensive-Integrated Critical Literature Review 
Introduction 
      The primary purpose of this paper is to provide a critical review of the literature 
as it relates to substance abuse treatment evaluations and client treatment retention. More 
specifically, the review will include a brief summary of the current status of large-scale 
drug and alcohol treatment evaluations, providing a solid framework which supports the 
notions that substance abuse treatment is effective in producing positive treatment 
outcomes (i.e., increasing abstinence, decreasing severity of use) and that treatment 
programs would benefit from conducting substance abuse treatment research on-site. 
Additionally, a critical analysis of the methodologies employed, including research 
designs, will be included for both efficacy and effectiveness investigations. Unanswered 
research questions that have been spurred as a result of the large- and small-scale studies 
will be described. Despite investigations consistently indicating that substance abuse 
treatment is effective, questions remain regarding which specific components of 
treatment impede and/or facilitate change. In recent years, studies have begun focusing 
on treatment processes that are thought to impact outcomes. It has been found that 
engaging and retaining clients in substance use treatment is an especially important 
consideration since large numbers of clients have been found not to return to treatment 
after their initial assessment, or remain in treatment once it has begun (Weisner, Mertens, 
Tam and Moore, 2001). This point, coupled with the fact that research has demonstrated 
that the length of time one spends in treatment is positively associated with more 
favorable treatment outcomes (Simpson, 1993), indicates a need to better understand the 
factors related to clients remaining in treatment.  
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As such, a detailed case will be made stressing the importance of investigating 
and maximizing client treatment retention, specifically as it relates to the documented 
longer retention rates associated with producing more favorable client treatment 
outcomes. Treatment engagement will also be described since it is a documented 
phenomenon linked to treatment retention. As such, a critical analysis of the treatment 
engagement literature will be included. Reviewing specific variables that have been 
found to be related to treatment retention was removed from this appended version to 
avoid redundancy since it was included in Chapter II of this document. Finally, a case 
will be made emphasizing the call for additional research on treatment retention as it 
relates to the need for treatment programs to bridge the gap between science and practice 
through on-site investigations. It will be argued that by continuing to conduct research on 
retention in naturalistic treatment settings, programs stand to improve their retention rates 
while joining forces in the evidence-based practice movement. One viable model to guide 
this process will be explained.  
In order to achieve these ends, a comprehensive literature search was conducted 
through Marquette University’s library system. Searches on PsychInfo, ERIC, and 
Medline were completed in an effort to thoroughly explore the literature base in the areas 
of substance abuse treatment engagement, retention, and outcomes. Article bibliography 
lists were also utilized to identify pertinent articles not located through the main search 
engines. Both published and unpublished work was included and no specific exclusionary 
criteria were employed, although an effort was made to ensure that the most up to date 
literature was included. 
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History of Drug Treatment Evaluations 
Introduction 
Over time, perspectives on drug abuse have changed. Once deemed an inherent 
character flaw or inability to control one’s behavior, drug abuse began to be recognized 
as a disease by the 1960s (Simpson, 1993). In part, this shift was a result of society no 
longer associating drug use only with minorities and criminals (Simpson, 1993). The use 
of illicit drugs began to move its way outside of the inner city and into the suburbs among 
non-minorities (Simpson, 1993). Up to, and during this time, there was limited drug 
abuse treatment available. It wasn’t until the 1970s when drug use skyrocketed and a 
heroin epidemic ensued that community-based treatment even became a viable option to 
those outside of the prison system (Fletcher, Tims, & Brown, 1997; Simpson, 1993).  As 
the need for drug abuse treatment became increasingly recognized, treatment options 
grew. By the late 1970s more community-based programs addressing illegal drug use 
became available and the delivery of drug abuse treatment emerged as a “new” field 
(Simpson, 2004).  As the field grew, different treatment modalities began to be offered to 
address differences in drug use severity, drugs of choice, and beliefs about rehabilitation. 
Three main types of drug treatment emerged: methadone maintenance, therapeutic 
communities, and outpatient drug-free programs (Etheridge, Hubbard, Anderson, 
Craddock, & Flynn, 1997). 
Drug Abuse Reporting Program (DARP) 
Although drug treatment options increased, whether the treatments were effective 
in reducing drug use remained in question. Additionally, whether there were any 
differences in the effectiveness associated with the different treatment modalities and 
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settings remained to be determined. Therefore, during the 1970s the National Institute on 
Drug Abuse (NIDA) sponsored the first long-term national drug treatment evaluation, the 
Drug Abuse Reporting Program (DARP). DARP spanned 20 years of data collection on 
almost 44,000 clients in an attempt to better understand the clients who were entering 
into community drug treatment centers, the treatments being provided there, and client 
drug use patterns during and after treatment (Simpson, 1993). Data collected included 
intake assessments, treatment improvement measures while in treatment, and follow-up 
evaluations up to 12 years post-treatment (Fletcher et al., 1997). DARP was conducted 
across various treatment sites and treatment modalities including methadone 
maintenance, therapeutic communities, outpatient drug-free programs, and detoxification 
sites.  
The results showed that methadone maintenance, therapeutic communities and 
outpatient drug-free programs were effective in reducing daily opioid use and criminal 
activity. Perhaps more promising, treatment effects remained even after treatment ended; 
the key, however, appeared to be time spent in treatment. Clients who remained in 
treatment for a period of 90 days or more demonstrated statistically significantly better 
outcomes at a one-year follow-up than those who only attended an intake session or 
engaged in detoxification (Simpson & Sells, 1982). It was the first time that large-scale 
addiction research evaluated outcomes by demonstrating follow-up rates of 83% of 
participants from the first to third year following treatment and 80% of participants 12 
years after initial admission (Simpson, 1993).  
The DARP investigation faced numerous challenges including a lack of 
“operational standards and definition for conducting treatment evaluations” (Simpson, 
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1993, p. 121) as well as criticisms surrounding the self-report data generated from the 
unreliable source of drug addicts. Additionally, problems with the study design being 
naturalistic and quasi-experimental rather than carefully controlled and randomized 
raised questions about the true efficacy of treatment. Challenges also existed in achieving 
high compliance rates with respondents due to the multi-site design. Additionally, the 
investigators faced difficulties in managing and analyzing such a large data set with 
primitive computers and limited statistical programs. Despite these obstacles, the results 
of DARP did assist future research efforts by pointing to the importance of standardizing 
outcome assessments and moving research towards the utilization of more objective 
behaviorally-based evaluation approaches rather than relying on clinical impressions. 
DARP has been hailed as “one of the longest and most productive studies of drug abuse 
treatment outcomes ever conducted” (Fletcher et al., 1997, p. 219) providing initial 
evidence that drug abuse treatment is not only effective, but that the longer a client 
remains in treatment, the more favorable their outcomes (Simpson & Sells, 1982). 
Treatment Outcome Prospective Study (TOPS) 
Later, in 1979, NIDA launched the Treatment Outcome Prospective Study 
(TOPS), which was the second large national investigation of community drug treatment 
centers. Its research questions mirrored DARP’s and included investigating the 
effectiveness, duration, organization, and intensity of different types of treatment 
programs associated with 11,182 clients who entered treatment from 1979-1981. The 
TOPS study looked to expand the goals of DARP by including additional client and 
program attributes in its evaluation (Fletcher et al., 1997) and focused on treatment 
offered in methadone maintenance, outpatient drug free, and long-term residential 
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programs. The results of the TOPS analyses provided evidence that clients entering 
treatment often experience co-morbid psychiatric distress, specifically symptoms of 
depression, and that those who enter treatment with extensive, or long-term addictive 
histories, have poorer treatment prognoses (Fletcher et al., 1997). TOPS also 
demonstrated that, since DARP, drug use patterns had changed. In the TOPS sample 
there was less daily heroin use, yet more participants demonstrated polysubstance use as 
compared to DARP (Hubbard et al., 1989). Furthermore, the results provided additional 
evidence to support the previous finding that length of stay in treatment was positively 
associated with more favorable treatment outcomes in terms of reducing daily drug use, 
suggesting that drug treatment can both be cost-effective and valuable (Simpson, 1993; 
Fletcher et al., 1997). 
Drug Abuse Treatment Outcome Studies (DATOS) 
The late 80s and early 90s witnessed significant cultural and policy changes that 
continued to emphasize the need for quality drug treatment. These changes included but 
were not limited to: decreased funding for treatment sources, the growing AIDS 
epidemic, shifts in patterns of drug use including significant increases in cocaine and 
poly-substance abuse, decreased coverage of drug treatment from insurance companies, 
and the increased awareness of clients entering treatment with comorbid psychiatric 
disorders. Furthermore, the early 1990s saw significant decreases in length of stay in 
treatment due to slashed funding and increased pressure for clinics to demonstrate 
accountability (Etheridge et al., 1997). These significant cultural shifts resulted in 
questions about the generalizability of the DARP and TOPS findings, which NIDA 
addressed by launching a third study in 1989, the Drug Abuse Treatment Outcome 
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Studies (DATOS). Whereas previous investigations maintained a strict focus on how 
treatment outcomes are related to client characteristics, DATOS shifted this focus away 
from the client and attempted to investigate how well treatment programs, both public 
and private, served specific drug use populations and addressed their needs. The included 
treatment programs were purposefully selected as those deemed to have “long-term stable 
operating histories to ensure their viability as research sites” over the two year data 
collection period (Etheridge et al., 1997, p. 247). Although DATOS investigated client 
outcomes, it was distinct from the other large-scale investigations by exploring outcomes 
as they related to various programmatic factors ranging from the overall program 
modality down to counselor-client factors (Etheridge et al., 1997). To this end, the 
DATOS investigation collected data from long-term residential, short-term residential, 
outpatient drug-free, and methadone maintenance programs (Leschner, 1997).  
Mirroring, as well as building upon DARP and TOPS, DATOS data was collected 
on clients as well as on treatment-related factors, at the point of treatment engagement, 
throughout the treatment process, and post-treatment (Flynn, Craddock, Hubbard, 
Anderson & Etheridge, 1997). The DATOS research initiative involved the collaboration 
of various sites, each maintaining a specific focus. The goals of the respective sites 
included: (1) health services research, (2) retention and engagement, (3) life course of 
treated addicts, and (4) policy-relevant drug abuse treatment (Fletcher et al., 1997, p. 
222).  
Results suggested that across treatment modalities, the most common treatment 
approach was supportive psychotherapy, which was delivered in both individual and 
group settings and stressed abstinence goals. Treatment programs were found to 
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individualize service delivery based on specific client needs. Matching strategies to 
appropriately connect clients with counselors were found to be employed in most of the 
programs included in the study. Unfortunately, the offering of more widespread services, 
including ancillary support, was found to decrease over time (Etheridge et al., 1997). The 
decrease in ancillary services was likely symptomatic of the dramatic cuts in funding that 
were noted as taking place during this time. 
Regarding treatment settings, outpatient drug-free programs demonstrated the 
greatest amount of client heterogeneity in terms of type of diagnosed substance 
dependence. Furthermore, DATOS data confirmed that clients in treatment settings often 
demonstrated long-term treatment “careers”; characterized by more severe drug use 
patterns and criminality over time coupled with repeated treatment seeking due to high 
relapse rates. Results suggested that having extensive treatment histories was related to 
more severe addiction behaviors as well as more legal difficulties and employment 
problems (Anglin, Hser & Grella, 1997). Programs found to have difficulty retaining 
clients tended to treat clients who presented with more severe problems. This increased 
problem severity was reflective of clients who were diagnosed with antisocial personality 
disorder, who demonstrated more severe substance use diagnoses (e.g., dependence vs. 
abuse), were addicted to cocaine, and abused heroin as well as crack-cocaine. According 
to Dwayne Simpson, “these programs are dealing with some tough people. Programs with 
the highest concentration of these problem patients naturally tend to have low retention” 
(Mueller & Wyman, 1997, p. 1). Nonetheless, the results of the DATOS investigation 
continued to provide support to the finding that across treatment modalities substance 
abuse treatment is beneficial to clients and society in reducing drug use and illegal 
180 
 
activity. Fittingly, Leschner (1997) purports that the most valuable finding of the DATOS 
investigation “is that patients who enter drug abuse treatment do significantly reduce their 
illicit drug use” (p. 211). Together, DARP, TOPS, and DATOS suggest that drug 
treatment appreciably decreases drug use while people are in treatment as well as over a 
decade after treatment is completed. 
 Despite this important finding, these large-scale drug treatment evaluations faced 
methodological challenges. The utilization of a multi-site design created significant 
complexities associated with aggregating data across a broad range of treatment 
modalities and client populations (Simpson, Joe, & Brown, 1997; Simpson et al., 1997). 
According to Etheridge et al. (1997), “wide program variation may mask clinically 
meaningful treatment effects in large-scale outcome studies such as DATOS and offers 
methodological challenges in identifying meaningful strategies for clustering programs to 
account for potential impacts at the client level” (p. 259). Furthermore, there are 
limitations associated with making direct comparisons of findings between the different 
treatment modalities since the modalities demonstrated a fair amount of variability 
related to treatment approaches, average length of stay, and clientele (Broome, Simpson, 
& Joe, 1999). Despite these challenges, the multi-site design did allow for general 
conclusions to be drawn about treatment effectiveness across a variety of therapeutic 
settings (Joe, Simpson, & Broome, 1999). In addition, DATOS incorporated more 
sophisticated data analytic techniques than were employed in the DARP and TOPS 
investigations (Simpson et al., 1997). 
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Large-Scale Alcohol Research 
Project MATCH 
 There have also been large-scale studies investigating alcohol treatment programs 
and treatment matching efforts; Project MATCH and Project COMBINE are two such 
investigations. In contrast to the large-scale drug evaluations, which were effectiveness 
studies conducted in naturalistic settings, Project MATCH was an efficacy study, 
carefully controlled and randomized. This study was conducted with the notion that 
clients diagnosed with alcohol dependence are not a homogenous group in terms of both 
their treatment needs and responses. Because one specific treatment approach has not 
been identified as resulting in superior treatment outcomes, treatment matching based on 
client needs/presentations has gained interest in recent years (Project MATCH Research 
Group, 1997a). Project MATCH utilized a randomized control trial (RCT) method to 
investigate how client-treatment factors interact to influence treatment outcomes. There 
were two parallel studies conducted at the same time pulling clients from two separate 
treatment modalities: outpatient treatment and clients receiving aftercare treatment 
following an inpatient stint. With the goal of investigating treatment matching, clients 
were randomly assigned to one of three treatment approach groups: Twelve-Step 
Facilitation Therapy (TSF), Cognitive Behavioral Coping Skills Therapy (CBT), or 
Motivational Enhancement Therapy (MET) (Project MATCH Research Group, 1997a).  
Investigators hypothesized that clients who presented with specific characteristics 
would be more or less likely to have better outcomes depending on the treatment 
modality to which they were assigned. The researchers postulated that clients who 
presented with a greater degree of alcohol dependence would demonstrate more favorable 
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outcomes when matched to the TSF model since this model stresses absolute abstinence. 
Further, it was thought that clients who presented to treatment with higher levels of anger 
or hostility would demonstrate better outcomes when matched to MET since this method 
is designed to increase treatment readiness and reduce “resistance”. Finally, investigators 
suspected that clients who met DSM-III-R criteria for antisocial personality disorder 
would demonstrate better outcomes when matched to CBT since this approach focuses 
less upon the therapist-client relationship and are more behaviorally structured/focused 
(Project MATCH Research Group, 1997c).  
Clients were evaluated at 3-month intervals for up to year after completing 
treatment in an effort to monitor their drinking patterns, quality of life reports, and the 
utilization of treatment services (Project MATCH Research Group, 1997b). Results 
pointed to two statistically significant findings related to treatment matching, one for the 
outpatient group that entered treatment with a high degree of anger, and the other for the 
aftercare group that presented with more severe alcohol dependence. More specifically, 
the outpatient clients with high levels of anger, when placed in the MET treatment 
modality, were found to demonstrate statistically significantly lower post-treatment 
drinking rates than clients who entered treatment with high levels of anger yet were 
matched to the CBT group. Additionally, aftercare clients who presented with more 
severe alcohol dependence, demonstrated statistically significantly more favorable post-
treatment outcomes when matched with the TSF. Despite these findings, the overall 
results did not demonstrate clear and robust conclusions that treatment matching 
significantly improves post-treatment drinking outcomes (Project MATCH Group, 
1997a; 1997b).  
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A separate analysis utilizing the Project MATCH data suggested that when the 
treatment focus is on quickly and significantly reducing alcohol use and negative 
associated consequences CBT or TSF were most useful (Project MATCH Group, 1998a). 
Nonetheless, by and large, the results supported earlier findings suggesting that “when 
the results of the Project MATCH primary and secondary matching findings are 
considered together, no strong conclusions can be drawn that matching clients to specific 
treatment modalities can improve post-treatment drinking patterns” (Project MATCH 
Group, 1997c, p. 1690). Regardless of the notion that treatment matching may not play a 
significant role in treatment outcomes, the results lend support that the three treatment 
modalities can be appropriate options for a wide variety of clients seeking treatment for 
alcohol addiction (Project MATCH Group, 1998b). It should be noted that the 
generalizability of the results is limited since the randomized control design was intended 
to maximize internal validity. The researchers noted that the observed treatment 
outcomes could have been inflated, due to the rigorous efforts made to ensure that 
therapists followed the study protocols with the manualized treatment. In the event that 
treatment outcomes were inflated the effects associated with treatment mismatching 
could have been mitigated (Project MATCH Group, 1998b) 
Project COMBINE 
 Project COMBINE set out to investigate the efficacy of behavioral therapies, 
pharmacological treatments, and the combination of both in the treatment of alcohol 
dependence (The COMBINE Study Research Group, 2003). The study was one of the 
first designed to investigate whether treatment was more efficacious when 
pharmacological and behavioral approaches are combined. Both naltrexone and 
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acamprosate are drugs that have been used to treat alcohol dependence. The potential 
outcome of combining these two drugs (with the addition of psychotherapeutic 
interventions) however, had never been investigated. More specifically, the goals of the 
COMBINE project included: (1) to determine how individuals with alcohol dependence 
respond to treatment involving medication coupled with counseling, (2) to determine if 
counseling would be enhanced by clients taking placebo medication while also seeing a 
health care professional, and (3) to determine if any improvements made over the 16-
week period of the investigation would extend to one year after treatment cessation 
(Anton, Miller, O’Malley, Zweben, & Hosking, 2006). There were two behavioral 
treatment approaches included in the study. The first, medical management (MMT), was 
a manualized intervention focused on improving medication compliance and abstinence 
rates that could be implemented in primary care settings. The second behavioral approach 
was a cognitive behavioral intervention (CBI) which was also guided by a manual and 
intended to provide specialized treatment of alcohol dependence (The COMBINE Study 
Research Group, 2003).  
Like Project MATCH, COMBINE was an RCT. The investigation included 1383 
adults drinking at harmful levels (21 or more drinks/week for men, or 14 or more 
drinks/week for women) who also met criteria for alcohol dependence. Treatment groups 
were formed based upon various combinations of the interventions previously listed for a 
total a nine possible treatment conditions. Participants were randomly assigned to one of 
these nine conditions. More specifically, a total of eight groups received MMT; four of 
the groups receiving MMT were also exposed to the CBI. All of the participants in the 
eight groups were also assigned to a medication condition (e.g., placebo, acamprosate, 
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naltrexone, or acamprosate plus naltrexone). This then resulted in four distinct 
medication conditions for each of the two behavioral interventions (e.g., MMT or MMT 
plus CBI). A ninth group, that was exposed only to the CBI, was included to investigate 
possible placebo effects.  
Results indicated that all groups in the study demonstrated a statistically 
significant decrease in drinking. More specifically, “all treatment groups experienced a 
large increase in percent days abstinent, from 25 prestudy to 73 during treatment” (Anton 
et al., 2006, p. 2013). Furthermore, when medical management was combined with 
cognitive behavioral interventions or naltrexone, participants demonstrated more 
favorable outcomes. On the other hand, combining the behavioral interventions and 
naltrexone was not found to further enhance treatment outcomes (Anton et al., 2006). 
The COMBINE investigation demonstrated high internal validity due to the 
similarities between the groups on baseline characteristics, medication and treatment 
compliance rates, and the collection of drinking data. There were limitations associated 
with the study however. External validity was compromised due to the study’s 
exclusionary criteria (e.g., participants with significant mo-morbid psychiatric 
disturbances and/or co-occurring drug abuse) and the fact that study locations only 
included academic sites (Anton et al., 2006). The limited time of treatment exposure (16 
weeks) was an additional limitation, given that individuals diagnosed with alcohol 
dependence often demonstrate a high probability of relapse (Anton et al., 2006). Despite 
these limitations, the results of the COMBINE investigation further point to the notion 
that treatment of alcohol disorders is effective both with the use of behavioral 
interventions and medical management. Because many treatment programs include the 
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use of addictionologists in the treatment of alcohol disorders medical management is 
often a viable option in treatment settings. 
Time in Treatment and Treatment Outcomes 
Although the efficacy and effectiveness of substance abuse treatment appears to 
be established, in order for treatment to produce favorable outcomes a client must be 
engaged and retained in it. This can be a challenge due to high rates of drop-outs 
typically associated with substance abuse treatment. Weisner, Mertens, Tam, and Moore 
(2001) note that approximately 29-42% of clients who are admitted for treatment do not 
subsequently return to receive it. Their study, and other research, has demonstrated 
similar results in that about a third of clients have been found not to return for treatment 
following the initial intake assessment (Jackson, Booth, McGuire & Salmon, 2006; King 
& Canada, 2004; Weisner et al., 2001). Once clients are engaged in treatment attrition 
rates have been reported to be around 65% (and up to 75%) and those clients who leave 
treatment tend to do so early on in the process (i.e., before completing even half of the 
treatment regimen) (Justus, Burling, & Weingardt, 2006; Sayre et al., 2002; Siqueland et 
al., 2002; Veach, Remley, Kippers, & Sorg, 2000). Other reported retention rates have 
varied depending on the treatment modality. For example, retention rates (defined as 
treatment completion) have been reported as being higher in intensive inpatient programs 
(75% for intensive inpatient alcohol treatment, 71% for intensive inpatient drug 
treatment) and much lower in intensive outpatient (23% for intensive outpatient alcohol 
treatment, 18% for intensive outpatient drug treatment) (Wickizer, Maynard, Atherly, & 
Frederick, 1994).  
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It has been hypothesized that clients need to be exposed to counseling for several 
months in order for their behavior to be representative of stable treatment benefits. This 
notion has been supported by research. According to Simpson and Joe (2004) better 
treatment outcomes have been found to be predicted by minimum retention thresholds 
associated with different treatment modalities. More specifically, if clients in residential 
and outpatient drug-free programs are retained for an average of at least three months, 
and clients in methadone outpatient treatment are retained for at least a year, their post-
treatment outcomes improve compared those clients not retained for those periods.  
Other research has replicated the finding that longer stays in methadone treatment 
are associated with more favorable outcomes. Simpson, Joe, and Rowan-Szal (1997) 
launched one such investigation on retention in methadone treatment. Results 
demonstrated statistically significant improvement in client drug use patterns and 
criminal behavior from intake to follow-up. As length of stay in treatment increased post-
treatment outcomes also improved up to one year following discharge. The authors assert, 
“the magnitude of improvement over time was dependent on how long patient remained 
in treatment” (p. 232). Those clients retained in treatment for at least one year were five 
times more likely to demonstrate more favorable outcomes than those not retained as 
long. Treatment retention effects were statistically significantly related to all the 
outcomes measures including drug use, alcohol use, criminality, and problem severity.  
The finding that client retention for at least 90 days in residential and outpatient 
treatment modalities is predictive of more favorable treatment outcomes (Simpson, 1993) 
has also been replicated. Hser, Evans, Huang, and Anglin (2004) investigated the 
relationship between drug treatment services, retention, and outcomes among clients 
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engaged in multi-site out-patient drug free and residential treatment programs in 
California. The authors analyzed the relationship between treatment processes, retention, 
and outcomes through path analysis. Their results demonstrated that greater treatment 
intensity and satisfaction was directly linked to clients remaining in treatment for a longer 
period or through completion. In turn, longer retention (at least 90 days) in treatment, or 
treatment completion, was statistically significantly associated with more positive 
treatment outcomes (i.e., no illicit drug use in past 30 days, no criminal activity, and were 
living in the community). The authors caution though that the generalizability of these 
findings across programs is compromised since the treatment programs were not 
randomly selected. Furthermore, the study excluded about half of the potential 
participants who were identified during the recruitment period. These were individuals 
who were engaged in methadone maintenance programs, incarcerated, died, or whom lost 
contact with the researchers during the follow-up period.  
These very specific retention thresholds of three months and one year have been 
examined to address the criticism that such arbitrary cut-offs could be misleading. 
Additionally, clients cannot always be retained throughout this critical period as 
treatment lengths are increasingly determined by managed care requirements rather than 
treatment need (Leshner, 1997). To address this question Zhang, Friedmann and Gerstein 
(2003) investigated how well the retention thresholds predicted treatment outcomes. 
Their findings did not support an optimal treatment threshold across treatment modalities. 
They found positive linear relationships associated with time spent in treatment and 
overall client improvement. For outpatient and long-term residential however, if clients 
remained in treatment for an unusually long period of time (i.e., more than 18 months) 
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treatment effects had diminishing returns. The authors hypothesize that this finding could 
indicate “optimal” treatment lengths for different modalities. Although these findings did 
not substantiate the optimal treatment thresholds identified by Simpson and Joe (2004), 
the results do provide additional evidence to suggest that time spent in treatment is a vital 
factor related to overall client improvement and that retention does indeed “matter” 
(Zhang et al., 2003). If programs have difficultly retaining clients within a period of 
adequate treatment exposure, client outcomes would certainly seem to suffer. Ball, 
Carroll, Canning-Ball, and Rounsaville (2006) maintain that early attrition from treatment 
is the most profound variable associated with treatment outcomes; as cited, if clients are 
retained in treatment, outcomes improve. As indicated by Etheridge et al. (1997), “over 
the past 15 years, one of the most consistently replicated research findings is the 
importance of length of stay as a predictor of treatment outcome” (p. 258). Ironically, 
despite this highly reliable finding, it is length of stay that has been compromised most by 
managed care. 
Early Treatment Engagement and Retention 
Early treatment engagement appears to be a critical factor in client retention. In 
other words, if a client is not engaged or connected to treatment early on, it is suspected 
that they would be more likely to prematurely drop out of treatment. Research suggests 
that when clients have a shorter wait time from intake assessment to the first treatment 
episode, they are more likely to engage in treatment (Claus & Kindleberger, 2002; 
Jackson et al., 2006). Not surprisingly, it appears that consistent contact with treatment 
staff early may be a factor assisting clients to engage in treatment. For example, clients 
referred to residential treatment have been found to be more likely to engage in and 
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attend treatment than those clients referred to outpatient treatment. (Claus & 
Kindleberger, 2002). These results may be related to the notion that clients enrolled in 
inpatient treatment are seen more often by clinical staff and have more consistent 
exposure to treatment sessions. Although “decisions to seek help and to accept help are 
distinct” (Claus & Kindleberger, 2002, p. 25), early engagement and retention are related 
constructs.  
Without early engagement retention is not likely to take place (Simpson, 2004). 
Simpson describes a complex process of linked elements which interact to influence 
engagement and retention. He notes client motivation or readiness for change, treatment 
factors including, but not limited to, the therapeutic alliance, session attendance, social 
support networks, and other client factors such as higher levels of addiction severity as all 
contributing to early engagement and hence overall retention. All of these factors have 
been found to be implicated in both treatment engagement and retention; unfortunately 
they have not been investigated comprehensively. Although treatment engagement and 
retention are related constructs, the factors associated with a client initially becoming 
involved in treatment and those associated with the client then remaining in treatment 
may be distinct (Weisner et al., 2001). As such, a separate section focused on the 
treatment engagement literature will follow. 
Treatment Engagement –Review of the Literature 
Simpson and Joe (2004) have postulated that early engagement is related to two 
primary factors: program participation and therapeutic relationship. Both factors and their 
relationship with early recovery appear to be positively related to retention and post-
treatment recovery. For example, in the counseling and therapeutic literature, the 
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therapeutic alliance is often found to be at least a moderate predictor of client 
engagement, retention, and positive therapeutic outcome (Martin, Garske, & Davis, 
2000). Although perhaps not as thoroughly, this phenomenon has also been investigated 
in the substance use treatment arena. Dearing, Barrick, Derman, and Walitzer (2005) 
focused on the relationship between different aspects of client engagement (e.g., 
therapeutic alliance, session attendance, and treatment expectations) from the clients’ 
perspective and how those factors relate to outcomes. Results suggested that when clients 
perceive a positive working (or therapeutic) alliance, they have positive expectations 
about treatment, and in turn engage in treatment more, tend to report greater satisfaction 
in treatment, and have better treatment outcomes (Dearing et al., 2005). Supporting these 
findings was a review article by Meier, Barrowclough and Donmall (2005) which 
examined 18 studies conducted over a period of 20 years and focused on the impact of 
the therapeutic alliance on drug treatment processes. Although a limited number of 
studies focused on the link between the therapeutic alliance and early engagement, those 
included in the review reported a consistent positive relationship between client-therapist 
alliance and early engagement in treatment. 
Program Participation and Treatment Intensity 
 Program participation and treatment intensity appear to be other critical 
components of treatment engagement and outcome. For example, research has suggested 
that clients who attend more counseling sessions while in treatment tend to have more 
favorable outcomes (Fiorentine & Anglin, 1996). It therefore seems reasonable to suspect 
that frequency of program participation can also be related to how well a client engages 
early on in treatment; if a client does not participate regularly at the point of treatment 
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onset they would likely continue with sporadic attendance or stop engaging altogether. 
Related, offering more consistent opportunities to engage in treatment (i.e., treatment 
intensity) may help to increase how often a client attends treatment early on. Indeed, 
research has supported the notion that treatment intensity is related to treatment initiation; 
clients assigned to higher levels of treatment intensity (i.e., day treatment vs. outpatient) 
were more likely to return for it than those assigned to lower levels of intensity (Weisner 
et al., 2001). 
Client and Treatment Factors Related to Engagement 
 Although Simpson and Joe (2004) maintain that program participation and 
therapeutic alliance are the two primary factors related to early engagement, other factors 
have also been found to be related. For example, Fiorentine, Nakashima & Anglin (1999) 
investigated both client and treatment factors that may be related to client early 
engagement. They maintain that early treatment engagers may be those clients who are 
receptive to treatment (client attribute), or it may be that the treatment regimen is one that 
assists clients in becoming engaged (treatment factor). They questioned which factors 
appear to be more strongly linked to treatment engagement, and because treatment 
engagement factors have been thought to vary based on gender they investigated men and 
women separately.  
Their findings were consistent with other research results suggesting that women 
were statistically significantly more likely to engage in treatment than men (Green, Polen, 
Dickinson, Lynch & Bennett, 2002; Weisner et al., 2001), but for both men and women 
treatment factors (e.g., perceived counselor empathy, ancillary service availability, and 
utility of treatment) were more often associated with engagement than client factors were. 
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The authors also uncovered specific relationships between gender and engagement. For 
women, the most powerful predictors of treatment engagement were perceived 
helpfulness of medical services, intensity of pre-treatment alcohol use, and perceived 
care/empathy of their counselor. For men, perceived helpfulness of medical services, 
transportation, and relapse prevention training were the most powerful predictors of 
engagement. For both genders, treatment variables were more predictive of engagement 
than were client variables (Fiorentine et al., 1997). This was in contrast to previous 
research cited by the authors which historically pointed to client characteristics (e.g., 
marital status, employment etc.) as being more predicative of treatment engagement than 
program characteristics. 
Other treatment variables like therapeutic approaches have been investigated as it 
relates to treatment engagement efforts. Client motivation, which will be discussed in 
greater depth when reviewing the retention literature, has been linked to early 
engagement. Higher levels of motivation and treatment readiness have been found to be 
associated with early retention (DeLeon, Melnick & Kressel, 1997). It is not surprising 
then that research has demonstrated that when treatment approaches include techniques to 
enhance client motivation (i.e., motivational interviewing), it can help to increase the 
chances of clients initiating and attending treatment early on (Carroll, Libby, Sheehan & 
Hyland, 2001).  
Specific client factors have also been found to be related to treatment 
initiation/early engagement. For example, women who are over 30, receive an annual 
income over $20,000, and report a high degree of alcohol severity have been found to be 
statistically significantly more likely to engage in initial treatment sessions (Weisner et 
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al., 2001). Age has been implicated in other research as well suggesting that older clients 
are more likely to engage in initial treatment sessions (Green et al., 2002; Jackson et al., 
2006). On the other hand, research has also demonstrated that clients who have less 
severe dependence on alcohol are more likely to engage in initial treatment sessions 
(Jackson et al., 2006). Decreased levels of treatment initiation were found to be 
associated with drug dependent clients versus alcohol dependent clients. Being employed 
was also associated with a higher level of treatment initiation following intake. 
Furthermore, men who enter treatment with lower levels of education, and women who 
are dually diagnosed have been found to demonstrate decreased treatment initiation 
(Green et al., 2002). On the other hand, research has also suggested that clients who 
present for treatment with multimorbidity (i.e., an “overlap” of psychiatric symptom 
clusters coupled with a substance use disorder) have demonstrated increased treatment 
engagement (Castel, Rush, Urbanoski & Toneatto, 2006). 
Personal relationships, psychosocial functioning and level of motivation at 
treatment onset have also been linked to engagement. Griffith, Knight, Joe and Simpson’s 
(1998) tested a model which indicated that when a client with poor family interactions 
enters into treatment they are more likely to report experiencing psychosocial distress. In 
turn, this distress appears to predict higher levels of motivation at treatment onset, which 
predicts higher engagement and more favorable outcomes (related to decreasing both 
opioid use and criminal activity). These results suggest that early engagement may be 
directly tied to treatment outcomes. Clients who enter treatment with higher levels of 
distress may be more motivated for treatment in an effort to reduce this distress. This 
increased level of motivation may help clients engage in treatment early on in turn 
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improving chances for recovery. Seen this way, programs that work to engage clients 
early on by helping clients increase their motivation may stand to see more favorable 
treatment outcomes.  
Program Characteristics and Engagement 
 Program characteristics have been implicated in treatment engagement research 
as well. Ricketts, Bliss, Murphy and Booker (2005) hypothesized that program 
characteristics are stronger predictors of engagement than client characteristics. In an 
effort to investigate this hypothesis, they conducted a qualitative study utilizing grounded 
theory to investigate treatment engagement factors with a criminal population being 
treated for drug use. Their results did find program characteristics were related to how 
well clients felt they were able to fulfill program requirements. Clients’ relationships with 
staff were identified as having a very large impact on how readily clients were able to 
engage in and subsequently meet program requirements. Their results suggest that clients 
are more likely to engage in treatment when it is well organized, the clients believe in the 
treatment programs, and medical interventions are available to them. Although the 
sample size was small and the study was conducted outside of the United States, the 
results still point to the potential impact that programs can have on client engagement. 
Factors outside of the program’s control, like distance from a client’s house to program 
location and living with others have also been linked to treatment attendance after 
assessment (Jackson et al., 2006). More specifically, when there was a greater distance 
from a client’s home to the treatment center and clients did not live with others they were 
less likely to start treatment. 
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Summary of Engagement Literature 
Taken together, these investigations support the notion that treatment engagement 
is a complex interplay of both client and program characteristics. Early treatment 
engagement appears to be related to how clients connect with a program, their level of 
motivation, and how long they are willing to remain in treatment, which has obvious 
implications for treatment outcomes. Early engagement has been linked to more 
favorable treatment outcomes (Meier et al., 2005), so factors related to it should be 
seriously considered when attempting to connect clients to the therapeutic milieu early 
on. Research has also demonstrated the intimate relationship that engagement has with 
retention. If a client does not engage in treatment early on they are less likely to remain in 
treatment. Because various client characteristics (e.g., age, marital status, gender, level of 
motivation) have been found to be related to, or predictive of engagement it may be 
prudent for programs to utilize different treatment approaches to help engage various 
populations. For example, efforts to assess for and interventions designed to increase 
client level of motivation for treatment could help to improve engagement rates in 
programs. 
Furthermore, because the variables that are related to engagement are quite 
diverse additional research in this area is warranted. Investigating how program and 
client factors interact to impact engagement is one area that could assist programs in 
tailoring services to improve their client engagement rates. Once related or predicted 
elements of engagement at the program and client level are identified, programs would 
then be better equipped to identify clients at risk of not engaging in treatment and perhaps 
alter the intensity or frequency of treatment options.  
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As aforementioned, in an effort to avoid redundancy, the section devoted to 
literature that has focused on variables related to treatment retention can be found in 
Chapter II of this document. The subsequent section of this appended paper will detail 
some of the methodological limitations and challenges associated with the treatment 
engagement and retention literature that was reviewed for this literature review and study. 
Methodological Considerations and Limitations Associated with Quantitative Substance 
Abuse Treatment Engagement and Retention Research 
In examining some of the large-scale research efforts in drug treatment outcomes 
research, methodological concerns related to operational standards, naturalistic designs, 
and difficulty with compliance rates of follow-ups emerge (Simpson, 1993). Furthermore, 
the assorted, and often conflicting, results in determining the predictive factors and 
correlates of retention have spurred questions regarding the variety of methods utilized in 
investigations (Broome et al., 1999). Methodological considerations and the importance 
of scientifically-sound research have continued to gain momentum and attention as 
substance abuse treatment has become increasingly evidenced-based and quality-
controlled (Moyer, Finney, & Swearingen, 2002). What began as an effort to manage the 
rising health care costs, the current movement of evidenced-based practice has extended 
into the “need for a scientifically grounded approach to health care” (Tucker & Roth, 
2006). Part of establishing scientifically grounded approaches for treatment involves 
careful consideration of methodological issues related to efficacy and effectiveness 
research and improving methodological soundness. Therefore, it is important that the 
scientific integrity of the body of literature cited throughout this review be critically 
examined. 
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Randomized Control Trials 
Historically, as seen in much of the alcohol treatment research field, the “gold 
standard” of empirically evaluating treatments has been randomized clinical trials 
(RCTs). One of the most attractive characteristics of RCTs includes the design’s 
simplicity. By utilizing a random approach to assignment a researcher is able to answer 
the question: Does the treatment cause an improvement on the outcome measure that is 
independent of other possible causal agents? Seen this way, RCTs maximize the internal 
validity by controlling for confounding variables that could impact detecting the “true” 
effect of a treatment approach (Tucker & Roth, 2006). Because RCT designs provide 
stronger evidence of a casual relationship than a non-experimental design, it has earned 
the reputation as the most robust approach in establishing efficacy. 
It should be noted, however, that RCTs do not come without limitations that 
potentially negatively influence the scientific community’s ability to apply findings to 
treatment settings. Efficacy trials tend to lack generalizability since the trials include, 
“tightly controlled settings and more narrowly defined, homogeneous samples than those 
seen in clinical practice” (Carroll & Rounsaville, 2003, p. 335). For example, clients with 
comorbid psychiatric diagnoses or more than one substance use disorder are often 
excluded from a trial to control for variance, which diverges from typical treatment 
conditions. Consequently, these more homogenous samples likely exclude participants 
that may be at a greater risk of prematurely drop out of treatment (i.e., polysubstance 
abusers, clients with comorbid psychiatric distress), which could potentially distort 
retention rates. It has also been suggested that participant treatment compliance can be 
artificially enhanced in RCTs by recruiting participants with high degrees of motivation, 
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and scheduling frequent appointments (Roy-Byrne, et al., 2003). Finally, the “common 
factors” (e.g., therapist empathy, patient expectations) that have been identified as 
impacting treatment outcomes cannot always be studied directly when therapists are 
required to respond to clients in a standardized manner (Tucker & Roth, 2006). 
Of all the studies cited in this literature review, only a very small percentage 
utilized a randomized control clinical trial (e.g., COMBINE Study Research Group, 
2003; Mullins et al., 2004; Project MATCH Research Group, 1997a). Indeed, according 
to Carroll and Rounsaville (2003), “only a handful of supporting clinical trials may exist” 
in substance abuse treatment evaluations (p. 336). And although there may be a need for 
additional RCTs in substance abuse treatment literature, other methodological approaches 
have significantly added to the literature base and will continue to do so. In fact Tucker 
and Roth (2006) indicate:  
The substance abuse field cannot afford a view of evidence that is overly 
restrictive in focus or methodology, which we risk if we follow uncritically the 
research conventions of medicine and other health-care disciplines that value the 
RCT over all other forms of evidence for informing practice. RCTs are invaluable 
for addressing some research questions, especially for evaluating treatment 
efficacy, and we have used them for this purpose ourselves. However, the design 
has limitations that are not always recognized and can render it less than ideal for 
investigating key aspects of the addictive behavior change process. For example, 
questions concerning what influences people with substance-related problems to 
seek and engage treatment, and how these self-selection processes and contextual 
influences contribute to the change process, are not investigated readily by studies 
that assign participants randomly to treatment and control groups (p. 919)  
 
Perhaps not surprisingly then, the majority of the quantitative investigations 
reviewed for this paper were not efficacy studies but rather effectiveness investigations 
carried out in actual treatment settings. It has been argued that effectiveness 
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investigations may be particularly suited for studying treatment as a process (including 
factors related to it) versus an outcome. In other words, once a treatment is deemed 
efficacious, other questions become more relevant, particularly those related to treatment 
engagement and retention since clients need to remain in treatment to reap its associated 
benefits. Furthermore, factors related to engagement and retention that are identified in 
effectiveness studies may have more generalizability since treatment compliance is 
measured as it takes place in real-world settings as opposed to the incentive-based 
approach associated with RCTs (i.e., financial incentives or free medication for 
participation) (Tucker & Roth, 2006). Of course, non-RCT studies can have a variety of 
limitations and weaknesses, and these should also be noted. Because such a large number 
of studies were cited in the review of the engagement and retention literature, it is not 
feasible to comment comprehensively on the specific limitations associated with each 
investigation. As such, this section of the review will focus on the more common 
methodological limitations that were found to be associated with the previously cited 
treatment engagement and retention investigations that are not categorized as RCTs. 
Research Design Weakness 
 Since many of the cited investigation did not fall into the category of RCT, 
different types of threats to validity emerge as potential limitations. For example, some 
studies employed nonrandomized comparisons, or lacked control groups making casual 
inferences associated with retention difficult (e.g., Bride, 2001; Charney et al., 2005; 
Fiorentine & Anglin, 1996; Hser et al., 2003). A lack of randomization results in a 
number of deleterious effects. For example, if groups are not randomly assigned to a 
treatment group, researchers cannot definitively determine if the experimental treatment 
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was indeed superior to standard treatment, and are not able to rule out possible 
confounding variables impacting treatment effect (Carroll & Rounsaville, 2003). 
Additionally, a large percentage of the studies utilized a naturalistic design (e.g., Broome 
et al., 1999; Joe, et al., 1998; McLellan, 1994; Meier et al., 2006; Moos & Moos, 2003; 
Veach et al., 2000; White et al., 1998). The high frequency of naturalistic designs is not 
surprising since engagement and retention research investigates a treatment phenomenon. 
As such, it is quite feasible to conduct this research in the centers where treatment is 
already taking place. Although a naturalistic design has the strength of increasing a 
study’s external validity by studying retention phenomenon as they occur in the treatment 
setting, internal validity is compromised since many variables can “neither be held 
constant nor assessed and statistically controlled” (Meier et al., 2006, p. 62). For 
example, it may be that factors external to treatment are impacting engagement and 
retention, not the treatment itself, but these factors are not measured or controlled for in 
the analyses. Finally, smaller sample size, potentially compromising the studies’ overall 
power, was also associated with some of the cited literature (e.g., Aharonovich et al., 
2006; Burke & Gregoire, 2007; Brocato & Wagner, 2008; Carroll et al., 2001; Daughters 
et al., 2005; Green et al., 2002; Haller et al., 2002; Justus et al., 2006; Westreich, et al. 
1997). 
Definition of Retention 
A common methodological problem associated with retention investigations 
includes the manner with which the variable “retention” is measured and defined. Some 
investigations looked at treatment completion status as indicative of retention, while 
others included specific lengths of stay as representative of retention. The duration of 
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time utilized to define retention through these specific lengths of stay has also been 
inconsistent. These definitions have been found to vary significantly from study to study, 
and the only consistency is the inconsistency with which variables like completion, drop-
out, and retention are defined (Wickizer, et al., 1994). For example, even when clients 
have been described as “treatment completers” the amount of time that each “completer” 
actually remained in treatment has been found to vary from 10 to 64 days (White et al., 
1998). Furthermore, allotted treatment duration varies depending on the treatment center, 
mode of treatment, and/or insurance coverage, and can result in dramatically different 
lengths of treatment exposure. For example, Hser et al., (2003) reported that of the 12 
inpatient treatment centers utilized for data collection, six centers involved treatment 
durations of less than a three months, three centers provided three month treatment 
durations, one center provided six month treatment durations, and two provided treatment 
durations of longer than six months. Variability in planned durations for outpatient 
programs has also been identified. For example, McLellan (1994) noted that of the eight 
included outpatient programs, treatment duration varied from four to 10 weeks and the 
time clients spent in treatment each week ranged from eight hours to 30 hours. 
Treatment retention is often defined by completion of the programs themselves; 
the service providers would make the determination if a client successfully completed 
their program (Green et al., 2002; Sinqueland et al., 2002), and again, the amount of time 
needed to complete different treatment programs will vary depending on both client and 
program factors. Often treatment completion was defined by staff, but when this 
information was not available, treatment completion was defined in different ways. For 
example, Green et al., (2002) defined a treatment completer as someone who attended at 
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least 17 outpatient visits, which was based upon the average number of visits by those 
clients deemed completers by treatment staff. On the other hand, Broome et al. (2002) 
defined completion as participants attending five weeks or more of inpatient treatment 
since that “generally” meant a client had completed treatment. Treatment retention was 
also defined in some studies based upon a client remaining in treatment for a prescribed 
period of time. For example, treatment retention was defined as “sufficient” when clients 
either completed a treatment program (as stipulated by the program) or were retained for 
at least 90 days (Hser et al., 2003; Hser et al., 2004). Other investigations have also 
utilized the treatment retention thresholds that are predictive of more favorable outcomes 
(90 days or longer for inpatient or outpatient treatment) defined early on by Simpson and 
Sells (1982) (e.g., Aharonovich et al., 2006; Brocato & Wagner, 2008; Joe, Simpson, & 
Broome, 1998; Meier et al., 2006; Rawson et al., 2000; Rowan-Szal, et al. 2000). The 
lack of consistency in how retention is being defined begs the questions of whether 
retention studies are investigating the same phenomenon and if some of the lack of 
reliability associated with the results is related to the variability in definitions of retention 
(Wickizer,et al., 1994).  
Participation and Attrition in Substance Abuse Treatment Research 
 Attrition from substance use treatment programs is quite common and has been 
documented as reaching upward of 70-75% (Justus et al., 2006; Sayre, et al., 2002; 
Siqueland et al., 2002). The client and programmatic level effects of such attrition have 
already been described, and yet it is also important to note that poor retention rates can 
similarly negatively impact research efforts. Treatment efficacy and effectiveness 
investigations rely on adequate recruitment of participants and also retention of those 
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participants throughout the course of the investigation to achieve reliable and valid 
results. Research trials commonly lose participants when they prematurely drop out of 
treatment, and there is disagreement among researchers on what constitutes an adequate 
follow-up rate (Vaughn, Sarrazin, Saleh, Huber, & Hall, 2002). Seen this way, high 
attrition from research protocols has the potential to decrease the validity of study 
findings, while also compromising the researchers’ ability to determine between group 
differences since those who drop out may not receive adequate treatment exposure 
(Aharonovich et al., 2006; Festinger et al., 2005; Vaughn et al., 2002).  
Additionally, high levels of attrition have been found to limit a thorough analysis 
of client prognosis and outcomes (Paraherakis et al., 2000). The reasons why clients 
initially agree to participate in substance abuse treatment research, and then remain in the 
study through long-term follow-up periods vary. Some of these reasons, though, are 
worth considering in terms of how they could potentially impact study results. For 
example, clients who self-select to participate in research may likely be distinct from 
those who do not, hence potentially compromising the generalizability of the results. 
Additionally, substance abuse treatment clients who feel coerced to participate in 
research protocols, or are paid to do so, may remain in treatment for reasons outside than 
those investigated directly in the study. As such, it will be discussed how these three 
factors (i.e. self-selection, coercion to participate, and incentive to participate) have the 
potential to impact retention research. 
 Self-selection to participate. Consideration of the initial agreement to participate 
in and subsequent retention of study participants is important; there is a potential for 
biased findings since clients self-select to participate. In other words, clients who choose 
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not to participate in research, or treatment for that matter, are not accounted for in 
treatment effectiveness literature (Vaughn et al., 2002). Although it has been noted that a 
certain percentage of clients may decline to participate in the research protocol, 
investigating the differences between participants and non-participants cannot always be 
conducted (McLellan et al., 1994). Vaughn et al. (2002) explained that clients who agree 
to participate could have specific characteristics that are not associated with those who 
choose not to participate. As a result, these differences “may alter the representation of 
the treatment groups, resulting in invalid conclusions being drawn regarding treatment 
effectiveness. In addition, systematic differences in retention in research across groups 
may reflect systematic differences in treatment effectiveness between the subgroups” (p. 
394). Put another way, positive treatment outcomes could be mediated by participant self-
selection, longer treatment stays, and its associated motivation (Moos & Moos, 2003).  
The Vaughn et al. (2002) investigation tested for any significant differences 
between the research participants and the client population in general and found that the 
two groups were quite similar in terms of demographic characteristics and baseline 
problem severity. On the other hand, certain client characteristics were found to be more 
commonly associated with research participation and retention. For example, clients with 
more intense treatment needs, females, and those who lived in closer proximity to the 
research site, were more likely to participate in the research. Considering that 
participation in the study required additional time and effort on behalf of the client, the 
researchers concluded that only the most highly motivated clients likely agreed to 
participate. This may be a particularly salient finding as it relates to treatment retention. If 
those clients who self-selected to participate in the research protocol were indeed highly 
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motivated, it begs the question how that group would compare to the clients who declined 
to participate in terms of treatment retention. Unfortunately, comparing the research 
participants and non-participants on treatment retention rates was not investigated.  
Coercion to participate. In order to conduct addiction treatment research, it is 
typically necessary to elicit the participation of those abusing the substances and/or 
receiving treatment to investigate the phenomenon connected to it. Following the ethical 
guidelines associated with human subjects research is an essential component of any type 
of human research. Inherent within and central to the process associated with protecting 
research participants is informed consent. In order for participants to provide true 
informed consent they must be able to comprehend what they are consenting to and 
voluntarily do so. Informed consent has been described as the “ultimate ethical criterion” 
in research (Stricker, 1991, p. 256). Substance abusing populations present unique 
challenges to obtaining informed consent. Some of these challenges arise from issues 
inherent in the disorder itself. For example, researchers run the risk of the potential 
participant being under the influence of substances, or in acute detoxification when 
signing an informed consent document, which would limit their ability to fully 
comprehend the parameters of the study (Anderson & DuBois, 2006).  
 Voluntariness to consent is also a concern with substance abusing populations; 
coercion to participate compromises voluntariness and can be subtle or more obvious. 
More subtly, if substance abusers are also experiencing medical problems and have 
limited access to treatment options they may feel forced to turn to clinical trials that offer 
free or reduced fee treatment. Potential coercion to participate in substance abuse 
treatment and/or research takes place on a more overt level as well. For example, 
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incarcerated or court supervised individuals may not have full autonomous choice to 
participate in treatment or a study connected to it (Burke & Gregoire, 2007; McCrady & 
Bux, 1999; Vaughn et al., 2002). Large numbers of substance abusers are arrested and 
face incarceration or come under supervision of the court system (DuVal & Salmon, 
2004). The voluntariness of such participants to provide informed consent can be 
compromised, especially if participants feel they might not meet program requirements in 
an effort to avoid an incarceration. Individuals who both abuse drugs and/or alcohol and 
are connected to the criminal justice system often seek substance abuse treatment for a 
variety of reasons. Reduced sentencing, avoiding further legal difficulties, relieving 
urges/cravings, and addressing family stress to alter substance use are all possible reasons 
individuals involved in the legal system seek treatment. Noteworthy, these treatment 
regimens are often connected to research endeavors and in this way, incarcerated 
individuals may also feel pressured to participate in research efforts for the same cited 
reason associated with engagement in treatment services. Experiencing a degree of 
coercion to participate can limit voluntariness in informed consent for fear that they could 
be punished by court officials if they refuse (DuVal &Salmon, 2004).  
In terms of impact on research efforts, it is hypothesized that coercion to 
participate in treatment and research could result in higher retention rates than those 
groups not forced to engage in treatment. Theoretically, if this confounding variable of 
external motivation is not controlled for in retention research, the validity of the results 
could be compromised. Research has demonstrated that when clients experience legal 
coercion to participate in treatment, they have been found to complete treatment at higher 
rates than clients who are not legally coerced to attend treatment (Hser et al., 2004; 
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Maglione et al., 2000b; Mammo & Weinbaum, 1993). Young and Belenko (2002) looked 
at the differences in retention between clients enrolled in extremely coercive treatment 
settings compared to clients enrolled in less coercive programs. The most coercive 
settings were one-and-a-half year residential drug treatment programs offered in lieu of a 
one to three year prison sentence. If those clients remained in treatment for the one-and-
a-half year duration, the charges were subsequently dropped. However, clients who left 
treatment prematurely were faced with a mandatory prison sentence as a repeat offender. 
The less coercive settings involved parolees and other legally mandated clients who were 
referred to treatment by the courts. Results demonstrated that clients participating in 
residential treatment programs which were deemed “most coercive” were three times 
more likely to remain in treatment for at least six months compared to clients enrolled in 
less coercive programs. Mandated participation in treatment has also been found to be 
related to treatment outcomes. Research has shown that clients legally coerced to 
participate in treatment were more likely to demonstrate abstinence from substance use 
30 days after treatment completion than those clients not legally required to attend 
treatment (Burke & Gregoire, 2007).  
It is important to note that it can be difficult to separate coercion to participate in 
research and treatment since the two are likely related. For example, it would not be 
surprising that those clients who are forced into treatment as an effort to avoid further 
legal ramifications would also agree to participate in a research protocol connected to it. 
Clearly both subtle and overt coercion to participate in substance abuse treatment and 
research exists. Ethically, this raises concerns about the voluntariness of informed 
consent, while also potentially creating the confounding variable of external motivation, 
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which may not be controlled for in analyses. Furthermore, the question remains whether 
the longer stays and more favorable outcomes found to relate to coerced treatment would 
hold once this coercion is removed. Simply because clients are forced into treatment does 
not automatically assume that they will engage in the treatment process. For example, a 
significant limitation of the Burke and Gregoire (2007) investigation is that they did not 
subsequently investigate substance use rates after supervision of the courts was lifted and 
the risk of being incarcerated had passed. This is noteworthy since it has also been found 
that client relapse rates can increase significantly once monitoring probation programs 
end (Brecht, Anglin, Whang, 1993). Furthermore, a recent investigation conducted by 
Perron and Bright (2008) replicated the finding that clients legally coerced to attend 
treatment were statistically significantly more likely to be retained for longer periods than 
those clients not coerced to attend, however, treatment outcomes did not reflect the same 
positive trend. In fact, clients legally coerced to attend treatment demonstrated worse 
outcomes. This finding could lend support to the hypothesis above that for clients coerced 
to attend treatment, treatment effects may not necessarily hold simply because they 
remain in treatment for a longer period of time. 
Financial incentives for participation. Coercion related to substance abuse 
treatment research is also a concern as it relates to paying individuals to participate. 
Within clinical research illicit drug users are typically considered a “hidden population” 
that is especially challenging to recruit and retain in studies (Barratt, Norman, & Fry, 
2007). And yet, successful completion of research efforts relies on adequate recruitment 
and retention. To address this issue research efforts often pay for substance abusers to 
participate. For example, out of 91 researchers conducting studies in the field of 
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addictions 85% of them offered cash compensation to participants (McCrady & Bux, 
1999). Payment for participation is often gauged according the amount of time a 
participant devotes to the research effort. The determination of how much to compensate 
participants is often more difficult when including substance abusing populations in 
research efforts. The most obvious risk is associated with participants utilizing the money 
to purchase substances (McCrady & Bux, 1999). There are other issues though related to 
financial incentives and retention in research within treatment programs.  
 In theory, providing monetary incentives for participation could inflate retention 
rates. Cash incentives could unduly influence clients to remain in a treatment setting and 
participate in the research being conducted. Despite this line of reasoning, there has been 
very little research investigating this phenomenon. Festinger et al. (2005) recently 
examined this topic noting that prior to their efforts they found no other empirical 
investigations focused on the relationship between financial incentives and its influence 
on participation in research. The study involved 350 clients from three outpatient 
substance abuse treatment programs who were offered $10, $40, or $70 incentives for 
participation in the study through a six month follow-up. Results demonstrated that 
higher payments were related to higher follow-up rates after treatment completion. 
Although this study did not investigate retention during treatment as it related to payment 
amount, theoretically, incentives could impact it. For example, clients may decide to 
remain in treatment for a longer period if they are also being compensated by 
participating in a research protocol, especially if they consider the incentive to be 
significant. Although high payments are generally not associated with research 
participation, there are exceptions. One study offered to pay alcohol dependent fathers 
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$400-$500 for participation (Jacob, Krahn, & Leonard, 1991). The concerns around the 
true voluntariness of these participants were discussed in a follow-up article stressing that 
offering such a payment for participation “may be considered coercive for a group that 
included a large number of unemployed men” (Stricker, 1991, p. 256). Additionally, what 
would seem like a small incentive to a researcher may in fact be substantial enough for a 
participant to remain in treatment if only to receive the compensation for the associated 
research project. In summary, although there is not overwhelming evidence to suggest 
that participants are offered substantial financial incentives to engage in treatment 
research, it is still worth noting that payment could create an external motivation to 
continue with treatment and consequently inflate retention rates. Seen this way it could be 
an additional confounding variable that deserves noting. 
Generalizability 
Sampling. Sampling limitations were associated with various studies due to both 
exclusionary and inclusionary criteria. For example, sampling biases were indentified 
with investigations that excluded participants who were incarcerated (Simpson et al., 
1997), diagnosed with poly-substance abuse/dependence (Aharonovich, 2006; Dearing et 
al., 2005), or had substantial co-morbid psychological distress (Anton et al., 2006; 
Cannon et al., 1997; Dearing et al., 2005; Ross et al., 1997; Siqueland et al., 2002). When 
clients are excluded from a study based on a specific characteristic, especially one that is 
commonly associated with substance abuse and treatment retention (i.e., psychiatric 
distress, poly-substance abuse, or significant legal problems), the generalizability of the 
sample/results can be significantly compromised. In a similar manner, generalizability 
can also be limited when studies only include a sample drawn from a very specific 
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population, like those who are incarcerated or connected to the criminal justice system 
(Brocato & Wagner, 2008; Lang & Belenko, 2000) or involve clients who are privately 
insured or can self-pay for treatment (White et al., 1998). Because a large proportion of 
substance abusers are incarcerated or come under the supervision of the courts research 
efforts are often focused on incarcerated populations and may exclude participation of 
those substance abusers not incarcerated (Duval & Salmon, 2004). The authors indicate 
that “given the high rates of criminal justice involvement among addicted persons, it may 
be that there are not sufficient available subjects outside of the criminal justice system to 
meet the needs of a particular research trial or program” (p. 994). Researchers also have 
difficultly generalizing from samples that over-represent specific populations relative to 
the general population, like women and employed clients (Ross et al., 1997), clients with 
high problem severity (Meier et al., 2006), or ethnic minorities (Brocato & Wagner, 
2008). The nonrandom sampling of participants was a limitation associated with a 
number of studies also (Brocato & Wagner, 2008; Hser et al., 2003; McLellan, 1994; 
Ross et al., 1997). 
 Treatment programs and their clientele. Due to the aforementioned sampling 
biases, observed patterns of the participants of substance abuse treatment research cannot 
always generalize to any treatment program or group of individuals who abuse 
substances. Different treatment programs will attract different types of clients and the 
characteristics associated with those clients and their retention rates may be distinct. For 
example, a female addicted to cocaine with a co-morbid diagnosis of depression may 
have different treatment needs and demonstrate different correlates and predictors of 
retention than a male addicted to alcohol with no combined disorder. Moreover, different 
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treatment programs employ different treatment approaches and offer different types of 
services (Simpson et al., 1997). For instance, it has been found that residential and 
intensive outpatient programs tend to incorporate problem-solving techniques in 
treatment delivery services, while methadone treatment tends to integrate case 
management techniques. Furthermore, residential programs have been found to 
incorporate milieu therapy and 12-step strategies where outpatient programs coupled 12-
step approaches with cognitive-behavioral techniques (Etheridge et al., 1997).  
Related, the effectiveness of distinct treatment programs vary, which can have a 
direct impact on how long clients are willing to remain in treatment and make stable 
behavioral changes. Consequently, the correlative and predictive relationships associated 
with treatment retention may be site-specific and the generalizability of such results 
should be interpreted with caution (Broome et al., 1999; White et al., 1998), especially 
when studies included multi-site treatment centers that were not randomly selected (Hser 
et al., 2004; McLellan, 1994; Meier et al., 2006). Single site studies also have limitations 
associated with the generalizability. For example, one study included a hospital that 
incorporated the Minnesota model of treatment. These results may not be generalized to 
programs that incorporate different treatment approaches and serve different populations 
(Veach et al., 2000). 
Client populations also vary depending on the site and locations, which can 
negatively influence external validity. Even if specific client populations are not excluded 
from participating, the characteristics of individuals engaged in different treatment 
programs will likely vary. For example, studies that draw participants from a HMO may 
differ from non-HMO populations (Green et al., 2002), or those that conduct research in 
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programs that typically involve participants that are insured may not share the same 
characteristics of those uninsured. In summary, although a number of potential correlates 
and predictors of retention have been suggested “there is little agreement on the 
generalizability of the findings” (Sayre et al., 2002, p. 56) due to the variability across 
clientele and programs. 
Methodological Quality Improvements 
As indicated, there are a variety of limitations associated with the cited body of 
literature. It should be noted, however, that the movement toward more methodologically 
sound investigations has not just been called for, but appears to be taking place. Moyer et 
al. (2002) investigated the methodological quality of alcohol treatment studies conducted 
from 1970-1998. They reviewed a total of 701 studies and focused on four specific 
domains of “methodological rigor”: (1) sampling procedure and description of 
participants; (2) specification and provision of treatment; (3) outcome assessments and 
follow-up procedures; and (4) accuracy of estimates of treatment effects (p. 255). 
Overall, the “methodological quality” score was 9.5 out of 28.5 and was found to 
improve over time (e.g., average score of 8.2 in the 70s to 10.6 during the 90s). The 
authors noted that generally study strengths included reporting the number of participants 
and the utilization of follow-ups of 12 or more months. Weaknesses included lack of 
provider training, the use of manualized treatment, and not ensuring that participants 
were drug and/or alcohol free during follow-up sessions. One of the most significant 
changes over time included the utilization of diagnostic tools to assess for severity of 
alcohol problems. The authors suggest that future research efforts should include 
reporting reliability and validity associated with measures used, examining phenomenon 
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that may underlie treatment effects, ensuring sobriety when collecting follow-ups, and 
testing for differences associated with drop-out in different treatment groups. 
Bridging the Gap between Clinical Research and Clinical Practice 
Historically, clinical research and clinical practice remained quite distinct; as 
cited by Carroll and Rounsaville (2003), this gap has been especially apparent in drug 
abuse treatment. According to Carroll (1997), “although the ultimate purpose of clinical 
treatment research is to improve clinical practice, these two fields have, unfortunately, 
developed along separate lines” (p. 357); and the stressed importance of linking research 
and practice has grown tremendously. The high cost associated with health care for both 
drug and alcohol dependent individuals reinforces a need to demonstrate that treatment of 
these populations can indeed be cost-effective and help decrease some of the associated 
expenses (Booth, Blow, Cook, Bunn, & Fortney, 1997). Key stakeholders from treatment 
centers and managed care systems are increasingly making demands for treatment 
programs to prove effectiveness. This increased pressure provides ideal opportunities to 
help connect science and practice. Still, narrowing the gap between research and practice 
is not always easy. Drug treatment continues to be offered most often through 
community-based organizations and the clinicians practicing within the organizations 
often have difficulty incorporating research findings into their treatment delivery 
approaches. Typically, this is a consequence of the complexity associated with 
understanding the research results or knowing how to translate the findings into 
evidenced based clinical practice (Polcin, 2004; Van den Ende, et al., 2007). 
Furthermore, studies in the field are often conducted with treatment programs that 
are very specific in terms of types of clients they attract and serve (i.e., the insured, 
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homeless etc.) and hence may not be as generalizable to other public programs (Weisner 
et al., 2001). Indeed, clinicians have been found to question the applicability of research 
results due to “differences between research and treatment settings, including staffing and 
other resources, selection criteria for the subject populations treated (e.g., problem 
severity; volunteers versus non-volunteers) and other characteristics and artifacts that 
affect outcomes in studies of treatment effectiveness” (Gottheil, Thornton & Weinstein, 
1997, p. 63). As such, the utility of clinical research is not typically realized in clinical 
practice. One of the more significant obstacles in translating research into the clinical 
realm is that articles often remain in peer-reviewed journals, which sit on book shelves. 
This significantly inhibits a clinician’s ability to tease out components of research to 
assist with delivering evidenced-based practices (Clay, 2006). 
Another factor directly related to conducting in-house treatment evaluations is 
that retention is clearly linked to client attributes that are amenable to change through the 
therapeutic relationship (e.g., problem severity, motivation). This means that treatment 
programs would be better equipped to evaluate the characteristics of clients entering their 
programs and in turn tweak treatment interventions to more adequately serve such 
populations whereby improving retention rates. There has also been a call for additional 
research to be conducted in the area of treatment retention (Simpson, 2004). “In addition 
to replicating previous findings concerning treatment retention, more work is needed to 
address these effects in terms of treatment compliance and related process indicators for 
different therapeutic settings and types of clients” (Simpson et al., 1997, p. 294). The 
researchers involved with the large-scale multi-site drug treatment evaluations (i.e., 
DARP, TOPS, DATOS) also echo the need for smaller scale investigations to be 
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conducted in single treatment settings. Important variations in treatment philosophies and 
clientele across modalities need to be considered and investigated. This type of 
investigation has been especially recommended to take place in outpatient treatment 
programs due to the vast variability typically seen in both “the range of drug users they 
treat and the philosophies that guide them” (Simpson et al., 1997, p. 291). The 
importance of incorporating research within specific treatment settings has been 
encouraged on a larger scale as well. A push to create increased partnerships between 
researchers and clinicians in the area of substance abuse treatment has been promoted by 
The Substance Abuse and Mental Health Services Administration (SAMHSA) and the 
National Institute on Drug Abuse (NIDA) through major initiatives (Polcin, 2004).  
As such, research should be informing treatment and likewise, treatment should 
drive and inform future research. Consequently, it is extremely important and prudent for 
treatment programs to evaluate their own treatment approaches, retention issues and 
outcomes. Theoretically, by incorporating substance use treatment evaluations within 
treatment programs research and clinical staff can work collaboratively one informing the 
other. A close collaboration between clinical treatment providers and clinical researchers 
can lead “to a situation in which the treatment staff and research team often grow in the 
understanding of an appreciation for each member’s collaborative role and importance in 
reaching common goals” (Simpson, 1993, p. 123). In turn, research results can be used to 
inform treatment staff of the specific characteristics and predictive elements related to 
their retention/outcome rates whereby allowing for a process where at-risk clients can be 
screened up front and treatment approaches can then be tailored to address their specific 
needs (McKellar, Harris, & Moos, 2006). By doing so, treatment centers would stand to 
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decrease their up-front intake costs, improve their retention rates and outcomes, while at 
the same time providing the much needed documentation of their treatment effectiveness. 
It is important therefore, to conduct treatment research within the setting in which 
treatment is actually taking place. This is especially the case considering the retention 
literature has demonstrated inconsistent findings due to the variety of populations and 
treatment centers evaluated. An additional advantage to conducting research on-site is 
that client populations, in terms of their patterns and severity of use, is constantly in flux 
which calls for consistent evaluation of treatment outcomes to help identify important 
correlations of treatment drop-outs from specific programs (Mammo & Weinbaum, 
1993).  
A Model for Treatment Processes and Outcomes 
On-site treatment evaluations are one method to bridge the gap between clinical 
research and clinical practice. Although on-site investigations are not typically rigorously 
controlled designs, it has been cautioned that RCTs should not be the only legitimate 
method investigating the usefulness of treatment (Tucker & Roth, 2006), because a 
limitation of this design includes controlling factors that are actually very difficult to 
control, like interpersonal interactions (Simpson, 2004). Furthermore, because it is well 
established that substance abuse treatment can significantly decrease substance use, 
provided clients are retained to receive it (Gerstein & Harwood, 1990, as cited in 
Simpson and Joe, 2004; Gossop et al., 2003; Hubbard, Craddock, Flynn, Anderson, & 
Etheridge, 1997; Hubbard et al., 1989), research questions have shifted from focusing 
only on treatment outcomes, to investigating the components of the treatment process 
itself. Results of DATOS suggest that different types of clients are tapping into different 
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treatment programs and in turn, those programs offer various types of treatment 
approaches (Leshner, 1997). Those important program level factors and client 
characteristics (not limited to demographic factors) have not been investigated 
comprehensively. To address this gap in the research, Dwayne Simpson (2004) produced 
a seminal work, creating a model “framework for drug treatment process and outcomes”. 
Employing such a model not only addresses the call to comprehensively investigate 
components of the treatment process, but it also can better equip treatment programs to 
evaluate their current treatment regime. By doing so, the gap between research and 
practice will continue to narrow while providing treatment centers with the ability to 
demonstrate effective treatment approaches. 
Simpson notes that taking a more “systemic” view of treatment processes can help 
us better understand the numerous factors that contribute to treatment retention and 
outcome within the specific system in which it is found. For example, as demonstrated in 
the literature, although agency factors (e.g., program characteristics, therapist skills, etc.) 
have a direct impact on treatment retention, so can larger social factors, including 
extended familial/employer support, social policies, and treatment availability, just to 
name a few. Viewing treatment this way allows one to conceive it as a larger change 
agent than simply as isolated therapeutic interventions and specific behavior 
modifications. Simpson asserts that by altering this traditional view of treatment, 
researchers are better prepared to consider other factors that are likely related to treatment 
retention and outcomes, which include, but are not limited to the following: (1) patient 
motivation or readiness for treatment at time of engagement, (2) the therapeutic alliance 
formed between therapist and patient, (3) client alterations that take place during 
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treatment, including both cognitive and behavioral changes (4) length of time spent in 
treatment, (5) the impact of the agency’s organizational factors, and (6) examining 
treatment while in progress including soliciting client feedback. 
Taking a systemic approach to more fully understand treatment processes and 
outcomes provides helpful data about not only what takes place during different points of 
the treatment process, but also how agency policies and client characteristics directly 
impact the course of treatment. Therefore, this information can assist in the process of 
developing therapies for different settings and populations as well as provide evidence for 
when and with whom varying types of therapeutic interventions may be most useful. As 
such, Simpson stresses the importance of taking a services approach (i.e., a method to 
link treatment delivery and evaluation) to drug treatment evaluation, and not simply 
relying on clinical trials methods/data since so many client-therapist dynamics and 
therapeutic factors simply cannot be controlled for (Simpson, 1993; Simpson, 2004). He 
asserts, “it is longitudinal effectiveness studies, as opposed to highly restricted efficacy 
designs, that emphasize external validity and the interactions of clinical protocol with 
patient dynamics in natural setting. Furthermore, providers of behavioral health services 
and policymakers need evidence based on real-world applications of treatment in field 
studies” (Simpson, 2004, p. 101). Conducting evaluations within treatment settings 
allows for greater impact in the recovery process, the opportunity to test cutting edge 
techniques, create change within the agency’s infrastructure over time, and influence key 
stake holders who make decisions regarding funding for treatment programs (Simpson, 
2001). 
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 Simpson goes on to note that although the progress of client change related to 
substance abuse has been demonstrated to happen in stages or steps (DiClemente, 
Bellino, & Neavins, 1999), a model for evaluating drug treatment outcomes involves 
more than just specific client change. Regardless of the associated challenge, he believes 
a treatment model should also inform treatment providers on what the most useful 
interventions are during various points of the change process. He therefore created the 
Texas Christian University (TCU) Treatment Model, which includes the following 
purposes: (1) allow for patient progress/monitoring to evaluate effectiveness and inform 
treatment planning/adjustments, (2) utilize a stage of change model whereby indicating 
when certain interventions would provide the most effective results, (3) utilize patient 
data (i.e., performance, engagement) to provide feedback to clients, direct service 
providers, and other agency staff to assist with program evaluation (Simpson, 2004).  
Although more complex, by including various factors, one can approach treatment 
evaluation  more holistically and in turn make appropriate changes at the treatment level 
to improve client retention and outcome. A significant increase in health care costs over 
the past twenty years was addressed through the implementation of a managed care 
system. The advent of this system brought about increased pressure for service providers 
to demonstrate evidenced based practice (Wampold, Licthenberg, & Waehler, 2002). As 
such, agencies could utilize the TCU model to strategically address the need for basic 
treatment evaluations. Simpson claims that the TCU model “focuses attention on 
sequential phases of the recovery process and how therapeutic interventions link together 
over time to help sustain engagement and retention” (Simpson, 2004, p. 102).  The model 
is illustrated below and a brief description of the components involved will follow. 
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Figure 1. The TCU Treatment Model, representing sequential influences of patient 
attributes, stages of treatment, and evidence-based interventions on post-treatment 
outcomes.  
1 From “A Conceptual Framework for Drug Treatment Process and Outcomes,” by D. D. Simpson, 2004, Journal of Substance Abuse 
Treatment, 27, p. 103.
 
Treatment Induction: Patient and Program Attributes 
 Patient attributes at intake include those client characteristics that are thought to 
impact the treatment process. These features include client readiness or motivation for 
change, the degree of severity of the problems experienced upon engagement, appropriate 
treatment intensity matching, and self-efficacy. Related to the “motivational 
interviewing” work by Miller and Rollnick (2002), and DiClemente’s (2003) work on 
client stages of change, Simpson (2004) asserts that treatment readiness and motivation 
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for change remains the most important client factor. A more thorough description of 
research findings linking client motivation and treatment retention were previously cited 
and will not be repeated in this section. Instead, a brief summary of how client motivation 
is thought to impact the treatment process is found below. 
For example, Joe, Simpson, and Broome (1998) found that clients’ level of 
motivation at treatment onset was significantly associated with retention in methadone 
maintenance programs, intensive outpatient drug free programs, and long-term residential 
care. Treatment readiness was also significantly positively associated with early 
treatment engagement. The authors found that these specific client attributes were more 
robust predictors of client engagement and retention than demographic/background 
variables and severity of drug use. Many other studies have also demonstrated that level 
of motivation is positively related to client retention and engagement (Broome et al., 
1999; Simpson & Joe, 2004; Joe et al., 1999; Simpson et al., 1997; Simpson et al., 1997; 
Simpson, Joe, Rowan-Szal & Greener, 1995) and that readiness to change can also be 
predictive of treatment outcomes (Demmel, Beck, Richter & Reker, 2004). This is likely 
due to the fact that most treatment programs are designed to serve clients who are already 
in the “active” stage of change, as opposed to those who are still contemplating altering 
their drug or alcohol use (Di Clemente et al., 1999). 
Despite the importance of motivational factors, problem severity is also a 
component of client characteristics and includes both the pretreatment intensity of 
drug/alcohol problems as well as psychiatric disturbance/distress. Increased levels of 
severity related to frequency and intensity of drug use, as well as psychiatric distress, 
have been found to require more intense therapeutic interventions and often result in a 
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lack of early engagement and treatment retention (Woody et al., 1984, as cited in 
Simpson, 2004). For example, increased intensity of drug use just prior to treatment 
engagement has been statistically significantly related to premature drop-out (Alterman, 
McKay, Mulvaney, & McLellan, 1996) and increased problem severity at treatment 
engagement for women has also been associated with decreased retention (Arfken, Klein, 
di Menza, & Schuster, 2001).  
Outside of client factors, there are also agency and program characteristics that 
play a role in treatment engagement and retention. These features include the agency’s 
resources, treatment philosophies, and atmosphere/surroundings. There are thousands of 
treatment programs in the US and they vary both in the type of clients they attract (i.e., 
substance use severity) and the orientation of treatment they provide. Furthermore, no 
one treatment method is likely to be effective with every client (Chou, Hser, & Anglin, 
1998). Indeed, research has suggested that less accurate treatment matching in terms of 
level of treatment (i.e., matching high symptom severity clients with low intensity 
treatment) leads to less favorable one year outcomes (Chen, Barnett, Sempel & Timko, 
2006).  
Because programs have been found to be quite distinct in terms of the type of 
treatment matching, service offerings, personnel differences and therapeutic techniques 
they provide, different programs will have varying levels of engagement and retention 
(Simpson, 2004). Regardless of these differences, Simpson notes that even when similar 
treatments are delivered and differences in client characteristics are controlled for, 
program retention rates have been found to differ (Broome et al., 1999; Joe et al., 1998). 
As such, it appears that program characteristics are likely related to their ability to engage 
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and retain clients. This includes how well a program is able to match the level treatment 
needed (e.g., intensive inpatient) based upon the degree of severity demonstrated by the 
client and how well they are able to deliver the treatment interventions.  
Although agency characteristics (e.g., program features, staff characteristics) are 
thought to play a significant role in treatment engagement and retention, very little 
empirical research has directly studied this phenomenon (Ball et al., 2006). Negative 
perceptions of and interactions with treatment staff has been found to be related to 
premature drop-out. For example, experiencing interpersonal problems with staff 
members, feeling judged and not valued by staff, viewing staff as incompetent or 
insensitive, and lack of trust in staff appears to be related to decreased retention (Ball et 
al., 2006; Battjes, Onken, & Delany, 1999).  
Early Engagement 
Simpson asserts that a client’s early engagement in treatment is the first 
progression towards recovery. Because a review of engagement literature can be found in 
earlier text, only a brief review of how early engagement is specifically related to 
Simpson’s model will follow. Engagement involves two primary components including 
the degree to which a client participates in treatment activities and forms relationships 
with treatment staff (Simpson & Joe, 2004). Joe et al. (1999) indicate that engagement is 
more than simply attending treatment sessions. They explain, “clinically, it refers to the 
degree to which a patient actively participates in the treatment process. This active 
participation suggests both an objective aspect representing patient compliance and 
session content, and a subjective aspect that reflects cognitive involvement and 
satisfaction with the process” (p. 113). Without early engagement client retention is not 
226 
 
likely to take place (Simpson, 2001). Simpson notes that client motivation is directly 
related to early engagement. Clients who are motivated for treatment are much more 
likely to demonstrate regular participation early on in treatment and in turn, those clients 
who are more actively engaged in treatment are more likely to develop a positive 
relationship with treatment staff. 
Participating in treatment has been found to be linked to client retention. For 
example, a higher degree of treatment readiness, as measured by program participation 
(Joe et al., 1998; Joe et al., 1999; Simpson et al., 1995), and level of motivation at intake 
(Joe et al., 1999) has been significantly positively associated with and predictive of early 
therapeutic engagement/involvement. Higher levels of treatment readiness have also been 
identified as one of the strongest predictors of overall client engagement and retention 
(Joe et al., 1998). Because those clients who regularly participate in early treatment are 
more likely to develop a therapeutic relationship with treatment staff, the therapeutic 
alliance is also related to a client’s ability to engage and remain in treatment. Negative 
interactions with treatment staff, including feeling judged, and a lack of trust in treatment 
staff has been linked to premature drop-out (Ball et al., 2006; Battjes et al., 1999). 
Conversely, when clients report positive early therapeutic involvement (including 
therapeutic rapport with counselor and confidence in treatment) treatment retention 
improves (Joe et al., 1999). Additionally, more favorable outcomes of drug treatment 
have also been positively related with counselor ratings of the degree of their rapport with 
clients even when treatment retention is controlled for (Joe, Simpson, Danseruad & 
Rowan-Szal, 2001). 
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Early Recovery 
The subsequent component in Simpson’s model (2004) includes early recovery, 
which is demonstrated by specific behavioral changes and inter/intrapersonal shifts. As 
Simpson explains, clients often first experience new ways of thinking about their drug 
use and subsequently changes in behavior result. Positive changes in psychological 
functioning (e.g., including decreasing distress) often lead to more positive behavior 
changes (e.g., decreased drug use), which in turn reinforces retention in treatment. 
Essentially, this phase grows out of the first stage of engagement and helps to foster 
recovery and sustain participation (i.e., retention). If client motivation and strong 
therapeutic alliance is maintained in this stage this also assists with continued treatment 
engagement. During this stage treatment should focus on developing coping skills, 
preventing relapse in an attempt to assist the client in developing new ways to think and 
behave regarding their drug use, and fostering social and family support to reinforce 
client changes. As Simpson states, “The core objective of these interventions, of course, 
is to build social skills that link to support systems” (Simpson, 2004, p. 109). 
Retention and Transition 
Retention and transition comprises the fourth component of Simpson’s model. 
The primary goal of this phase includes retaining clients beyond the minimum thresholds 
(i.e., 90 days for outpatient and residential treatment) (Simpson & Joe, 2004), in an effort 
to assist with the transition from treatment while helping to sustain the positive behavior 
changes. This goal subsumes that for lasting behavior change to take place it must be 
practiced and reinforced consistently until it becomes part of one’s preferred lifestyle. By 
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doing so treatment programs can continue to provide on-going support regarding problem 
solving to further prevent relapse (Simpson, 2004). 
Community Wrap-Around and Transitional Services 
In order for successful transition to take place clients require ongoing support in 
the community. Simpson reports that these services often take the form of either wrap-
around services or “re-entry” services. Wrap-around services often include 
educational/vocational assistance, child care, housing, help with utility services, 
transportation, and assistance with legal problems (Pringle et al., 2002). These types of 
services may be especially important when it comes to maintaining clients in treatment. 
Clients who are not offered ancillary services feel that all their identified needs (while in 
treatment) are not adequately addressed through treatment alone (Hser, Polinsky, 
Maglione & Anglin, 1999).  When clients receive wrap-around services treatment 
retention and outcomes have been shown to improve. Educational, medical, or mental 
health services were positively associated with treatment retention and assistance with 
basic needs or educational services was positively associated with more favorable 
treatment outcomes. When ancillary services, including childcare, transportation and job 
training, are appropriately assigned and/or offered to clients who identify a need for such 
services, it has been found to significantly predict longer retention rates and improve 
treatment outcomes (Hser, et al., 1999).  
These findings suggest that by attending to clients’ needs outside of the 
therapeutic milieu itself, these clients may in turn be better equipped to remain focused 
on their treatment and therefore stay in treatment for a longer period (Pringle et al., 
2002). Despite the increased need for and importance of such services, results of the 
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DATOS investigation suggested that ancillary services are not being offered or provided 
as often as in the past (Leshner, 1997). The reduced availability of wrap-around services 
is likely due to budget cuts and decreased funding available to treatment centers. 
Unfortunately, research on the benefits associated with providing ancillary services 
suggests that the lack of such benefits could negatively impact treatment retention and 
outcomes (Hser et al., 1999). 
Transitional services assist clients in the “stepping down” of treatment intensity 
and often involve 12-step programs, which aim to offer additional community support in 
recovery. Although Simpson described how formal re-entry services can impact recovery, 
informal social support can also impact how well a client is able to transition out of 
treatment. Research has demonstrated that social support plays a role in post-treatment 
recovery, specifically when treatment was short-term and did not maintain clients past the 
critical thresholds. Broome, Simpson and Joe (2002) reported that social support was one 
of the most consistent correlates with post-treatment drug use. More specifically, clients 
who maintained contact with peers who were using, or who lived with someone who did 
not support their abstinence by using themselves, were at least 2 ½ times more likely to 
use alcohol or cocaine during the year following treatment. Additionally, when clients 
engaged in treatment for alcohol dependence were offered higher levels of support in 
terms of reassurance of their worth from family and friends, there was longer period of 
time before being re-admitted for treatment (Booth, Russell, Soucek & Laughlin, 1992). 
The authors conclude that these results suggest that support can boost self-esteem and 
efficacy levels in alcohol dependent people perhaps improving their ability to remain 
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abstinent from alcohol use. Booth’s and colleagues study also further supports Simpson’s 
notion of how crucial support is in assisting clients in their recovery process. 
Simpson stresses the importance of implementing a drug evaluation treatment 
method which would include assessments that can measure “client-level progress and 
treatment satisfaction, as well as organizational factors related to program effectiveness 
and adaptability” (Simpson, 2004, p. 1). These assessment strategies are best suited to 
take place throughout the treatment process in an attempt to identify clients who are not 
improving and hence would have a greater chance of leaving treatment prematurely 
(Simpson, 2004). Because programs have been found to attract specific types of clients, 
and the service delivery methods vary from program to program, it behooves programs to 
conduct their own research on their own populations. By doing so they will be much 
better equipped to adjust treatment methods/interventions to better serve their populations 
and improve outcomes. Furthermore, by conducting on-site treatment evaluations, centers 
will be able to monitor changes in their own client populations (i.e., patterns of drug use, 
demographics) which could potentially signal a need to adopt new or different clinical 
interventions to meet client needs (Simpson, 2004). Improving treatment outcomes is not 
only better for the clients involved but for the agency as well. Until programs have a 
clearer understanding of the types of clients they have difficulty retaining it is more 
difficult to adequately address client needs. It appears especially important for treatment 
centers to conduct their own research due to the “large program variations in overall 
client engagement and retention levels” (Simpson, 2004, p. 4). 
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Conclusion 
Substance abuse is a chronic condition that negatively impacts individuals, 
family, and society. Substance abuse treatment has been investigated for many years. As 
treatment options grew in the 1970s studies were launched to determine if treatment was 
effective. Over 30 years of investigations have firmly established that substance abuse 
treatment is effective in improving client functioning and decreasing their substance use 
(Gossop et al., 1997; Gossop, Marsden, Stewart, & Kidd, 2003; Hubbard et al., 1997; 
Hubbard et al., 1989; Longabaugh et al., 2005; Pearson & Lipton, 1999). Although 
empirically it has been shown to be the most effective means to reduce substance use, 
many people drop out of treatment before reaping the associated benefits (Justus et al., 
2006; Sayre et al., 2002; Siqueland et al., 2002). As a result, the focus of many research 
efforts has been to gain a deeper understanding of the treatment phenomena related to 
drop-out, which has helped to continue building our theoretical base and applied 
knowledge in the field. In has been demonstrated that retention in substance abuse 
treatment has bearings of positive effects on individuals in the process of their recovery. 
Time in treatment has consistently been found to be positively associated with treatment 
outcomes including decreasing the amount and frequency of substance use and criminal 
behavior (Simpson, 2004). The 90 day retention threshold identified by Simpson and 
Sells (1982) has been replicated in other studies and yet ironically, it is precisely time 
spent in treatment that has been hit the hardest by managed care. If decreasing funding 
for time spent in treatment continues to take place, it may be prudent for future research 
to focus efforts on examining how to maximize treatment benefits during shorter 
durations.  
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Since length of stay has been implicated as a critical variable regarding treatment 
outcomes, client retention has become a very important factor to investigate. Early 
research efforts tended to focus only on client characteristics related to retention. Inherent 
within this client-only focus was an assumption that if clients prematurely dropped out of 
treatment it was due to the unredeemable qualities of being a substance abuser rather than 
treatment factors also playing a role (Fiorentine et al., 1999). The field now recognizes 
there is likely a dynamic interplay between both client and program factors that impact 
client retention, although this remains an understudied area (Simpson, 2001). It is also 
important to note that continuing to investigate client factors related to retention remains 
an important focus for future study since many client factors (i.e. psychiatric distress, 
motivation, subjective distress, self-efficacy to abstain) are amenable to change in the 
therapeutic environment. Furthermore, even client factors found to be associated with 
retention that are static (i.e. gender, ethnicity) are also important to understand more 
fully. For example, if females are found to drop out of treatment more often than their 
male counterparts treatment centers could attempt to gain a deeper understanding of why 
and attempt to incorporate programmatic changes that could positively alter this dynamic 
(i.e. provide child care during treatment regimens if it is found that lack of child care is a 
barrier to treatment).  
Despite there being a large body of literature focusing on varied correlates and 
predictors of treatment retention, these studies have produced conflicting findings, hence, 
it remains difficult to draw sweeping conclusions about any consistent predictors of 
treatment retention. For example, a review of earlier research investigating the 
relationship between ethnicity and retention unveiled conflicting results with studies 
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finding higher, lower, and no difference in rates of drop-out for African American clients 
compared to that of Whites and other ethnic minorities (Stark, 1992). Questions 
concerning the reliability of the findings potentially stem from inconsistencies in 
operationally defining retention and the lack of standardized assessments employed in the 
evaluation process (Rounsaville, 1993, as cited in Broome et al., 1999). Compounding 
these issues is the variability of the treatment approaches employed at various centers and 
the types of clients they attract. Even when similar treatments are delivered and 
differences in client characteristics are controlled for, retention rates have been found to 
differ between programs (Broome et al., 1999; Joe et al., 1998). As such, it appears that 
various program characteristics are likely related to their ability to engage and retain 
clients. This includes issues like how well a program is able to match the level of 
treatment needed (e.g., intensive inpatient) based upon the degree of severity 
demonstrated by the client and how well they are able to deliver their adopted treatment 
interventions. Although both client and program factors have been found to be related to 
retention, how these factors interact to impact retention is not well understood. 
Additionally, although a wide variety of factors have been implicated as potentially 
impacting retention, these have not been investigated comprehensively and more 
accurately identifying the factors remains an ongoing research challenge (Simpson, 
2004). Substance abuse treatment centers are in an ideal position to contribute to this 
charge to more comprehensively examine client and program variables by conducting the 
evaluations.  
Treatment programs could benefit greatly from conducting treatment evaluations 
on-site for a variety of reasons. First, although naturalistic designs tend to have greater 
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generalizability to real client populations, this can also be comprised by wide variations 
from program to program as indicated above. If programs conduct in-house evaluations 
they can utilize the findings to better understand the treatment phenomenon taking place 
within their program and among their clientele. The results could be utilized to develop 
screens in an effort to identify at-risk clients up front and programmatic changes could 
then be made in an attempt to better serve and improve retention rates (and hopefully 
outcomes) of their clients.  Second, on a larger scale, the findings can also contribute to 
the scientific literature base to help gain clarification with the inconsistencies identified. 
Third, treatment programs can join forces to help narrow the gap between research and 
practice that has existed in the substance abuse field for many years. Finally, treatment 
programs can demonstrate treatment effectiveness in a world where evidence based 
practice continues to be a critical component. 
The TCU model for treatment evaluations is one viable method for conducting in-
house investigations that allows treatment processes to be conceptualized within a larger, 
more complex, systemic perspective (Simpson, 2004). By incorporating a more complex 
conceptualization of treatment, and evaluating the processes as they are taking place real-
time, with real-clients, researchers and treatment staff stand to gain a deeper 
understanding of treatment phenomenon while also having the opportunity to intervene at 
the treatment level. Part of the beauty in such an approach includes the synergistic 
interaction that can then take place between two historically relatively distinct disciplines 
of research and clinical practice. This in turn has the potential to create an ideal 
opportunity to significantly improve treatment regimens and outcomes for people 
struggling with addiction. 
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Appendix B 
 
Marquette University Agreement of Consent for Research Participants 
 
RESEARCH SUBJECT INFORMATION AND SUBJECT CONSENT FORM 
Rogers Memorial Hospital, West Allis, WI 
Marquette University, Milwaukee, WI 
 
TITLE:  Rogers Memorial Hospital Chemical Dependency Program 
Assessment Project, Phase 2 
SPONSOR: Rogers Memorial Hospital,  
Center for Addiction and Behavioral Health Research - Marquette 
University 
PRINCIPAL INVESTIGATOR: Todd C. Campbell, Ph.D., CADCIII, CCSII 
 
PURPOSE OF STUDY 
When I sign this statement, I am giving consent to the following basic considerations:I 
understand clearly that the purpose of this study is to evaluate the treatment processes and 
treatment outcomes for the Chemical Dependency Program at Rogers Memorial Hospital-West 
Allis. I understand that all patients admitted into the Chemical Dependency Program are required 
to participate in the standard clinical intake procedure and that the information obtained is kept in 
my medical record. The information in the medical record is utilized by the treatment staff and 
subject to state and federal regulations regarding confidentiality.  I understand the standard 
clinical intake Session will last approximately 2 to 4 hours. I understand that I may be asked to 
complete several questionnaires about my age, education level, my alcohol and other drug use 
history, health history, mental health history, and perceptions regarding treatment. I understand 
that I will be contacted when I am discharged from the Chemical Dependency program and by 
telephone or mail at one-month, 3 months, 6 months, and 12 months post-discharge to complete 
an interview assessment regarding my drug and alcohol use and progress in my recovery. I 
understand that these follow-up interviews/assessments will last approximately 30 minutes. I also 
understand that this study is ongoing and there will be approximately 208 participants in this 
study during any given year. 
AUDIOTAPING 
Session I and Session II may be audiotaped. The audiotapes will be used to supervise the 
research assistants who are conducting the sessions. The research assistants will be 
supervised by the primary investigator, Todd C. Campbell, Ph.D. All audiotapes will be 
erased utilizing a large magnet designed to fully erase audiotapes after feedback has been 
provided by the primary investigator (a process which is expected to take approximately 
1-2 weeks following the sessions). The tapes will then be destroyed and thrown away. 
 
Participant Initials _________ 
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CONFIDENTIALITY 
I understand that there are two purposes for collecting the assessment information: 1. 
Clinical purposes to inform the treatment team regarding my treatment plan, and 2. 
Research purposes to assist in the evaluation of the program’s treatment processes and 
outcomes.  
 
I understand that for the clinical purposes the assessment information is contained in my 
medical record, is available to appropriate treatment staff, and is protected by all relevant 
state and federal regulations pertaining to medical records.   
 
I understand that for the research purposes of this research project, the data from the 
standard intake assessment will be copied and the copies will be placed in the research 
file. These copies will be de-identified (i.e., my name and other identifying information 
will be removed) and assigned an arbitrary code. I understand that if I choose to 
participate in this study that all information I reveal in this study will be kept confidential. 
Your name will not be publicly disclosed at any time, and the records will be strictly 
maintained according to current legal requirements. When the results of the study are 
published, I will not be identified by name.  I have been promised that any information 
obtained from this study that can be identified with me will remain confidential. 
However, I am in agreement that scientific data not identifiable with me resulting from 
the study may be presented at meetings and published so that the information can be 
useful to others. No references to individual participants, or any identifying information 
will be released to anyone other than the investigative professionals at Rogers Memorial 
Hospital or Marquette University without my express written consent, unless required by 
law.   I understand that once the data is no longer of use it will be destroyed and will be 
held no longer than 7 years. 
 
This applies to the audiotapes of treatment sessions as well as to any written records 
obtained. Only authorized study personnel will have access to the session audiotapes and 
records. This protection, however, is not absolute.  It does not, for example, apply to any 
state requirement to report certain communicable diseases.  In addition, the investigators 
will report certain cases of child or elder abuse to appropriate authorities.  Furthermore, if 
you indicate that you are in imminent danger of hurting yourself or others, the 
investigators may need to reveal this in order to protect you or that person. However, it is 
the policy of these agencies and of the investigators that every attempt will be made to 
resist demands to release information that identifies you.  
 
RIGHT TO REFUSE OR WITHDRAW FROM THE STUDY 
Your participation in this study is voluntary. Thus, you may refuse to participate or 
withdraw at any time once the study has started.  I have been informed that my decision 
about whether or not to participate will not change my present or future relationship with 
Rogers Memorial Hospital or the staff of this institution; nor will it change the quantity or 
quality of care that is otherwise available to me. If I participate, I understand that I am 
free to withdraw at any time without prejudice, and that withdrawal would not in any way 
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affect the nature of the care or treatment otherwise available to me. Information collected 
on participants who choose to withdraw will remain in the study files. 
Participant Initials _________ 
The primary investigators have the right to stop your participation in the study at any 
time.  This could be because you have had an unexpected reaction, or have not followed 
instructions, or because the entire study has been stopped.  Regardless of whether you 
choose to withdraw or if your participation in the study is terminated, certain procedures 
must be followed in ending your participation in the study in order to protect your safety.  
You may be asked questions about any reactions you may have had with this project. 
 
PAYMENTS TO PARTICIPANTS 
There are no payments for participation in this study. Should you need further treatment 
for alcohol-related problems after leaving Rogers Memorial Hospital, you and your 
insurance provider will be responsible for such costs in the same way that you would if 
you did not participate in this study. 
RISKS 
I understand that there are no known risks associated with participation in this study. I 
also understand that the only benefit of my participation is to help improve scientific 
understanding of the intake assessment process, treatment processes, and treatment 
outcomes. I understand that participating in this study is completely voluntary and that I 
may stop participating in the study at any time without penalty or loss of benefits to 
which I am otherwise entitled. I am not involved in any agreement for this study, whether 
written or oral, which includes language that clears Marquette University or its 
representatives from liability for negligence, if any, which may arise in the conduct of the 
research project. 
NEW INFORMATION 
Participation in this study could have risks that we cannot anticipate.  If new information 
is found during the study that might influence your willingness to continue to participate, 
we will inform you as soon as possible 
OFFER TO ANSWER QUESTIONS AND CONTACTS FOR INFORMATION 
If you have any questions about the general nature of the study, you may contact Dr. 
Todd C. Campbell at (414) 288-5889 or Mr. Mickey Gabbert at (414) 327-3000.   
 
INSTITUTIONAL REVIEW BOARD REVIEW: 
This project has been reviewed by the Rogers Memorial Hospital Human Subjects 
Committee and the Marquette University Institutional Review Board for the Protection of 
Human Subjects.  All my questions about this study have been answered to my 
satisfaction. I understand that if I later have additional questions concerning this project, I 
can contact Todd C. Campbell. If you believe that there is any infringement upon your 
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rights or if you have any questions about your rights as a research subject, you may 
contact the Rogers Memorial Hospital Human Subjects Committee at (414) 327-3000 
and/or you may contact Marquette University's Office of Research Compliance at 414-
288-1479.  
Participant Initials _________ 
I, ________________________________________, have read the information provided 
above.  I voluntarily agree to participate in this study.  My signature also indicates that I 
have been given a copy of this documented informed consent, and may request an 
additional copy at any time.  I know that this research has been reviewed by the Rogers 
Memorial Hospital Human Subjects Committee and the Marquette University 
Institutional Review Board for the Protection of Human Subjects and has been found to 
meet the federal, state, and the Rogers Memorial Hospital Human Subjects Committee 
and the Marquette University Institutional Review Board for the Protection of Human 
Subjects guidelines for the protection of human subjects.  Finally, I understand that if the 
principal investigator decides it is wise to limit or terminate my participation in the study, 
he can do so without my consent. 
I agree to have my intake session(s) audiotaped, as described above: 
 
____________________________________________     ______________________  
Signature of Subject or Authorized Representative                Date  
  
____________________________________________     ______________________  
Signature of Witness                                                               Date  
 
I have defined and fully explained the study as described herein to the subject.  
TYPE OR PRINT:    
___________________________________________________________  
Name of Principal Investigator or Authorized Representative  
 
TYPE OR PRINT:  
___________________________________________  
Position Title   
____________________________________________     ______________________  
Signature       Date  
Participant Initials _________ 
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Appendix C 
 
Personal Feedback Report for: 
Date Completed: 
Client Perception of Problem/Need for Treatment 
 
 
Legend: 
A= Perceived Problems, B= Desire for Treatment 
0=Not all, 1=Slightly, 2=Moderately, 3=Considerably, 4=Extremely 
 
Interview Severity Ratings 
 
Medical Employ Alcohol Drug Legal Family Psych 
9 9 9 9 9 9 9 
8 8 8 8 8 8 8 
7 7 7 7 7 7 7 
6 6 6 6 6 6 6 
5 5 5 5 5 5 5 
4 4 4 4 4 4 4 
3 3 3 3 3 3 3 
2 2 2 2 2 2 2 
1 1 1 1 1 1 1 
0 0 0 0 0 0 0 
 
Legend: 
0-1: No Real Problem, 2-3: Slight Problem, 4-5: Moderate Problem, 6-7: Considerable Problem, 8-9: 
Extreme Problem 
 
Treatment Problem List 
 
According to the ASI interview, the following are possible problem statements that could be addressed on 
the treatment care plan: 
 
Medical: 
Employment: 
Alcohol/Drug: 
Legal: 
Family/Social: 
Psychiatric: 
 
Medica
l 
Employ Alcohol Drug Legal Family Social Psych 
 
A
 
B 
 
A 
 
B 
 
A 
 
B 
 
A 
 
B 
 
A 
 
B 
 
A B A 
 
B 
 
A 
 
B 
4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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Alcohol Use 
 
 
Other Drug Use 
 
Percentiles 
(US Adults) 
      
Your use 
(days) in 
last 90  
                       
        Tobacco/     Marijuana/ Stimulants/     Cocaine        Opiates       Other  
        Nicotine     Cannabis Amphetamines 
 
 
Preparation for Change 
 
Socrates Profile Very Low Low Medium High Very High 
Recognition _______ 7-26 27-30 31-33 34-35 N/A 
Ambivalence ______ 4-8 9-13 14-15 16-17 18-20 
Taking Steps ______ 8-25 26-30 31-33 34-36 37-40 
*Alcohol Use: 
 
 
 
 
 
 
 
 
Socrates Profile Very Low Low Medium High Very High 
Recognition _______ 7-26 27-30 31-33 34-35 N/A 
Ambivalence ______ 4-8 9-13 14-15 16-17 18-20 
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YOUR DRINKING 
 
Last 90 days: ____days abstinent ____days light drinking  ____days heavy drinking 
                                                              (1-4 standard drinks)         (5+ standard drinks) 
Typical week:   _______standard drinks 
Your drinking compared to American adults:  ______ percentile (same sex) 
Estimated blood alcohol concentration (BAC) level on heaviest drinking day:   
256 
 
Inventory of Drug Use Consequences Scores 
 
Physical 
Consequences 
Interpersonal 
Consequences 
Intra-personal 
Consequences 
Impulse 
Control 
Social 
Responsibility 
Total 
Score 
Control 
Scale* 
       
Out of 8 Out of 10 Out of 8 Out of 
12 
Out of 7 Out of 
45 
Out of 
5 
*This score is separate, and does not contribute to the Total InDUC score.  Scores on Control Scale items 
may indicate careless or dishonest responding. 
 
Alcohol Abstinence Efficacy Scale: Temptation to Drink 
 
Negative 
Affect Social/Positive Physical and Other Concerns Cravings and Urges Total 
     
0-Not at all 1-Not very 2-Moderately       3-Very       4-Extremely 
 
Alcohol Abstinence Efficacy Scale: Confidence in Ability to Abstain 
 
Negative 
Affect Social/Positive Physical and Other Concerns Cravings and Urges Total 
     
0-Not at all 1-Not very 2-Moderately 3-Very 4-Extremely 
 
 
 
Diagnostic Criteria (Mini International Neuropsychiatric Interview) 
 
DSM-IV-TR  Axis I: ___________________________________________________________ 
 
        ___________________________________________________________ 
 
         __________________________________________________________ 
 
 
Client Strengths 
1. 
 
 
2. 
 
 
3. 
 
 
Components of Interview or Results Processed with Client (i.e. percentiles, peak BAC etc): 
 
 
Overall Impression of Client: 
